original_value,curated_ontology,match_level,stage,top1_match,top1_score,top2_match,top2_score,top3_match,top3_score,top4_match,top4_score,top5_match,top5_score
Abiraterone,Abiraterone,1,1,Abiraterone,1.0,Abiraterone,1.0,Abiraterone,1.0,Abiraterone,1.0,Abiraterone,1.0
Adalimumab,Adalimumab,1,1,Adalimumab,1.0,Adalimumab,1.0,Adalimumab,1.0,Adalimumab,1.0,Adalimumab,1.0
Afatinib,Afatinib,1,1,Afatinib,1.0,Afatinib,1.0,Afatinib,1.0,Afatinib,1.0,Afatinib,1.0
Alisertib,Alisertib,1,1,Alisertib,1.0,Alisertib,1.0,Alisertib,1.0,Alisertib,1.0,Alisertib,1.0
Alpelisib,Alpelisib,1,1,Alpelisib,1.0,Alpelisib,1.0,Alpelisib,1.0,Alpelisib,1.0,Alpelisib,1.0
Anastomosis,Anastomosis,1,1,Anastomosis,1.0,Anastomosis,1.0,Anastomosis,1.0,Anastomosis,1.0,Anastomosis,1.0
Anterior Pelvic Exenteration,Anterior Pelvic Exenteration,1,1,Anterior Pelvic Exenteration,1.0,Anterior Pelvic Exenteration,1.0,Anterior Pelvic Exenteration,1.0,Anterior Pelvic Exenteration,1.0,Anterior Pelvic Exenteration,1.0
Arsenic Trioxide,Arsenic Trioxide,1,1,Arsenic Trioxide,1.0,Arsenic Trioxide,1.0,Arsenic Trioxide,1.0,Arsenic Trioxide,1.0,Arsenic Trioxide,1.0
Aspiration,Aspiration,1,1,Aspiration,1.0,Aspiration,1.0,Aspiration,1.0,Aspiration,1.0,Aspiration,1.0
Atezolizumab,Atezolizumab,1,1,Atezolizumab,1.0,Atezolizumab,1.0,Atezolizumab,1.0,Atezolizumab,1.0,Atezolizumab,1.0
Autopsy,Autopsy,1,1,Autopsy,1.0,Autopsy,1.0,Autopsy,1.0,Autopsy,1.0,Autopsy,1.0
Axitinib,Axitinib,1,1,Axitinib,1.0,Axitinib,1.0,Axitinib,1.0,Axitinib,1.0,Axitinib,1.0
Azacitidine,Azacitidine,1,1,Azacitidine,1.0,Azacitidine,1.0,Azacitidine,1.0,Azacitidine,1.0,Azacitidine,1.0
Azathioprine,Azathioprine,1,1,Azathioprine,1.0,Azathioprine,1.0,Azathioprine,1.0,Azathioprine,1.0,Azathioprine,1.0
Bevacizumab,Bevacizumab,1,1,Bevacizumab,1.0,Bevacizumab,1.0,Bevacizumab,1.0,Bevacizumab,1.0,Bevacizumab,1.0
Bicalutamide,Bicalutamide,1,1,Bicalutamide,1.0,Bicalutamide,1.0,Bicalutamide,1.0,Bicalutamide,1.0,Bicalutamide,1.0
Bilateral Mastectomy,Bilateral Mastectomy,1,1,Bilateral Mastectomy,1.0,Bilateral Mastectomy,1.0,Bilateral Mastectomy,1.0,Bilateral Mastectomy,1.0,Bilateral Mastectomy,1.0
Bilateral Salpingectomy,Bilateral Salpingectomy,1,1,Bilateral Salpingectomy,1.0,Bilateral Salpingectomy,1.0,Bilateral Salpingectomy,1.0,Bilateral Salpingectomy,1.0,Bilateral Salpingectomy,1.0
Biochemotherapy,Biochemotherapy,1,1,Biochemotherapy,1.0,Biochemotherapy,1.0,Biochemotherapy,1.0,Biochemotherapy,1.0,Biochemotherapy,1.0
Biopsy,Biopsy,1,1,Biopsy,1.0,Biopsy,1.0,Biopsy,1.0,Biopsy,1.0,Biopsy,1.0
Bleomycin,Bleomycin,1,1,Bleomycin,1.0,Bleomycin,1.0,Bleomycin,1.0,Bleomycin,1.0,Bleomycin,1.0
Bortezomib,Bortezomib,1,1,Bortezomib,1.0,Bortezomib,1.0,Bortezomib,1.0,Bortezomib,1.0,Bortezomib,1.0
Buparlisib,Buparlisib,1,1,Buparlisib,1.0,Buparlisib,1.0,Buparlisib,1.0,Buparlisib,1.0,Buparlisib,1.0
Busulfan,Busulfan,1,1,Busulfan,1.0,Busulfan,1.0,Busulfan,1.0,Busulfan,1.0,Busulfan,1.0
Cabazitaxel,Cabazitaxel,1,1,Cabazitaxel,1.0,Cabazitaxel,1.0,Cabazitaxel,1.0,Cabazitaxel,1.0,Cabazitaxel,1.0
Cabozantinib,Cabozantinib,1,1,Cabozantinib,1.0,Cabozantinib,1.0,Cabozantinib,1.0,Cabozantinib,1.0,Cabozantinib,1.0
Capecitabine,Capecitabine,1,1,Capecitabine,1.0,Capecitabine,1.0,Capecitabine,1.0,Capecitabine,1.0,Capecitabine,1.0
Carboplatin,Carboplatin,1,1,Carboplatin,1.0,Carboplatin,1.0,Carboplatin,1.0,Carboplatin,1.0,Carboplatin,1.0
Carmustine,Carmustine,1,1,Carmustine,1.0,Carmustine,1.0,Carmustine,1.0,Carmustine,1.0,Carmustine,1.0
Cediranib,Cediranib,1,1,Cediranib,1.0,Cediranib,1.0,Cediranib,1.0,Cediranib,1.0,Cediranib,1.0
Cetuximab,Cetuximab,1,1,Cetuximab,1.0,Cetuximab,1.0,Cetuximab,1.0,Cetuximab,1.0,Cetuximab,1.0
Cilengitide,Cilengitide,1,1,Cilengitide,1.0,Cilengitide,1.0,Cilengitide,1.0,Cilengitide,1.0,Cilengitide,1.0
Cisplatin,Cisplatin,1,1,Cisplatin,1.0,Cisplatin,1.0,Cisplatin,1.0,Cisplatin,1.0,Cisplatin,1.0
Cladribine,Cladribine,1,1,Cladribine,1.0,Cladribine,1.0,Cladribine,1.0,Cladribine,1.0,Cladribine,1.0
Clofarabine,Clofarabine,1,1,Clofarabine,1.0,Clofarabine,1.0,Clofarabine,1.0,Clofarabine,1.0,Clofarabine,1.0
Cobimetinib,Cobimetinib,1,1,Cobimetinib,1.0,Cobimetinib,1.0,Cobimetinib,1.0,Cobimetinib,1.0,Cobimetinib,1.0
Craniotomy,Craniotomy,1,1,Craniotomy,1.0,Craniotomy,1.0,Craniotomy,1.0,Craniotomy,1.0,Craniotomy,1.0
Crenolanib,Crenolanib,1,1,Crenolanib,1.0,Crenolanib,1.0,Crenolanib,1.0,Crenolanib,1.0,Crenolanib,1.0
Cyclophosphamide,Cyclophosphamide,1,1,Cyclophosphamide,1.0,Cyclophosphamide,1.0,Cyclophosphamide,1.0,Cyclophosphamide,1.0,Cyclophosphamide,1.0
Cystectomy,Cystectomy,1,1,Cystectomy,1.0,Cystectomy,1.0,Cystectomy,1.0,Cystectomy,1.0,Cystectomy,1.0
Cytarabine,Cytarabine,1,1,Cytarabine,1.0,Cytarabine,1.0,Cytarabine,1.0,Cytarabine,1.0,Cytarabine,1.0
Cytosine,Cytosine,1,1,Cytosine,1.0,Cytosine,1.0,Cytosine,1.0,Cytosine,1.0,Cytosine,1.0
Dabrafenib,Dabrafenib,1,1,Dabrafenib,1.0,Dabrafenib,1.0,Dabrafenib,1.0,Dabrafenib,1.0,Dabrafenib,1.0
Dacomitinib,Dacomitinib,1,1,Dacomitinib,1.0,Dacomitinib,1.0,Dacomitinib,1.0,Dacomitinib,1.0,Dacomitinib,1.0
Daratumumab,Daratumumab,1,1,Daratumumab,1.0,Daratumumab,1.0,Daratumumab,1.0,Daratumumab,1.0,Daratumumab,1.0
Dasatinib,Dasatinib,1,1,Dasatinib,1.0,Dasatinib,1.0,Dasatinib,1.0,Dasatinib,1.0,Dasatinib,1.0
Daunorubicin,Daunorubicin,1,1,Daunorubicin,1.0,Daunorubicin,1.0,Daunorubicin,1.0,Daunorubicin,1.0,Daunorubicin,1.0
Decitabine,Decitabine,1,1,Decitabine,1.0,Decitabine,1.0,Decitabine,1.0,Decitabine,1.0,Decitabine,1.0
Dexamethasone,Dexamethasone,1,1,Dexamethasone,1.0,Dexamethasone,1.0,Dexamethasone,1.0,Dexamethasone,1.0,Dexamethasone,1.0
Docetaxel,Docetaxel,1,1,Docetaxel,1.0,Docetaxel,1.0,Docetaxel,1.0,Docetaxel,1.0,Docetaxel,1.0
Donor Lymphocyte Infusion,Donor Lymphocyte Infusion,1,1,Donor Lymphocyte Infusion,1.0,Donor Lymphocyte Infusion,1.0,Donor Lymphocyte Infusion,1.0,Donor Lymphocyte Infusion,1.0,Donor Lymphocyte Infusion,1.0
Doxorubicin,Doxorubicin,1,1,Doxorubicin,1.0,Doxorubicin,1.0,Doxorubicin,1.0,Doxorubicin,1.0,Doxorubicin,1.0
Doxorubicin Hydrochloride,Doxorubicin Hydrochloride,1,1,Doxorubicin Hydrochloride,1.0,Doxorubicin Hydrochloride,1.0,Doxorubicin Hydrochloride,1.0,Doxorubicin Hydrochloride,1.0,Doxorubicin Hydrochloride,1.0
Durvalumab,Durvalumab,1,1,Durvalumab,1.0,Durvalumab,1.0,Durvalumab,1.0,Durvalumab,1.0,Durvalumab,1.0
Dutasteride,Dutasteride,1,1,Dutasteride,1.0,Dutasteride,1.0,Dutasteride,1.0,Dutasteride,1.0,Dutasteride,1.0
Enasidenib,Enasidenib,1,1,Enasidenib,1.0,Enasidenib,1.0,Enasidenib,1.0,Enasidenib,1.0,Enasidenib,1.0
Entospletinib,Entospletinib,1,1,Entospletinib,1.0,Entospletinib,1.0,Entospletinib,1.0,Entospletinib,1.0,Entospletinib,1.0
Enucleation,Enucleation,1,1,Enucleation,1.0,Enucleation,1.0,Enucleation,1.0,Enucleation,1.0,Enucleation,1.0
Enzalutamide,Enzalutamide,1,1,Enzalutamide,1.0,Enzalutamide,1.0,Enzalutamide,1.0,Enzalutamide,1.0,Enzalutamide,1.0
Epirubicin,Epirubicin,1,1,Epirubicin,1.0,Epirubicin,1.0,Epirubicin,1.0,Epirubicin,1.0,Epirubicin,1.0
Eribulin,Eribulin,1,1,Eribulin,1.0,Eribulin,1.0,Eribulin,1.0,Eribulin,1.0,Eribulin,1.0
Esophagectomy,Esophagectomy,1,1,Esophagectomy,1.0,Esophagectomy,1.0,Esophagectomy,1.0,Esophagectomy,1.0,Esophagectomy,1.0
Estramustine,Estramustine,1,1,Estramustine,1.0,Estramustine,1.0,Estramustine,1.0,Estramustine,1.0,Estramustine,1.0
Etoposide,Etoposide,1,1,Etoposide,1.0,Etoposide,1.0,Etoposide,1.0,Etoposide,1.0,Etoposide,1.0
Everolimus,Everolimus,1,1,Everolimus,1.0,Everolimus,1.0,Everolimus,1.0,Everolimus,1.0,Everolimus,1.0
Excision,Excision,1,1,Excision,1.0,Excision,1.0,Excision,1.0,Excision,1.0,Excision,1.0
Exemestane,Exemestane,1,1,Exemestane,1.0,Exemestane,1.0,Exemestane,1.0,Exemestane,1.0,Exemestane,1.0
Filgrastim,Filgrastim,1,1,Filgrastim,1.0,Filgrastim,1.0,Filgrastim,1.0,Filgrastim,1.0,Filgrastim,1.0
Fludarabine,Fludarabine,1,1,Fludarabine,1.0,Fludarabine,1.0,Fludarabine,1.0,Fludarabine,1.0,Fludarabine,1.0
Fluorouracil,Fluorouracil,1,1,Fluorouracil,1.0,Fluorouracil,1.0,Fluorouracil,1.0,Fluorouracil,1.0,Fluorouracil,1.0
Fotemustine,Fotemustine,1,1,Fotemustine,1.0,Fotemustine,1.0,Fotemustine,1.0,Fotemustine,1.0,Fotemustine,1.0
Galunisertib,Galunisertib,1,1,Galunisertib,1.0,Galunisertib,1.0,Galunisertib,1.0,Galunisertib,1.0,Galunisertib,1.0
Gastrectomy,Gastrectomy,1,1,Gastrectomy,1.0,Gastrectomy,1.0,Gastrectomy,1.0,Gastrectomy,1.0,Gastrectomy,1.0
Gefitinib,Gefitinib,1,1,Gefitinib,1.0,Gefitinib,1.0,Gefitinib,1.0,Gefitinib,1.0,Gefitinib,1.0
Gemcitabine,Gemcitabine,1,1,Gemcitabine,1.0,Gemcitabine,1.0,Gemcitabine,1.0,Gemcitabine,1.0,Gemcitabine,1.0
Gemtuzumab,Gemtuzumab,1,1,Gemtuzumab,1.0,Gemtuzumab,1.0,Gemtuzumab,1.0,Gemtuzumab,1.0,Gemtuzumab,1.0
Gemtuzumab Ozogamicin,Gemtuzumab Ozogamicin,1,1,Gemtuzumab Ozogamicin,1.0,Gemtuzumab Ozogamicin,1.0,Gemtuzumab Ozogamicin,1.0,Gemtuzumab Ozogamicin,1.0,Gemtuzumab Ozogamicin,1.0
Gilteritinib,Gilteritinib,1,1,Gilteritinib,1.0,Gilteritinib,1.0,Gilteritinib,1.0,Gilteritinib,1.0,Gilteritinib,1.0
Hydroxyurea,Hydroxyurea,1,1,Hydroxyurea,1.0,Hydroxyurea,1.0,Hydroxyurea,1.0,Hydroxyurea,1.0,Hydroxyurea,1.0
Hysterectomy,Hysterectomy,1,1,Hysterectomy,1.0,Hysterectomy,1.0,Hysterectomy,1.0,Hysterectomy,1.0,Hysterectomy,1.0
Ibrutinib,Ibrutinib,1,1,Ibrutinib,1.0,Ibrutinib,1.0,Ibrutinib,1.0,Ibrutinib,1.0,Ibrutinib,1.0
Idarubicin,Idarubicin,1,1,Idarubicin,1.0,Idarubicin,1.0,Idarubicin,1.0,Idarubicin,1.0,Idarubicin,1.0
Idasanutlin,Idasanutlin,1,1,Idasanutlin,1.0,Idasanutlin,1.0,Idasanutlin,1.0,Idasanutlin,1.0,Idasanutlin,1.0
Ifosfamide,Ifosfamide,1,1,Ifosfamide,1.0,Ifosfamide,1.0,Ifosfamide,1.0,Ifosfamide,1.0,Ifosfamide,1.0
Imatinib,Imatinib,1,1,Imatinib,1.0,Imatinib,1.0,Imatinib,1.0,Imatinib,1.0,Imatinib,1.0
Immunoglobulin,Immunoglobulin,1,1,Immunoglobulin,1.0,Immunoglobulin,1.0,Immunoglobulin,1.0,Immunoglobulin,1.0,Immunoglobulin,1.0
Indoximod,Indoximod,1,1,Indoximod,1.0,Indoximod,1.0,Indoximod,1.0,Indoximod,1.0,Indoximod,1.0
Iniparib,Iniparib,1,1,Iniparib,1.0,Iniparib,1.0,Iniparib,1.0,Iniparib,1.0,Iniparib,1.0
Ipilimumab,Ipilimumab,1,1,Ipilimumab,1.0,Ipilimumab,1.0,Ipilimumab,1.0,Ipilimumab,1.0,Ipilimumab,1.0
Irinotecan,Irinotecan,1,1,Irinotecan,1.0,Irinotecan,1.0,Irinotecan,1.0,Irinotecan,1.0,Irinotecan,1.0
Isotretinoin,Isotretinoin,1,1,Isotretinoin,1.0,Isotretinoin,1.0,Isotretinoin,1.0,Isotretinoin,1.0,Isotretinoin,1.0
Itacitinib,Itacitinib,1,1,Itacitinib,1.0,Itacitinib,1.0,Itacitinib,1.0,Itacitinib,1.0,Itacitinib,1.0
Ivosidenib,Ivosidenib,1,1,Ivosidenib,1.0,Ivosidenib,1.0,Ivosidenib,1.0,Ivosidenib,1.0,Ivosidenib,1.0
Ketoconazole,Ketoconazole,1,1,Ketoconazole,1.0,Ketoconazole,1.0,Ketoconazole,1.0,Ketoconazole,1.0,Ketoconazole,1.0
Laparoscopic Biopsy,Laparoscopic Biopsy,1,1,Laparoscopic Biopsy,1.0,Laparoscopic Biopsy,1.0,Laparoscopic Biopsy,1.0,Laparoscopic Biopsy,1.0,Laparoscopic Biopsy,1.0
Laparoscopic Prostatectomy,Laparoscopic Prostatectomy,1,1,Laparoscopic Prostatectomy,1.0,Laparoscopic Prostatectomy,1.0,Laparoscopic Prostatectomy,1.0,Laparoscopic Prostatectomy,1.0,Laparoscopic Prostatectomy,1.0
Lapatinib,Lapatinib,1,1,Lapatinib,1.0,Lapatinib,1.0,Lapatinib,1.0,Lapatinib,1.0,Lapatinib,1.0
Lenalidomide,Lenalidomide,1,1,Lenalidomide,1.0,Lenalidomide,1.0,Lenalidomide,1.0,Lenalidomide,1.0,Lenalidomide,1.0
Letrozole,Letrozole,1,1,Letrozole,1.0,Letrozole,1.0,Letrozole,1.0,Letrozole,1.0,Letrozole,1.0
Liposomal Cytarabine,Liposomal Cytarabine,1,1,Liposomal Cytarabine,1.0,Liposomal Cytarabine,1.0,Liposomal Cytarabine,1.0,Liposomal Cytarabine,1.0,Liposomal Cytarabine,1.0
Liver Biopsy,Liver Biopsy,1,1,Liver Biopsy,1.0,Liver Biopsy,1.0,Liver Biopsy,1.0,Liver Biopsy,1.0,Liver Biopsy,1.0
Lobectomy,Lobectomy,1,1,Lobectomy,1.0,Lobectomy,1.0,Lobectomy,1.0,Lobectomy,1.0,Lobectomy,1.0
Lomustine,Lomustine,1,1,Lomustine,1.0,Lomustine,1.0,Lomustine,1.0,Lomustine,1.0,Lomustine,1.0
Lumpectomy,Lumpectomy,1,1,Lumpectomy,1.0,Lumpectomy,1.0,Lumpectomy,1.0,Lumpectomy,1.0,Lumpectomy,1.0
Macitentan,Macitentan,1,1,Macitentan,1.0,Macitentan,1.0,Macitentan,1.0,Macitentan,1.0,Macitentan,1.0
Mastectomy,Mastectomy,1,1,Mastectomy,1.0,Mastectomy,1.0,Mastectomy,1.0,Mastectomy,1.0,Mastectomy,1.0
Mefloquine,Mefloquine,1,1,Mefloquine,1.0,Mefloquine,1.0,Mefloquine,1.0,Mefloquine,1.0,Mefloquine,1.0
Melphalan,Melphalan,1,1,Melphalan,1.0,Melphalan,1.0,Melphalan,1.0,Melphalan,1.0,Melphalan,1.0
Memantine,Memantine,1,1,Memantine,1.0,Memantine,1.0,Memantine,1.0,Memantine,1.0,Memantine,1.0
Mercaptopurine,Mercaptopurine,1,1,Mercaptopurine,1.0,Mercaptopurine,1.0,Mercaptopurine,1.0,Mercaptopurine,1.0,Mercaptopurine,1.0
Methotrexate,Methotrexate,1,1,Methotrexate,1.0,Methotrexate,1.0,Methotrexate,1.0,Methotrexate,1.0,Methotrexate,1.0
Midostaurin,Midostaurin,1,1,Midostaurin,1.0,Midostaurin,1.0,Midostaurin,1.0,Midostaurin,1.0,Midostaurin,1.0
Mitomycin,Mitomycin,1,1,Mitomycin,1.0,Mitomycin,1.0,Mitomycin,1.0,Mitomycin,1.0,Mitomycin,1.0
Mitoxantrone,Mitoxantrone,1,1,Mitoxantrone,1.0,Mitoxantrone,1.0,Mitoxantrone,1.0,Mitoxantrone,1.0,Mitoxantrone,1.0
Modified Radical Mastectomy,Modified Radical Mastectomy,1,1,Modified Radical Mastectomy,1.0,Modified Radical Mastectomy,1.0,Modified Radical Mastectomy,1.0,Modified Radical Mastectomy,1.0,Modified Radical Mastectomy,1.0
Mogamulizumab,Mogamulizumab,1,1,Mogamulizumab,1.0,Mogamulizumab,1.0,Mogamulizumab,1.0,Mogamulizumab,1.0,Mogamulizumab,1.0
Momelotinib,Momelotinib,1,1,Momelotinib,1.0,Momelotinib,1.0,Momelotinib,1.0,Momelotinib,1.0,Momelotinib,1.0
Monalizumab,Monalizumab,1,1,Monalizumab,1.0,Monalizumab,1.0,Monalizumab,1.0,Monalizumab,1.0,Monalizumab,1.0
Nelarabine,Nelarabine,1,1,Nelarabine,1.0,Nelarabine,1.0,Nelarabine,1.0,Nelarabine,1.0,Nelarabine,1.0
Nephrectomy,Nephrectomy,1,1,Nephrectomy,1.0,Nephrectomy,1.0,Nephrectomy,1.0,Nephrectomy,1.0,Nephrectomy,1.0
Nintedanib,Nintedanib,1,1,Nintedanib,1.0,Nintedanib,1.0,Nintedanib,1.0,Nintedanib,1.0,Nintedanib,1.0
Nivolumab,Nivolumab,1,1,Nivolumab,1.0,Nivolumab,1.0,Nivolumab,1.0,Nivolumab,1.0,Nivolumab,1.0
Olaparib,Olaparib,1,1,Olaparib,1.0,Olaparib,1.0,Olaparib,1.0,Olaparib,1.0,Olaparib,1.0
Orchiectomy,Orchiectomy,1,1,Orchiectomy,1.0,Orchiectomy,1.0,Orchiectomy,1.0,Orchiectomy,1.0,Orchiectomy,1.0
Other,Other,1,1,Other,1.0,Other,1.0,Other,1.0,Other,1.0,Other,1.0
Oxaliplatin,Oxaliplatin,1,1,Oxaliplatin,1.0,Oxaliplatin,1.0,Oxaliplatin,1.0,Oxaliplatin,1.0,Oxaliplatin,1.0
Paclitaxel,Paclitaxel,1,1,Paclitaxel,1.0,Paclitaxel,1.0,Paclitaxel,1.0,Paclitaxel,1.0,Paclitaxel,1.0
Palbociclib,Palbociclib,1,1,Palbociclib,1.0,Palbociclib,1.0,Palbociclib,1.0,Palbociclib,1.0,Palbociclib,1.0
Partial Cystectomy,Partial Cystectomy,1,1,Partial Cystectomy,1.0,Partial Cystectomy,1.0,Partial Cystectomy,1.0,Partial Cystectomy,1.0,Partial Cystectomy,1.0
Partial Salpingectomy,Partial Salpingectomy,1,1,Partial Salpingectomy,1.0,Partial Salpingectomy,1.0,Partial Salpingectomy,1.0,Partial Salpingectomy,1.0,Partial Salpingectomy,1.0
Pembrolizumab,Pembrolizumab,1,1,Pembrolizumab,1.0,Pembrolizumab,1.0,Pembrolizumab,1.0,Pembrolizumab,1.0,Pembrolizumab,1.0
Pemetrexed,Pemetrexed,1,1,Pemetrexed,1.0,Pemetrexed,1.0,Pemetrexed,1.0,Pemetrexed,1.0,Pemetrexed,1.0
Pericardial Effusion,Pericardial Effusion,1,1,Pericardial Effusion,1.0,Pericardial Effusion,1.0,Pericardial Effusion,1.0,Pericardial Effusion,1.0,Pericardial Effusion,1.0
Pertuzumab,Pertuzumab,1,1,Pertuzumab,1.0,Pertuzumab,1.0,Pertuzumab,1.0,Pertuzumab,1.0,Pertuzumab,1.0
Pexidartinib,Pexidartinib,1,1,Pexidartinib,1.0,Pexidartinib,1.0,Pexidartinib,1.0,Pexidartinib,1.0,Pexidartinib,1.0
Platinum,Platinum,1,1,Platinum,1.0,Platinum,1.0,Platinum,1.0,Platinum,1.0,Platinum,1.0
Pleural Effusion,Pleural Effusion,1,1,Pleural Effusion,1.0,Pleural Effusion,1.0,Pleural Effusion,1.0,Pleural Effusion,1.0,Pleural Effusion,1.0
Ponatinib,Ponatinib,1,1,Ponatinib,1.0,Ponatinib,1.0,Ponatinib,1.0,Ponatinib,1.0,Ponatinib,1.0
Pracinostat,Pracinostat,1,1,Pracinostat,1.0,Pracinostat,1.0,Pracinostat,1.0,Pracinostat,1.0,Pracinostat,1.0
Pravastatin,Pravastatin,1,1,Pravastatin,1.0,Pravastatin,1.0,Pravastatin,1.0,Pravastatin,1.0,Pravastatin,1.0
Prednisolone,Prednisolone,1,1,Prednisolone,1.0,Prednisolone,1.0,Prednisolone,1.0,Prednisolone,1.0,Prednisolone,1.0
Prednisone,Prednisone,1,1,Prednisone,1.0,Prednisone,1.0,Prednisone,1.0,Prednisone,1.0,Prednisone,1.0
Procarbazine,Procarbazine,1,1,Procarbazine,1.0,Procarbazine,1.0,Procarbazine,1.0,Procarbazine,1.0,Procarbazine,1.0
Quizartinib,Quizartinib,1,1,Quizartinib,1.0,Quizartinib,1.0,Quizartinib,1.0,Quizartinib,1.0,Quizartinib,1.0
Radical Cystectomy,Radical Cystectomy,1,1,Radical Cystectomy,1.0,Radical Cystectomy,1.0,Radical Cystectomy,1.0,Radical Cystectomy,1.0,Radical Cystectomy,1.0
Radical Cystoprostatectomy,Radical Cystoprostatectomy,1,1,Radical Cystoprostatectomy,1.0,Radical Cystoprostatectomy,1.0,Radical Cystoprostatectomy,1.0,Radical Cystoprostatectomy,1.0,Radical Cystoprostatectomy,1.0
Radical Hysterectomy,Radical Hysterectomy,1,1,Radical Hysterectomy,1.0,Radical Hysterectomy,1.0,Radical Hysterectomy,1.0,Radical Hysterectomy,1.0,Radical Hysterectomy,1.0
Radical Prostatectomy,Radical Prostatectomy,1,1,Radical Prostatectomy,1.0,Radical Prostatectomy,1.0,Radical Prostatectomy,1.0,Radical Prostatectomy,1.0,Radical Prostatectomy,1.0
Ramucirumab,Ramucirumab,1,1,Ramucirumab,1.0,Ramucirumab,1.0,Ramucirumab,1.0,Ramucirumab,1.0,Ramucirumab,1.0
Regorafenib,Regorafenib,1,1,Regorafenib,1.0,Regorafenib,1.0,Regorafenib,1.0,Regorafenib,1.0,Regorafenib,1.0
Resection,Resection,1,1,Resection,1.0,Resection,1.0,Resection,1.0,Resection,1.0,Resection,1.0
Rigosertib,Rigosertib,1,1,Rigosertib,1.0,Rigosertib,1.0,Rigosertib,1.0,Rigosertib,1.0,Rigosertib,1.0
Rituximab,Rituximab,1,1,Rituximab,1.0,Rituximab,1.0,Rituximab,1.0,Rituximab,1.0,Rituximab,1.0
Ruxolitinib,Ruxolitinib,1,1,Ruxolitinib,1.0,Ruxolitinib,1.0,Ruxolitinib,1.0,Ruxolitinib,1.0,Ruxolitinib,1.0
Samalizumab,Samalizumab,1,1,Samalizumab,1.0,Samalizumab,1.0,Samalizumab,1.0,Samalizumab,1.0,Samalizumab,1.0
Segmental Mastectomy,Segmental Mastectomy,1,1,Segmental Mastectomy,1.0,Segmental Mastectomy,1.0,Segmental Mastectomy,1.0,Segmental Mastectomy,1.0,Segmental Mastectomy,1.0
Selinexor,Selinexor,1,1,Selinexor,1.0,Selinexor,1.0,Selinexor,1.0,Selinexor,1.0,Selinexor,1.0
Sirolimus,Sirolimus,1,1,Sirolimus,1.0,Sirolimus,1.0,Sirolimus,1.0,Sirolimus,1.0,Sirolimus,1.0
Sorafenib,Sorafenib,1,1,Sorafenib,1.0,Sorafenib,1.0,Sorafenib,1.0,Sorafenib,1.0,Sorafenib,1.0
Sunitinib,Sunitinib,1,1,Sunitinib,1.0,Sunitinib,1.0,Sunitinib,1.0,Sunitinib,1.0,Sunitinib,1.0
Tandutinib,Tandutinib,1,1,Tandutinib,1.0,Tandutinib,1.0,Tandutinib,1.0,Tandutinib,1.0,Tandutinib,1.0
Tasadenoturev,Tasadenoturev,1,1,Tasadenoturev,1.0,Tasadenoturev,1.0,Tasadenoturev,1.0,Tasadenoturev,1.0,Tasadenoturev,1.0
Temozolomide,Temozolomide,1,1,Temozolomide,1.0,Temozolomide,1.0,Temozolomide,1.0,Temozolomide,1.0,Temozolomide,1.0
Temsirolimus,Temsirolimus,1,1,Temsirolimus,1.0,Temsirolimus,1.0,Temsirolimus,1.0,Temsirolimus,1.0,Temsirolimus,1.0
Thalidomide,Thalidomide,1,1,Thalidomide,1.0,Thalidomide,1.0,Thalidomide,1.0,Thalidomide,1.0,Thalidomide,1.0
Thioguanine,Thioguanine,1,1,Thioguanine,1.0,Thioguanine,1.0,Thioguanine,1.0,Thioguanine,1.0,Thioguanine,1.0
Thiotepa,Thiotepa,1,1,Thiotepa,1.0,Thiotepa,1.0,Thiotepa,1.0,Thiotepa,1.0,Thiotepa,1.0
Topotecan,Topotecan,1,1,Topotecan,1.0,Topotecan,1.0,Topotecan,1.0,Topotecan,1.0,Topotecan,1.0
Total Abdominal Hysterectomy,Total Abdominal Hysterectomy,1,1,Total Abdominal Hysterectomy,1.0,Total Abdominal Hysterectomy,1.0,Total Abdominal Hysterectomy,1.0,Total Abdominal Hysterectomy,1.0,Total Abdominal Hysterectomy,1.0
Total Hepatectomy,Total Hepatectomy,1,1,Total Hepatectomy,1.0,Total Hepatectomy,1.0,Total Hepatectomy,1.0,Total Hepatectomy,1.0,Total Hepatectomy,1.0
Total Mastectomy,Total Mastectomy,1,1,Total Mastectomy,1.0,Total Mastectomy,1.0,Total Mastectomy,1.0,Total Mastectomy,1.0,Total Mastectomy,1.0
Trametinib,Trametinib,1,1,Trametinib,1.0,Trametinib,1.0,Trametinib,1.0,Trametinib,1.0,Trametinib,1.0
Trastuzumab,Trastuzumab,1,1,Trastuzumab,1.0,Trastuzumab,1.0,Trastuzumab,1.0,Trastuzumab,1.0,Trastuzumab,1.0
Tremelimumab,Tremelimumab,1,1,Tremelimumab,1.0,Tremelimumab,1.0,Tremelimumab,1.0,Tremelimumab,1.0,Tremelimumab,1.0
Treosulfan,Treosulfan,1,1,Treosulfan,1.0,Treosulfan,1.0,Treosulfan,1.0,Treosulfan,1.0,Treosulfan,1.0
Tretinoin,Tretinoin,1,1,Tretinoin,1.0,Tretinoin,1.0,Tretinoin,1.0,Tretinoin,1.0,Tretinoin,1.0
Unilateral Oophorectomy,Unilateral Oophorectomy,1,1,Unilateral Oophorectomy,1.0,Unilateral Oophorectomy,1.0,Unilateral Oophorectomy,1.0,Unilateral Oophorectomy,1.0,Unilateral Oophorectomy,1.0
Ureterectomy,Ureterectomy,1,1,Ureterectomy,1.0,Ureterectomy,1.0,Ureterectomy,1.0,Ureterectomy,1.0,Ureterectomy,1.0
Urethrectomy,Urethrectomy,1,1,Urethrectomy,1.0,Urethrectomy,1.0,Urethrectomy,1.0,Urethrectomy,1.0,Urethrectomy,1.0
Valproic Acid,Valproic Acid,1,1,Valproic Acid,1.0,Valproic Acid,1.0,Valproic Acid,1.0,Valproic Acid,1.0,Valproic Acid,1.0
Vemurafenib,Vemurafenib,1,1,Vemurafenib,1.0,Vemurafenib,1.0,Vemurafenib,1.0,Vemurafenib,1.0,Vemurafenib,1.0
Venetoclax,Venetoclax,1,1,Venetoclax,1.0,Venetoclax,1.0,Venetoclax,1.0,Venetoclax,1.0,Venetoclax,1.0
Vinblastine,Vinblastine,1,1,Vinblastine,1.0,Vinblastine,1.0,Vinblastine,1.0,Vinblastine,1.0,Vinblastine,1.0
Vincristine,Vincristine,1,1,Vincristine,1.0,Vincristine,1.0,Vincristine,1.0,Vincristine,1.0,Vincristine,1.0
Vincristine Sulfate,Vincristine Sulfate,1,1,Vincristine Sulfate,1.0,Vincristine Sulfate,1.0,Vincristine Sulfate,1.0,Vincristine Sulfate,1.0,Vincristine Sulfate,1.0
Vinorelbine,Vinorelbine,1,1,Vinorelbine,1.0,Vinorelbine,1.0,Vinorelbine,1.0,Vinorelbine,1.0,Vinorelbine,1.0
Vorinostat,Vorinostat,1,1,Vorinostat,1.0,Vorinostat,1.0,Vorinostat,1.0,Vorinostat,1.0,Vorinostat,1.0
Wide Local Excision,Wide Local Excision,1,1,Wide Local Excision,1.0,Wide Local Excision,1.0,Wide Local Excision,1.0,Wide Local Excision,1.0,Wide Local Excision,1.0
17-DMAG,Alvespimycin,99,2,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9131,MDM2/MDMX Inhibitor ALRN-6924,0.9130,HDM2 Inhibitor MK-8242,0.9120,Gemtuzumab,0.9101,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9097
19D12,Robatumumab,99,2,AALL0232 ALL Study Identifier;Dexamethasone,0.8962,Pracinostat,0.8937,MDM2/MDMX Inhibitor ALRN-6924,0.8909,Denintuzumab Mafodotin,0.8878,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.8872
5 fu,Fluorouracil,1,2,Fluorouracil,0.9518,Fluoropyrimidine,0.9310,Fotemustine,0.9190,Floxuridine,0.9170,Ifosfamide,0.9100
5-FU,Fluorouracil,1,2,Fluorouracil,0.9556,Fluoropyrimidine,0.9384,Fotemustine,0.9265,Floxuridine,0.9236,Ifosfamide,0.9182
5-fluorouracil,Fluorouracil,1,2,Fluorouracil,0.9747,Fluoropyrimidine,0.9459,Fotemustine,0.9287,Floxuridine,0.9281,Folic Acid,0.9212
5/FU,Fluorouracil,1,2,Fluorouracil,0.9367,Fluoropyrimidine,0.9206,Fotemustine,0.9148,Floxuridine,0.9095,FLT3/CDK4/6 Inhibitor FLX925,0.9028
5FU,Fluorouracil,1,2,Fluorouracil,0.9576,Fluoropyrimidine,0.9360,Floxuridine,0.9237,Fotemustine,0.9224,Fludarabine,0.9156
6-MP,Mercaptopurine,2,2,Mapatumumab,0.9171,Mercaptopurine,0.9168,Tamoxifen,0.9051,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9019,Peginterferon Alfa-2a,0.8988
6MP,Mercaptopurine,1,2,Mercaptopurine,0.9167,Mapatumumab,0.9053,Mycophenolate Mofetil,0.8975,Tamoxifen,0.8881,Methotrexate,0.8866
AA,Antiandrogen Therapy,99,2,AALL0331 ALL Study Identifier,0.9225,AALL0232 ALL Study Identifier,0.9173,AALL0232 ALL Study Identifier;Dexamethasone,0.9152,Adalimumab,0.9036,Tamibarotene,0.8955
AALL0232 therapy,AALL0232 ALL Study Identifier,1,2,AALL0232 ALL Study Identifier,0.9624,AALL0331 ALL Study Identifier,0.9560,AALL0232 ALL Study Identifier;Dexamethasone,0.9539,Anti-CD33 Monoclonal Antibody BI 836858,0.9124,Gamma-Secretase Inhibitor RO4929097,0.9114
AALL0232 w/Dex,AALL0232 ALL Study Identifier;Dexamethasone,1,2,AALL0232 ALL Study Identifier;Dexamethasone,0.9625,AALL0232 ALL Study Identifier,0.9479,AALL0331 ALL Study Identifier,0.9467,Anti-CD33 Monoclonal Antibody BI 836858,0.9127,MDM2/MDMX Inhibitor ALRN-6924,0.9120
AALL0331,AALL0331 ALL Study Identifier,1,2,AALL0331 ALL Study Identifier,0.9740,AALL0232 ALL Study Identifier,0.9606,AALL0232 ALL Study Identifier;Dexamethasone,0.9502,Anti-CD33 Monoclonal Antibody BI 836858,0.8990,Purine Analogue NSC 750854,0.8972
ABRAXANE,Nab-paclitaxel,99,2,Pexidartinib,0.9140,Crenolanib,0.9119,Lorazepam,0.9119,Afatinib,0.9075,Abiraterone,0.9068
ABSTRACTION_PENDING,Chart Abstraction;Pending,1,2,Chart Abstraction;Pending,0.9686,Bicalutamide,0.8979,Wertheim operation (procedure),0.8965,Abiraterone,0.8954,Seviteronel,0.8952
ABT-199,Venetoclax,99,2,Nab-paclitaxel,0.9206,JAK2 Inhibitor AZD1480,0.9190,Bevacizumab,0.9158,Anti-CD33 Monoclonal Antibody BI 836858,0.9150,CENP-E Inhibitor GSK-923295A,0.9127
ABT-263,Navitoclax,99,2,Anti-CD33 Monoclonal Antibody BI 836858,0.9183,Capecitabine,0.9115,Docetaxel,0.9105,JAK2 Inhibitor AZD1480,0.9101,Erlotinib,0.9097
ABT888,Veliparib,99,2,Anti-CD33 Monoclonal Antibody BI 836858,0.9133,Abiraterone,0.9004,Anti-CD33 Antibody-drug Conjugate IMGN779,0.8987,JAK2 Inhibitor AZD1480,0.8971,Folate Receptor-Targeted Tubulysin Conjugate EC1456,0.8962
AC220 (Ambit),Quizartinib Dihydrochloride,99,2,Akt Inhibitor MK2206,0.9077,AALL0232 ALL Study Identifier;Dexamethasone,0.9014,Anti-CD33 Monoclonal Antibody BI 836858,0.8995,Anti-CD33 Antibody-drug Conjugate IMGN779,0.8970,Bicalutamide,0.8969
ACTINOMYCIN D,Dactinomycin,99,2,Anthracycline Antineoplastic Antibiotic,0.9139,Dexamethasone,0.9082,Doxorubicin,0.9079,Adalimumab,0.9051,Azathioprine,0.9050
AG-120,Ivosidenib,99,2,Anti-ErbB3 Monoclonal Antibody REGN1400,0.9025,Polyamine Analogue PG11047,0.8982,Anti-CD33 Monoclonal Antibody BI 836858,0.8919,Anti-CD33 Antibody-drug Conjugate IMGN779,0.8901,Gemtuzumab,0.8868
AG-221,Enasidenib,99,2,AALL0232 ALL Study Identifier;Dexamethasone,0.8972,Polyamine Analogue PG11047,0.8969,PIM Kinase Inhibitor SGI-1776,0.8920,Anti-CD33 Monoclonal Antibody BI 836858,0.8913,Peginterferon Alfa-2a,0.8907
AIS,Aromatase Inhibitor,99,2,Estramustine,0.9005,Amifostine,0.8951,Gefitinib,0.8934,Momelotinib,0.8908,Abiraterone,0.8900
AKTi,AKT Inhibitor,1,2,AKT Inhibitor,0.9542,Pan-AKT Kinase Inhibitor GSK690693,0.9303,Trastuzumab,0.9205,Akt Inhibitor MK2206,0.9149,Vadastuximab Talirine,0.9097
ALND,Axillary Lymph Node Dissection,99,2,MDM2/MDMX Inhibitor ALRN-6924,0.9208,Cediranib,0.9110,Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Biopsy,0.9082,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9082,Sentinel Lymph Node Biopsy,0.9063
ALPELISIB,Alpelisib,1,2,Alpelisib,1.0000,Acalisib,0.9299,Taselisib,0.9259,Pilaralisib,0.9151,Pravastatin,0.9090
ALRN-6924,MDM2/MDMX Inhibitor ALRN-6924,1,2,MDM2/MDMX Inhibitor ALRN-6924,0.9599,NAMPT Inhibitor STF-118804,0.9140,AALL0331 ALL Study Identifier,0.9116,AALL0232 ALL Study Identifier,0.9113,AALL0232 ALL Study Identifier;Dexamethasone,0.9073
AMD,Dactinomycin,99,2,Daratumumab,0.9207,Denintuzumab Mafodotin,0.9143,Ramucirumab,0.9084,Vadastuximab Talirine,0.9083,Adalimumab,0.9055
ANTHRACYCLINE,Anthracycline Antineoplastic Antibiotic,1,2,Anthracycline Antineoplastic Antibiotic,0.9651,Doxorubicin,0.9547,Doxorubicin Hydrochloride,0.9335,Daunorubicin,0.9318,Imatinib,0.9280
ANTIHER2,HER2-targeting Agent,5,2,Anti-TIM-3 Monoclonal Antibody,0.9034,Anti-HGF Monoclonal Antibody TAK-701,0.9031,Anti-LAG-3 Monoclonal Antibody,0.9016,Peginterferon Alfa-2a,0.9006,HER2-targeting Agent,0.9000
APLIDIN,Plitidepsin,2,2,Apalutamide,0.9148,Plitidepsin,0.9075,Pipobroman,0.9073,Plerixafor,0.9070,Alvespimycin,0.9041
APR,Abdominoperineal Resection,99,2,Peginterferon Alfa-2a,0.8988,Radical;Anterior Pelvic Exenteration,0.8983,Anterior Pelvic Exenteration,0.8965,Everolimus,0.8950,Pelvic Lymphadenectomy,0.8936
ARN 509,Apalutamide,99,2,Anti-ErbB3 Monoclonal Antibody REGN1400,0.8988,MDM2/MDMX Inhibitor ALRN-6924,0.8935,Anti-CD98 Monoclonal Antibody IGN523,0.8902,Dutasteride,0.8896,Anti-HGF Monoclonal Antibody TAK-701,0.8888
ARN509,Apalutamide,99,2,Anti-CD98 Monoclonal Antibody IGN523,0.8877,Anti-ErbB3 Monoclonal Antibody REGN1400,0.8871,MDM2/MDMX Inhibitor ALRN-6924,0.8850,Gamma-Secretase Inhibitor RO4929097,0.8796,Trametinib,0.8796
ATG,Anti-Thymocyte Globulin,99,2,Ipilimumab,0.8980,Imatinib,0.8959,Erlotinib,0.8940,Anti-EGFR Monoclonal Antibody,0.8924,Docetaxel,0.8918
ATRA,Tretinoin,99,2,Tamibarotene,0.9276,Erlotinib,0.9240,Abiraterone Acetate,0.9176,Abiraterone,0.9164,Tamoxifen,0.9152
ATRA (Tretinoin),Tretinoin,1,2,Tretinoin,0.9729,Isotretinoin,0.9380,Treosulfan,0.9294,Topotecan,0.9245,Tamibarotene,0.9219
ATRA started,Tretinoin,99,2,Tamibarotene,0.9049,Abiraterone Acetate,0.8956,Steroid Therapy,0.8952,Gilteritinib,0.8945,Erlotinib,0.8944
AZD-2171,Cediranib,99,2,HDM2 Inhibitor MK-8242,0.9280,mTOR Kinase Inhibitor AZD8055,0.9279,PIM Kinase Inhibitor SGI-1776,0.9263,JAK2 Inhibitor AZD1480,0.9241,CENP-E Inhibitor GSK-923295A,0.9175
AZD-6244,Selumetinib,99,2,mTOR Kinase Inhibitor AZD8055,0.9489,HDM2 Inhibitor MK-8242,0.9476,MDM2/MDMX Inhibitor ALRN-6924,0.9331,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9326,JAK2 Inhibitor AZD1480,0.9312
AZD1480,JAK2 Inhibitor AZD1480,1,2,JAK2 Inhibitor AZD1480,0.9726,mTOR Kinase Inhibitor AZD8055,0.9221,Folate Receptor-Targeted Tubulysin Conjugate EC1456,0.9155,HDM2 Inhibitor MK-8242,0.9124,Erlotinib,0.9121
AZD8055,mTOR Kinase Inhibitor AZD8055,1,2,mTOR Kinase Inhibitor AZD8055,0.9725,JAK2 Inhibitor AZD1480,0.9210,HDM2 Inhibitor MK-8242,0.9200,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9187,Gamma-Secretase Inhibitor RO4929097,0.9164
AbiCabazi (abiraterone),Abiraterone,1,2,Abiraterone,0.9711,Abiraterone Acetate,0.9599,Cinrebafusp Alfa,0.9294,Bicalutamide,0.9292,Dabrafenib,0.9292
Abiraterone acetate,Abiraterone Acetate,1,2,Abiraterone Acetate,1.0000,Abiraterone,0.9848,Sirolimus,0.9295,Dabrafenib,0.9284,Bicalutamide,0.9268
Additional resection/ margins (taken after first margin positive),Resection,99,2,Surgical Margin;Resection,0.9508,Re-Excision;Superior;Margin,0.9502,Re-Excision;Inferior;Margin,0.9489,Inner;Upper;Surgical Margin;Re-Excision,0.9453,Right Breast;Re-Excision,0.9347
Adr,Doxorubicin Hydrochloride,99,2,Adalimumab,0.9097,Doxorubicin,0.9049,Ramucirumab,0.9026,MDM2/MDMX Inhibitor ALRN-6924,0.9014,Prednisolone,0.9006
Adriamycine,Doxorubicin Hydrochloride,2,2,Doxorubicin,0.9635,Doxorubicin Hydrochloride,0.9412,Daunorubicin,0.9330,Anthracycline Antineoplastic Antibiotic,0.9322,Adalimumab,0.9223
Alliance (enzalutamide),Enzalutamide,1,2,Enzalutamide,0.9712,Bicalutamide,0.9387,Abiraterone Acetate,0.9217,Antiandrogen Therapy,0.9215,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9205
AntiEGFR,Anti-EGFR Monoclonal Antibody,1,2,Anti-EGFR Monoclonal Antibody,0.9528,Anti-LAG-3 Monoclonal Antibody,0.9224,Anti-CD47 Monoclonal Antibody,0.9186,Anti-HGF Monoclonal Antibody TAK-701,0.9182,Antiandrogen Therapy,0.9157
Ara,Cytarabine,2,2,Pexidartinib,0.9120,Cytarabine,0.9089,Rituximab,0.9088,Cladribine,0.9054,Anti-EGFR Monoclonal Antibody,0.9052
Ara C,Cytarabine,1,2,Cytarabine,0.9044,Cladribine,0.9018,Chimeric Antigen Receptor T-Cell Therapy,0.8950,Chimeric Antigen Receptor T-Cell Therapy;Therapeutic Apheresis,0.8947,Carboxyamidotriazole,0.8932
Ara-C,Cytarabine,1,2,Cytarabine,0.9177,Cladribine,0.9124,Chimeric Antigen Receptor T-Cell Therapy;Therapeutic Apheresis,0.9093,Chimeric Antigen Receptor T-Cell Therapy,0.9085,Liposomal Cytarabine,0.9076
Arsenic.,Arsenic,1,2,Arsenic,0.9993,Arsenic Trioxide,0.9470,Seviteronel,0.9053,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9015,Vadastuximab Talirine,0.8996
Ascites,Ascites Drainage,1,2,Ascites Drainage,0.9631,Pericardial Effusion,0.9109,Pleural Effusion,0.9095,Adalimumab,0.9047,Peginterferon Alfa-2a,0.9039
Auto,Autologous Hematopoietic Stem Cell Transplantation,1,2,Autologous Hematopoietic Stem Cell Transplantation,0.8907,Erlotinib,0.8879,Ipilimumab,0.8869,MDM2/MDMX Inhibitor ALRN-6924,0.8868,Apoptotic Pathway-targeting Antineoplastic Agent,0.8853
Avastin,Bevacizumab,1,2,Bevacizumab,0.9330,Vadastuximab Talirine,0.9125,Asparaginase,0.9096,Sorafenib,0.9093,Ivosidenib,0.9078
Avatin,Lorazepam,99,2,Vinorelbine,0.9198,Vincristine,0.9150,Vinblastine,0.9108,Asparaginase,0.9101,Ivosidenib,0.9068
Aza,Azacitidine,1,2,Azacitidine,0.9528,Azathioprine,0.9403,Azacitidine Regimen,0.9303,Azathioprine Sodium,0.9121,Decitabine,0.9098
B/L Pelvic LN dissection,Bilateral Pelvic Lymph Node Dissection,1,2,Bilateral Pelvic Lymph Node Dissection,0.9598,Pelvic Lymphadenectomy,0.9575,Bilateral;Pelvic Lymphadenectomy,0.9493,Extend;Pelvic Lymphadenectomy,0.9443,Axillary Lymph Node Level I;Axillary Lymph Node Level II;Lymphadenectomy,0.9408
BAL101553,Lisavanbulin,99,2,Anti-CD33 Monoclonal Antibody BI 836858,0.9037,Anti-HGF Monoclonal Antibody TAK-701,0.9009,FACT Complex-targeting Curaxin CBL0137,0.9001,NAMPT Inhibitor STF-118804,0.8971,AALL0232 ALL Study Identifier;Dexamethasone,0.8964
BAY1161909,Empesertib,99,2,Dual IGF-1R/InsR Inhibitor BMS-754807,0.8975,Polyamine Analogue PG11047,0.8949,Gamma-Secretase Inhibitor RO4929097,0.8938,Glembatumumab,0.8906,FAK Inhibitor VS-4718,0.8894
BCG,Bacillus Calmette-Guerin Antigen,1,2,Bacillus Calmette-Guerin Antigen,0.9257,Bleomycin,0.9195,Vaccine,0.9113,Bevacizumab,0.9097,Ipilimumab,0.9053
BCNU,Carmustine,99,2,Navitoclax,0.9026,Neobladder,0.9009,Birinapant,0.8960,Orthotopic;Neobladder,0.8941,Crenolanib,0.8935
BEV,Bevacizumab,1,2,Bevacizumab,0.9195,Mivobulin Isethionate,0.9155,Bortezomib,0.9135,Buparlisib,0.9094,Valproic Acid,0.9081
BEZ235,Dactolisib,99,2,mTOR Inhibitor;Immunotherapeutic Agent,0.9151,Zoligratinib,0.9145,Lapatinib,0.9141,Bortezomib,0.9140,Everolimus,0.9139
BI 836858 (anti-CD33),Anti-CD33 Monoclonal Antibody BI 836858,1,2,Anti-CD33 Monoclonal Antibody BI 836858,0.9930,Anti-CD3 Monoclonal Antibody,0.9625,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9521,Anti-TIM-3 Monoclonal Antibody,0.9437,Anti-HGF Monoclonal Antibody TAK-701,0.9365
BI6727 (VOLASERTIB),Volasertib,1,2,Volasertib,0.9616,Anti-CD33 Monoclonal Antibody BI 836858,0.9265,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9185,FAK Inhibitor VS-4718,0.9172,Bevacizumab,0.9158
BI836858 (anti-CD33),Anti-CD33 Monoclonal Antibody BI 836858,1,2,Anti-CD33 Monoclonal Antibody BI 836858,0.9884,Anti-CD3 Monoclonal Antibody,0.9573,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9499,Anti-TIM-3 Monoclonal Antibody,0.9384,Anti-CD98 Monoclonal Antibody IGN523,0.9327
BKM120,Buparlisib,99,2,Binimetinib,0.8971,mTOR Kinase Inhibitor AZD8055,0.8887,DNA-PK/TOR Kinase Inhibitor CC-115,0.8885,Anti-PLGF Monoclonal Antibody TB-403,0.8882,Cetuximab,0.8874
BL-8040,Motixafortide,99,2,Anti-PLGF Monoclonal Antibody TB-403,0.9103,Anti-HGF Monoclonal Antibody TAK-701,0.9084,Anti-CD33 Monoclonal Antibody BI 836858,0.9058,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9032,mTOR Kinase Inhibitor AZD8055,0.9027
BMN-673,Talazoparib,99,2,Anti-CD33 Monoclonal Antibody BI 836858,0.9140,MDM2/MDMX Inhibitor ALRN-6924,0.9124,Purine Analogue NSC 750854,0.9076,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9058,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9030
BMS-354825,Dasatinib,99,2,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9392,Purine Analogue NSC 750854,0.9240,CENP-E Inhibitor GSK-923295A,0.9230,NAMPT Inhibitor STF-118804,0.9230,HDM2 Inhibitor MK-8242,0.9228
BMS-754807,Dual IGF-1R/InsR Inhibitor BMS-754807,1,2,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9536,MDM2/MDMX Inhibitor ALRN-6924,0.9272,Purine Analogue NSC 750854,0.9259,Glembatumumab,0.9251,NAMPT Inhibitor STF-118804,0.9235
BMS-986205 (IDO inhibitor),Linrodostat,99,2,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9525,IDO Inhibitor,0.9451,HDM2 Inhibitor MK-8242,0.9414,Anti-CD33 Monoclonal Antibody BI 836858,0.9412,NAMPT Inhibitor STF-118804,0.9412
BMS-986205 (P1T986205),Linrodostat,99,2,Purine Analogue NSC 750854,0.9322,NAMPT Inhibitor STF-118804,0.9275,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9275,Anti-CD33 Monoclonal Antibody BI 836858,0.9246,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9196
BORTEZOMIB,Bortezomib,1,2,Bortezomib,1.0000,Bevacizumab,0.9326,Nab-paclitaxel,0.9276,Vinblastine,0.9247,Paclitaxel,0.9226
BP1001,Prexigebersen,99,2,Everolimus,0.9029,JAK1 Inhibitor,0.8964,JAK2 Inhibitor AZD1480,0.8918,Pembrolizumab,0.8909,mTOR Kinase Inhibitor AZD8055,0.8868
BPX-501,Rivogenlecleucel,99,2,Anti-PLGF Monoclonal Antibody TB-403,0.9061,Purine Analogue NSC 750854,0.9060,Binimetinib,0.9056,Nab-paclitaxel,0.9049,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9035
BREAST CONSERVING,Breast Conservation Treatment,1,2,Breast Conservation Treatment,0.9586,Bilateral;Skin-Sparing Mastectomy,0.9257,Lumpectomy;Right Breast,0.9159,Mastectomy,0.9144,Skin-Sparing Mastectomy;Radical Mastectomy,0.9140
BSO,Buthionine Sulfoximine,4,2,Buparlisib,0.9035,Bilateral Salpingectomy,0.8992,Binimetinib,0.8970,Buthionine Sulfoximine,0.8964,Bevacizumab,0.8946
BU,Busulfan,1,2,Busulfan,0.9061,Bevacizumab,0.8947,Crenolanib,0.8939,Buparlisib,0.8916,Bleomycin,0.8882
BYL719,Alpelisib,99,2,MDM2/MDMX Inhibitor ALRN-6924,0.9100,Ifabotuzumab,0.9031,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9022,Purine Analogue NSC 750854,0.9015,Gamma-Secretase Inhibitor RO4929097,0.9010
Bacillus Calmette-Guerin,Bacillus Calmette-Guerin Antigen,1,2,Bacillus Calmette-Guerin Antigen,0.9730,Lisavanbulin,0.9061,Liposome-encapsulated Daunorubicin-Cytarabine,0.9054,Vaccine,0.9049,Imatinib,0.9021
Bacillus Calmette-Guerin (BCG),Bacillus Calmette-Guerin Antigen,1,2,Bacillus Calmette-Guerin Antigen,0.9702,Vaccine,0.9194,Lisavanbulin,0.9152,Glembatumumab,0.9108,Imatinib,0.9095
Bevasizumab,Bevacizumab,1,2,Bevacizumab,0.9335,Vinorelbine,0.9261,Vinblastine,0.9227,Vorinostat,0.9220,Vemurafenib,0.9214
Bevicizumab,Bevacizumab,1,2,Bevacizumab,0.9282,Bortezomib,0.9163,Mivobulin Isethionate,0.9143,Cabiralizumab,0.9121,Ramucirumab,0.9107
Bilateral Ovarian cystectomy,Bilateral;Ovarian;Cystectomy,1,2,Bilateral;Ovarian;Cystectomy,0.9893,Cystectomy,0.9547,Bilateral Salpingectomy with Oophorectomy,0.9535,Bilateral Salpingectomy,0.9534,Unilateral Salpingo-oophorectomy,0.9486
Bilateral Salpingo-Oophorectomy,Bilateral Salpingectomy with Oophorectomy,1,2,Bilateral Salpingectomy with Oophorectomy,0.9848,Unilateral Salpingo-oophorectomy,0.9845,Bilateral Salpingectomy,0.9792,Unilateral Oophorectomy,0.9678,Bilateral;Ovarian;Cystectomy,0.9570
Bilateral breast reconstruction with tissue expanders.,Tissue Expander-Implant Breast Reconstruction;Bilateral,1,2,Tissue Expander-Implant Breast Reconstruction;Bilateral,0.9892,Bilateral Mastectomy,0.9424,Bilateral;Total Mastectomy,0.9424,Bilateral;Skin-Sparing Mastectomy,0.9387,Bilateral;Ovarian;Cystectomy,0.9374
Bilateral skin sparing Mastectomy,Bilateral;Skin-Sparing Mastectomy,1,2,Bilateral;Skin-Sparing Mastectomy,0.9959,Skin-Sparing Mastectomy;Radical Mastectomy,0.9688,Bilateral Mastectomy,0.9488,Bilateral;Total Mastectomy,0.9379,Mastectomy,0.9361
Bile Duct Resection,Bile Duct;Resection,1,2,Bile Duct;Resection,0.9910,Resection,0.9432,Lung;Resection,0.9293,Pancreaticoduodenectomy,0.9259,Hepatectomy,0.9225
Binimetinib (MEK162),Binimetinib,1,2,Binimetinib,0.9785,Cobimetinib,0.9455,Anti-CD33 Monoclonal Antibody BI 836858,0.9308,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9294,Axitinib,0.9233
Biochemo,Biochemotherapy,1,2,Biochemotherapy,0.9580,Bleomycin,0.8988,Dasatinib,0.8952,Sabatolimab,0.8866,Ifabotuzumab,0.8855
Bisulfan,Busulfan,4,2,Pracinostat,0.9135,Vorinostat,0.9096,Histone Deacetylase Inhibitor,0.9094,Busulfan,0.9064,Azathioprine,0.9052
Bladder diverticulectomy,bladder diverticulectomy,1,2,bladder diverticulectomy,1.0000,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,0.9263,Cystectomy,0.9260,Nephroureterectomy,0.9158,Transurethral Resection of Bladder Tumor,0.9143
Bleo,Bleomycin,2,2,Bevacizumab,0.9161,Bleomycin,0.9144,Biopsy,0.8919,Binimetinib,0.8918,Bilateral Salpingectomy,0.8907
Blood Draw,Blood Sample,1,2,Blood Sample,0.9485,Donor Lymphocyte Infusion,0.9060,Biopsy,0.9040,Skin Biopsy,0.8920,Liver Biopsy,0.8907
Bone marrow transplant,Bone Marrow Transplantation,1,2,Bone Marrow Transplantation,0.9911,Hematopoietic Cell Transplantation,0.9430,Autologous Hematopoietic Stem Cell Transplantation,0.9316,Sibling;Allogeneic Hematopoietic Stem Cell Transplantation,0.9177,Matched Unrelated Donor;Allogeneic Hematopoietic Stem Cell Transplantation,0.9152
Breast Conservation,Breast Conservation Treatment,1,2,Breast Conservation Treatment,0.9747,Bilateral;Skin-Sparing Mastectomy,0.9271,Left;Biopsy of Breast,0.9190,Lumpectomy;Right Breast,0.9143,Tissue Flap Breast Reconstruction,0.9142
Bu,Busulfan,1,2,Busulfan,0.9061,Bevacizumab,0.8947,Crenolanib,0.8939,Buparlisib,0.8916,Bleomycin,0.8882
Busul,Busulfan,1,2,Busulfan,0.9366,Lisavanbulin,0.8928,Bevacizumab,0.8909,Lapatinib,0.8883,Zoligratinib,0.8871
CABOZANTINIB (XL-148),Cabozantinib,1,2,Cabozantinib,0.9621,Cabazitaxel,0.9419,JAK2 Inhibitor AZD1480,0.9225,Cabiralizumab,0.9214,Nab-paclitaxel,0.9188
CAI (NABTT 97212),Carboxyamidotriazole,99,2,Nab-paclitaxel,0.9245,AALL0232 ALL Study Identifier;Dexamethasone,0.9239,AALL0232 ALL Study Identifier,0.9145,Anti-CD33 Monoclonal Antibody BI 836858,0.9142,Anti-CD98 Monoclonal Antibody IGN523,0.9139
CAPECITABINE,Capecitabine,1,2,Capecitabine,1.0000,Gemcitabine,0.9270,Temozolomide,0.9240,Docetaxel,0.9227,Letrozole,0.9211
CARBOPLATIN,Carboplatin,1,2,Carboplatin,1.0000,Cisplatin,0.9385,Cetuximab,0.9345,Cyclophosphamide,0.9253,Platinum,0.9244
CBL0137,FACT Complex-targeting Curaxin CBL0137,1,2,FACT Complex-targeting Curaxin CBL0137,0.9368,AALL0331 ALL Study Identifier,0.9050,Anti-CD98 Monoclonal Antibody IGN523,0.9039,AALL0232 ALL Study Identifier,0.9012,Gamma-Secretase Inhibitor RO4929097,0.9008
CC115,DNA-PK/TOR Kinase Inhibitor CC-115,1,2,DNA-PK/TOR Kinase Inhibitor CC-115,0.9293,Celecoxib,0.9082,FACT Complex-targeting Curaxin CBL0137,0.8961,Anti-CD98 Monoclonal Antibody IGN523,0.8916,Capecitabine,0.8901
CCNU,Lomustine,99,2,Celecoxib,0.9151,Carboplatin,0.9060,Cyclin-Dependent Kinase Inhibitor,0.9053,Everolimus,0.9040,Cetuximab,0.9013
CD123,Immunotherapeutic Agent,99,2,AALL0232 ALL Study Identifier;Dexamethasone,0.9072,Dexamethasone,0.8988,Anti-CD33 Monoclonal Antibody BI 836858,0.8979,Anti-CD3 Monoclonal Antibody,0.8949,Anti-CD98 Monoclonal Antibody IGN523,0.8934
CD3,Anti-CD3 Monoclonal Antibody,1,2,Anti-CD3 Monoclonal Antibody,0.9601,Anti-CD33 Monoclonal Antibody BI 836858,0.9457,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9133,Chimeric Antigen Receptor T-Cell Therapy,0.9123,Cetuximab,0.9110
CDK46,Cyclin-Dependent Kinase Inhibitor,1,2,Cyclin-Dependent Kinase Inhibitor,0.9126,FLT3/CDK4/6 Inhibitor FLX925,0.9086,Vorinostat,0.8997,Lenalidomide,0.8972,FAK Inhibitor VS-4718,0.8967
CDX-011 (GLEMBATUMUMAB),Glembatumumab,1,2,Glembatumumab,0.9504,Anti-CD98 Monoclonal Antibody IGN523,0.9386,Anti-CD33 Monoclonal Antibody BI 836858,0.9332,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9311,AALL0232 ALL Study Identifier;Dexamethasone,0.9268
CELECOXIB,Celecoxib,1,2,Celecoxib,1.0000,Cetuximab,0.9257,Cyclophosphamide,0.9155,Everolimus,0.9145,Carboplatin,0.9145
CGC(PG)-11047,Polyamine Analogue PG11047,1,2,Polyamine Analogue PG11047,0.9439,Topoisomerase I Inhibitor Genz-644282,0.9171,DNA-PK/TOR Kinase Inhibitor CC-115,0.9167,Purine Analogue NSC 750854,0.9127,Gamma-Secretase Inhibitor RO4929097,0.9105
CI-980,Mivobulin Isethionate,99,2,Cixutumumab,0.9187,Gamma-Secretase Inhibitor RO4929097,0.9087,Anti-CD98 Monoclonal Antibody IGN523,0.9077,CENP-E Inhibitor GSK-923295A,0.9065,Purine Analogue NSC 750854,0.9040
CIS,Cisplatin,1,2,Cisplatin,0.9037,Cixutumumab,0.9009,Carboplatin,0.8985,Azacitidine,0.8897,Cetuximab,0.8893
CISPLATIN,Cisplatin,1,2,Cisplatin,1.0000,Platinum,0.9493,Carboplatin,0.9385,Oxaliplatin,0.9214,Cetuximab,0.9208
CORE,Core Biopsy,1,2,Core Biopsy,0.9543,Core Biopsy;Liver Lesion,0.9409,Cinrebafusp Alfa,0.8787,Liver Biopsy,0.8785,mTOR Inhibitor;Immunotherapeutic Agent,0.8771
CPI-613,Devimistat,99,2,Purine Analogue NSC 750854,0.9121,Nitrogen Mustard Prodrug PR-104,0.9101,DNA-PK/TOR Kinase Inhibitor CC-115,0.9063,Ponatinib,0.9025,Topoisomerase I Inhibitor Genz-644282,0.9025
CPT-11,Irinotecan Hydrochloride,5,2,Irinotecan,0.9176,DNA-PK/TOR Kinase Inhibitor CC-115,0.9154,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9122,Topoisomerase-I Inhibitor,0.9120,Irinotecan Hydrochloride,0.9113
CPX-351,Liposome-encapsulated Daunorubicin-Cytarabine,99,2,Purine Analogue NSC 750854,0.9144,Paclitaxel,0.9103,Anti-PLGF Monoclonal Antibody TB-403,0.9078,Nitrogen Mustard Prodrug PR-104,0.9074,FACT Complex-targeting Curaxin CBL0137,0.9064
CPX351,Liposome-encapsulated Daunorubicin-Cytarabine,99,2,Purine Analogue NSC 750854,0.9052,CXCR4 Inhibitor,0.9021,Gamma-Secretase Inhibitor RO4929097,0.8980,Nitrogen Mustard Prodrug PR-104,0.8974,DNA-PK/TOR Kinase Inhibitor CC-115,0.8963
CSF1R inhibitor,Immunosuppressant,99,2,CXCR4 Inhibitor,0.9309,FLT3/CDK4/6 Inhibitor FLX925,0.9294,mTOR Inhibitor,0.9246,AKT Inhibitor,0.9242,Gamma-Secretase Inhibitor RO4929097,0.9238
CTL019,Tisagenlecleucel,99,2,Talimogene Laherparepvec,0.8991,Vadastuximab Talirine,0.8972,FACT Complex-targeting Curaxin CBL0137,0.8958,Anti-CD98 Monoclonal Antibody IGN523,0.8907,Cilengitide,0.8906
CVT,Regadenoson,99,2,Valspodar,0.9135,Cyclophosphamide,0.9117,Cixutumumab,0.9084,Cetuximab,0.9065,Cytarabine,0.9061
CX-01,Dociparstat sodium,99,2,Cixutumumab,0.9109,DNA-PK/TOR Kinase Inhibitor CC-115,0.8983,Celecoxib,0.8920,FACT Complex-targeting Curaxin CBL0137,0.8908,NY-ESO-1 Peptide Vaccine,0.8905
CX-5461 (POL1),Pidnarulex,99,2,Purine Analogue NSC 750854,0.9287,Topoisomerase I Inhibitor Genz-644282,0.9274,HDM2 Inhibitor MK-8242,0.9230,CENP-E Inhibitor GSK-923295A,0.9224,DNA-PK/TOR Kinase Inhibitor CC-115,0.9222
CXCR4 inhibitor,CXCR4 Inhibitor,1,2,CXCR4 Inhibitor,1.0000,AKT Inhibitor,0.9320,Aromatase Inhibitor,0.9301,FLT3/CDK4/6 Inhibitor FLX925,0.9245,Topoisomerase-I Inhibitor,0.9240
CY,Cyclophosphamide,1,2,Cyclophosphamide,0.9315,Cytarabine,0.9111,Cyclosporine,0.9110,Cetuximab,0.9095,Cixutumumab,0.9092
CYCLOPHOSPHAMIDE,Cyclophosphamide,1,2,Cyclophosphamide,1.0000,Carboplatin,0.9253,Azathioprine,0.9185,Temozolomide,0.9171,Cladribine,0.9170
CYSTOPROSTATECTOMY,Radical Cystoprostatectomy,1,2,Radical Cystoprostatectomy,0.9804,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9605,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9600,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9548,Partial Cystectomy,0.9444
CYTARABINE,Cytarabine,1,2,Cytarabine,1.0000,Liposomal Cytarabine,0.9671,Liposome-encapsulated Daunorubicin-Cytarabine,0.9303,Cytosine,0.9231,Cyclosporine,0.9182
Cabivalizumab,Cabiralizumab,1,2,Cabiralizumab,0.9658,Cabazitaxel,0.9510,Cabozantinib,0.9393,Bevacizumab,0.9223,Ibrutinib,0.9207
Cabo,Cabozantinib,1,2,Cabozantinib,0.9507,Cabazitaxel,0.9490,Cabiralizumab,0.9345,Cetuximab,0.8870,Bicalutamide,0.8836
Cape,Capecitabine,3,2,Cetuximab,0.9058,Cytarabine,0.9036,Capecitabine,0.9020,Celecoxib,0.9000,Entospletinib,0.8942
Capectitabine,Capecitabine,99,2,Cladribine,0.9214,Azathioprine,0.9193,Gemtuzumab,0.9189,Clofarabine,0.9161,Gemcitabine,0.9139
Carbo,Carboplatin,4,2,Celecoxib,0.8976,Cytosine,0.8972,Carboxyamidotriazole,0.8933,Carboplatin,0.8919,Cyclophosphamide,0.8899
Cart-T cell therapy,Chimeric Antigen Receptor T-Cell Therapy,1,2,Chimeric Antigen Receptor T-Cell Therapy,0.9478,Chimeric Antigen Receptor T-Cell Therapy;Therapeutic Apheresis,0.9350,mTOR Inhibitor;Immunotherapeutic Agent,0.9145,Hematopoietic Cell Transplantation,0.9144,Anti-CD3 Monoclonal Antibody,0.9142
Casodex,Bicalutamide,99,2,Cetuximab,0.9082,Dutasteride,0.8971,Serdemetan,0.8956,Alisertib,0.8930,Dociparstat sodium,0.8928
Casoxdex,Bicalutamide,99,2,Indoximod,0.9138,Buthionine Sulfoximine,0.9069,Anti-CD33 Monoclonal Antibody BI 836858,0.9030,Anti-CD98 Monoclonal Antibody IGN523,0.9022,Cixutumumab,0.9016
Caudate segmentectomy,Caudate Lobe;Segmentectomy,1,2,Caudate Lobe;Segmentectomy,0.9850,Segmentectomy;Single,0.9430,Segmentectomy;Multiple,0.9166,Lobectomy,0.9150,Ureterectomy,0.9106
Celgene CC-15,DNA-PK/TOR Kinase Inhibitor CC-115,1,2,DNA-PK/TOR Kinase Inhibitor CC-115,0.9117,Cyclophosphamide,0.9096,Celecoxib,0.9085,Decitabine,0.8954,Cytosine,0.8949
Cellcept,Mycophenolate Mofetil,99,2,Chimeric Antigen Receptor T-Cell Therapy,0.9164,Rituximab,0.9163,Cetuximab,0.9115,Anti-CD33 Monoclonal Antibody BI 836858,0.9109,Ifabotuzumab,0.9094
Cepecitabine,Capecitabine,99,2,Decitabine,0.9387,Dacomitinib,0.9237,Azacitidine,0.9222,Edicotinib,0.9175,Cytarabine,0.9170
Cis,Cisplatin,1,2,Cisplatin,0.9037,Cixutumumab,0.9009,Carboplatin,0.8985,Azacitidine,0.8897,Cetuximab,0.8893
Cobemitinib,Cobimetinib,1,2,Cobimetinib,0.9497,Dacomitinib,0.9292,Cytarabine,0.9267,Gilteritinib,0.9222,Liposomal Cytarabine,0.9184
Conformal,"Radiotherapy, Conformal",1,2,"Radiotherapy, Conformal",0.9516,External Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9148,Proton Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9096,Rovalpituzumab Tesirine,0.8874,Azacitidine Regimen,0.8847
Core Biopsy of liver lesion,Core Biopsy;Liver Lesion,1,2,Core Biopsy;Liver Lesion,0.9945,Core Biopsy,0.9681,Liver Biopsy,0.9631,Biopsy,0.9239,Skin Biopsy,0.9207
CsPt,Cisplatin,99,2,Celecoxib,0.9031,DNA-PK/TOR Kinase Inhibitor CC-115,0.9028,Anti-PLGF Monoclonal Antibody TB-403,0.9020,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9019,Cyclosporine,0.9018
Ctx,Cyclophosphamide,1,2,Cyclophosphamide,0.9247,Capecitabine,0.9191,Cetuximab,0.9189,Celecoxib,0.9149,Carboplatin,0.9136
Cy,Cyclophosphamide,1,2,Cyclophosphamide,0.9315,Cytarabine,0.9111,Cyclosporine,0.9110,Cetuximab,0.9095,Cixutumumab,0.9092
CyPh,Cyclophosphamide,1,2,Cyclophosphamide,0.9086,Ketoconazole,0.9038,Cytarabine,0.9037,Prednisolone,0.9033,Cyclosporine,0.9011
Cyclophoshamide,Cyclophosphamide,99,2,Apalutamide,0.9118,Phenethyl Isothiocyanate,0.9076,Purine Analogue NSC 750854,0.9075,Hydroxyurea,0.9061,Carboxyamidotriazole,0.9039
Cyclophospha,Cyclophosphamide,99,2,Valspodar,0.9125,Cyclosporine,0.9052,Prednisone,0.9011,Apalutamide,0.8984,Prednisolone,0.8967
Cystoprostatectomy,Radical Cystoprostatectomy,1,2,Radical Cystoprostatectomy,0.9804,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9605,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9600,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9548,Partial Cystectomy,0.9444
Cystoprostatectomy (robotic),Radical Cystoprostatectomy;Robot-Assisted Surgery,2,2,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9807,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9798,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9761,Radical Cystoprostatectomy,0.9733,Robot-Assisted Surgery;Cystectomy,0.9574
Cystoprotatectomy,Radical Cystoprostatectomy,1,2,Radical Cystoprostatectomy,0.9561,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9442,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9440,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9401,Partial Cystectomy,0.9302
Cytarabine - liposomal,Liposomal Cytarabine,1,2,Liposomal Cytarabine,0.9874,Cytarabine,0.9661,Liposome-encapsulated Daunorubicin-Cytarabine,0.9610,Cyclosporine,0.9148,Chimeric Antigen Receptor T-Cell Therapy;Therapeutic Apheresis,0.9147
Cytoxan,Cyclophosphamide,99,2,Liposomal Cytarabine,0.9263,Cytarabine,0.9251,Mitoxantrone,0.9231,Capecitabine,0.9139,Cixutumumab,0.9133
Cyx,Cyclophosphamide,1,2,Cyclophosphamide,0.9271,Cixutumumab,0.9251,Cytarabine,0.9068,Cyclosporine,0.9063,Cetuximab,0.9048
DC vaccine,Dendritic Cell Vaccine,1,2,Dendritic Cell Vaccine,0.9684,Vaccine,0.9395,Decitabine,0.9181,Dexamethasone,0.9111,Liposome-encapsulated Daunorubicin-Cytarabine,0.9110
DC_VAX,Dendritic Cell Vaccine,2,2,Vadastuximab Talirine,0.9088,Dendritic Cell Vaccine,0.9063,Dactinomycin,0.8997,Vinorelbine,0.8957,Seviteronel,0.8953
DLL4/VEGF antibody OMP-305B83,Navicixizumab,99,2,Anti-PLGF Monoclonal Antibody TB-403,0.9424,FLT3/CDK4/6 Inhibitor FLX925,0.9289,Anti-CD98 Monoclonal Antibody IGN523,0.9266,Anti-HGF Monoclonal Antibody TAK-701,0.9259,Anti-CD33 Monoclonal Antibody BI 836858,0.9233
DOPAMINE,Dopamine,1,2,Dopamine,1.0000,Daunorubicin,0.9075,Epinephrine,0.9049,Adalimumab,0.9031,Liposome-encapsulated Daunorubicin-Cytarabine,0.9031
DTIC,Dacarbazine,1,2,Dacarbazine,0.9170,Dactolisib,0.9135,Dactinomycin,0.9133,Adalimumab,0.9096,Ifabotuzumab,0.9090
DURVALUMAB,Durvalumab,1,2,Durvalumab,1.0000,Daratumumab,0.9169,Ramucirumab,0.9113,Veliparib,0.9112,Robatumumab,0.9105
Debio-1347,Zoligratinib,99,2,Primary Debulking Surgery,0.9030,Purine Analogue NSC 750854,0.9014,PIM Kinase Inhibitor SGI-1776,0.8945,Anti-PLGF Monoclonal Antibody TB-403,0.8938,AALL0232 ALL Study Identifier;Dexamethasone,0.8921
Debulking surgery,Tumor Debulking,1,2,Tumor Debulking,0.9743,Primary Debulking Surgery,0.9736,Interval Debulking Surgery,0.9544,Secondary;Tumor Debulking,0.9486,Vulva;Resection,0.9061
Decitbne,Decitabine,1,2,Decitabine,0.9371,Dactinomycin,0.9084,Devimistat,0.9042,Dacarbazine,0.9022,Dactolisib,0.9006
Decortin H,Prednisolone,99,2,Dactinomycin,0.9195,Ivosidenib,0.8993,Decitabine,0.8990,Dacomitinib,0.8988,Denintuzumab Mafodotin,0.8981
Distal pancreatectomy,Distal Pancreatectomy,1,2,Distal Pancreatectomy,1.0000,Pancreaticoduodenectomy,0.9545,Total Pancreatectomy,0.9454,Pylorus-sparing pancreaticoduodenectomy (procedure),0.9313,Uncinate Process of Pancreas;Resection,0.9256
Double Umbilical Cord Blood Transplant (DUCBT),Double-Unit Umbilical Cord Blood Transplantation,1,2,Double-Unit Umbilical Cord Blood Transplantation,0.9689,Matched Unrelated Donor;Allogeneic Hematopoietic Stem Cell Transplantation,0.9338,Sibling;Allogeneic Hematopoietic Stem Cell Transplantation,0.9236,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9187,Autologous Hematopoietic Stem Cell Transplantation,0.9164
Durvalumab (GIC026),Durvalumab,1,2,Durvalumab,0.9607,Anti-CD98 Monoclonal Antibody IGN523,0.9287,MDM2/MDMX Inhibitor ALRN-6924,0.9282,AALL0232 ALL Study Identifier;Dexamethasone,0.9260,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9213
E7070,Indisulam,99,2,Anti-CD98 Monoclonal Antibody IGN523,0.8865,FAK Inhibitor VS-4718,0.8848,Imatinib,0.8838,Talimogene Laherparepvec,0.8795,Anti-PLGF Monoclonal Antibody TB-403,0.8795
E7438/EPZ6438,Tazemetostat,99,2,Anti-PLGF Monoclonal Antibody TB-403,0.8947,Esophagectomy;External,0.8937,CENP-E Inhibitor GSK-923295A,0.8924,Topoisomerase I Inhibitor Genz-644282,0.8920,Entospletinib,0.8892
EBRT,External Beam Radiation Therapy,1,2,External Beam Radiation Therapy,0.9307,External Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9198,Abiraterone,0.9170,Radiation Therapy,0.9161,Everolimus,0.9148
EC1456,Folate Receptor-Targeted Tubulysin Conjugate EC1456,1,2,Folate Receptor-Targeted Tubulysin Conjugate EC1456,0.9307,JAK2 Inhibitor AZD1480,0.9038,FAK Inhibitor VS-4718,0.8958,Etoposide,0.8947,Apoptotic Pathway-targeting Antineoplastic Agent,0.8945
EGFR inhibitor,Anti-EGFR Monoclonal Antibody,1,2,Anti-EGFR Monoclonal Antibody,0.9617,AKT Inhibitor,0.9335,Gefitinib,0.9321,Erlotinib,0.9317,Aromatase Inhibitor,0.9292
EPINEPHRINE,Epinephrine,1,2,Epinephrine,1.0000,Epirubicin,0.9147,l-Norepinephrine,0.9098,Dopamine,0.9049,Etoposide,0.9026
ERIBULIN,Eribulin,1,2,Eribulin,1.0000,Empesertib,0.9158,Regorafenib,0.9147,Dabrafenib,0.9133,Epirubicin,0.9110
ESD,Endoscopic Submucosal Dissection,1,2,Endoscopic Submucosal Dissection,0.9344,Esophagectomy,0.9168,Everolimus,0.9162,Edicotinib,0.9119,Decitabine,0.9102
EXCISION,Excision,1,2,Excision,1.0000,Skin Excision,0.9746,Excisional Biopsy,0.9607,Transanal Excision,0.9471,Re-Excision,0.9433
EXCISION WITH NEEDLE WIRE LOCALIZATION,Excision;Wire-Guided Localization,1,2,Excision;Wire-Guided Localization,0.9767,Wire-Guided Localization;Segmental Mastectomy,0.9543,Wire-Guided Localization;Right Breast;Biopsy;Wire-Guided Localization;Right Breast,0.9470,Wire-Guided Localization,0.9452,Excision,0.9312
Endoxan,Cyclophosphamide,99,2,Epinephrine,0.9082,Epirubicin,0.9078,Edicotinib,0.9069,Prexasertib,0.9021,Exploratory Surgery;External,0.9021
Esophagectomy (outside),Esophagectomy;External,2,2,Esophagectomy,0.9590,Esophagectomy;External,0.9567,Exploratory Surgery;External,0.9286,Right;Mediastinal Mass;Excision,0.9218,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,0.9213
Et,Etoposide,99,2,Trametinib,0.8891,Tamibarotene,0.8886,Tamoxifen,0.8886,Gemtuzumab,0.8853,Folate Receptor-Targeted Tubulysin Conjugate EC1456,0.8837
Etopside,Etoposide,1,2,Etoposide,0.9305,Topotecan,0.9103,Etoposide Phosphate,0.9059,Oxaliplatin,0.9033,Craniotomy,0.9010
Excisional biopsy,Excisional Biopsy,1,2,Excisional Biopsy,1.0000,Excision,0.9607,Skin Excision,0.9473,Re-Excision;Biopsy Site,0.9366,Punch Biopsy,0.9339
Excisional biospy,Excisional Biopsy,1,2,Excisional Biopsy,0.9460,Excision,0.9401,Skin Excision,0.9237,Re-Excision;Original;Lumpectomy;Surgical Site,0.9127,Local excision (procedure),0.9122
Exploration,Exploratory Surgery,1,2,Exploratory Surgery,0.9197,Exploratory Surgery;Laparotomy,0.9133,Exploratory Surgery;External,0.9059,Excision;Wire-Guided Localization,0.8948,Retromammary space (body structure);Lymphadenectomy,0.8937
Exploration (outside),Exploratory Surgery;External,1,2,Exploratory Surgery;External,0.9185,Inner;Upper;Surgical Margin;Re-Excision,0.9028,Wide;Re-Excision;Biopsy,0.9020,Excision;Wire-Guided Localization,0.9020,Esophagectomy;External,0.8998
Exploratory laparotomy,Exploratory Surgery;Laparotomy,1,2,Exploratory Surgery;Laparotomy,0.9831,Exploratory Surgery,0.9712,Exploratory Surgery;External,0.9385,Pelvic Exenteration,0.9162,Appendectomy,0.9120
Extended Lobectomy,Extend;Lobectomy,1,2,Extend;Lobectomy,0.9677,Lobectomy,0.9519,Lung;Resection,0.9183,Left Hemihepatectomy,0.9141,Right Hemihepatectomy,0.9104
External Beam,External Beam Radiation Therapy,1,2,External Beam Radiation Therapy,0.9828,External Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9361,Esophagectomy;External,0.9283,Exploratory Surgery;External,0.9179,Proton Beam Radiation Therapy,0.9164
"External Beam, 3D Conformal",External Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,1,2,External Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9769,External Beam Radiation Therapy,0.9567,"Radiotherapy, Conformal",0.9550,Proton Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9548,Proton Beam Radiation Therapy,0.9149
FENRETINIDE,Fenretinide,1,2,Fenretinide,1.0000,Isotretinoin,0.9242,Clofarabine,0.9206,Fluorouracil,0.9136,Ifosfamide,0.9131
FLUORO-PYRIMIDINE,Fluoropyrimidine,1,2,Fluoropyrimidine,0.9778,Fluorouracil,0.9420,Floxuridine,0.9180,Fludarabine,0.9175,Afatinib,0.9134
FLX925,FLT3/CDK4/6 Inhibitor FLX925,1,2,FLT3/CDK4/6 Inhibitor FLX925,0.9482,Afatinib,0.9032,FAK Inhibitor VS-4718,0.9004,Fludarabine,0.8993,Ifosfamide,0.8981
FNA,Fine-Needle Aspiration,1,2,Fine-Needle Aspiration,0.9487,Aspiration,0.9243,Fluorouracil,0.9198,Afatinib,0.9155,Biopsy,0.9089
FOLIC_ACID,Folic Acid,1,2,Folic Acid,0.9892,Valproic Acid,0.9242,Fluorouracil,0.9198,Clofarabine,0.9139,Purine Analogue NSC 750854,0.9076
FSRT,Fractionated Stereotactic Radiation Therapy,99,2,Ifosfamide,0.9227,Fluorouracil,0.9204,Afatinib,0.9127,Pexidartinib,0.9106,Fotemustine,0.9100
FU,Fluorouracil,1,2,Fluorouracil,0.9595,Fotemustine,0.9233,Fluoropyrimidine,0.9196,Floxuridine,0.9189,Fludarabine,0.9173
FUDR,Floxuridine,3,2,Fluorouracil,0.9464,Fludarabine,0.9314,Floxuridine,0.9213,Fotemustine,0.9193,Fluoropyrimidine,0.9152
FULVESTRANT,Fulvestrant,1,2,Fulvestrant,1.0000,Afatinib,0.9265,Tamoxifen,0.9234,Vemurafenib,0.9209,Dabrafenib,0.9192
Fine Needle aspiration biopsy,Fine-Needle Aspiration,1,2,Fine-Needle Aspiration,0.9879,Biopsy,0.9290,Aspiration,0.9217,Core Biopsy,0.9166,Skin Biopsy,0.9152
Fine needle aspiration biopsy,Fine-Needle Aspiration,1,2,Fine-Needle Aspiration,0.9879,Biopsy,0.9290,Aspiration,0.9217,Core Biopsy,0.9166,Skin Biopsy,0.9152
Flu,Fludarabine,1,2,Fludarabine,0.9470,Fluorouracil,0.9092,Afatinib,0.9058,Fluoropyrimidine,0.8993,Fenretinide,0.8986
Fluorouracil (5-FU),Fluorouracil,1,2,Fluorouracil,0.9770,Fluoropyrimidine,0.9478,Fotemustine,0.9343,Floxuridine,0.9334,Fludarabine,0.9294
Fluropyrimidine,Fluoropyrimidine,1,2,Fluoropyrimidine,0.9630,Fludarabine,0.9330,Fluorouracil,0.9285,Afatinib,0.9169,Clofarabine,0.9129
G-CSF,Granulocyte Colony-Stimulating Factor,1,2,Granulocyte Colony-Stimulating Factor,0.9386,Gemtuzumab,0.9165,Immunoglobulin,0.9102,Gemtuzumab Ozogamicin,0.9098,Gemcitabine,0.9091
G3139,Oblimersen Sodium,99,2,Anti-ErbB3 Monoclonal Antibody REGN1400,0.8972,PIM Kinase Inhibitor SGI-1776,0.8968,Gemcitabine,0.8916,Purine Analogue NSC 750854,0.8911,Polyamine Analogue PG11047,0.8905
GCSF,Granulocyte Colony-Stimulating Factor,1,2,Granulocyte Colony-Stimulating Factor,0.9075,Glasdegib,0.8986,Ganetespib,0.8929,Gefitinib,0.8854,Cytosine,0.8851
GDC0032,Taselisib,99,2,Purine Analogue NSC 750854,0.9002,AALL0232 ALL Study Identifier;Dexamethasone,0.9001,PIM Kinase Inhibitor SGI-1776,0.8986,Polyamine Analogue PG11047,0.8967,Anti-CD98 Monoclonal Antibody IGN523,0.8945
GEM,Gemcitabine,3,2,Gemtuzumab,0.9676,Gemtuzumab Ozogamicin,0.9526,Gemcitabine,0.9300,Pemetrexed,0.9104,Gefitinib,0.9065
GENZ-644282,Topoisomerase I Inhibitor Genz-644282,1,2,Topoisomerase I Inhibitor Genz-644282,0.9664,PIM Kinase Inhibitor SGI-1776,0.9026,DNA-PK/TOR Kinase Inhibitor CC-115,0.9008,Gamma-Secretase Inhibitor RO4929097,0.8990,AALL0232 ALL Study Identifier;Dexamethasone,0.8985
GK,Gamma Knife,1,2,Gamma Knife,0.9280,Gemtuzumab,0.9143,Gemcitabine,0.9132,Gemtuzumab Ozogamicin,0.9119,Ganetespib,0.9030
GS-9820,Acalisib,99,2,Gamma-Secretase Inhibitor RO4929097,0.9280,Anti-CD98 Monoclonal Antibody IGN523,0.9209,Purine Analogue NSC 750854,0.9194,Polyamine Analogue PG11047,0.9179,AALL0232 ALL Study Identifier;Dexamethasone,0.9162
GSK690693,Pan-AKT Kinase Inhibitor GSK690693,1,2,Pan-AKT Kinase Inhibitor GSK690693,0.9590,CENP-E Inhibitor GSK-923295A,0.9239,FAK Inhibitor VS-4718,0.9117,FLT3/CDK4/6 Inhibitor FLX925,0.9087,PIM Kinase Inhibitor SGI-1776,0.9085
GSK923295A,CENP-E Inhibitor GSK-923295A,1,2,CENP-E Inhibitor GSK-923295A,0.9548,Pan-AKT Kinase Inhibitor GSK690693,0.9354,FLT3/CDK4/6 Inhibitor FLX925,0.9277,Gamma-Secretase Inhibitor RO4929097,0.9259,FAK Inhibitor VS-4718,0.9221
Gamma knife,Gamma Knife,1,2,Gamma Knife,1.0000,Stereotactic Radiosurgery,0.9025,Gamma-Secretase Inhibitor RO4929097,0.9018,Heat-Treated Varicella-Zoster Virus Vaccine V212,0.8936,Gemcitabine,0.8921
Gem,Gemcitabine,3,2,Gemtuzumab,0.9676,Gemtuzumab Ozogamicin,0.9526,Gemcitabine,0.9300,Pemetrexed,0.9104,Gefitinib,0.9065
Gemcitabin,Gemcitabine,1,2,Gemcitabine,0.9378,Gemtuzumab Ozogamicin,0.9223,Gemtuzumab,0.9200,Galunisertib,0.9106,Cladribine,0.9082
Gemtuzumab ozogamicin,Gemtuzumab Ozogamicin,1,2,Gemtuzumab Ozogamicin,1.0000,Gemtuzumab,0.9775,Galunisertib,0.9204,Atezolizumab,0.9193,Gemcitabine,0.9185
Genasense,Oblimersen Sodium,99,2,Topoisomerase I Inhibitor Genz-644282,0.9112,Galunisertib,0.8962,Gemcitabine,0.8925,Crenolanib,0.8912,Navitoclax,0.8887
Gengraft (anti-GVHD),Cyclosporine,99,2,Topoisomerase I Inhibitor Genz-644282,0.9174,Granulocyte Colony-Stimulating Factor,0.9136,Anti-HGF Monoclonal Antibody TAK-701,0.9107,Graft,0.9105,Filgrastim,0.9076
Gilteritinib (ASP2215),Gilteritinib,1,2,Gilteritinib,0.9674,PIM Kinase Inhibitor SGI-1776,0.9327,Dacomitinib,0.9271,AALL0232 ALL Study Identifier;Dexamethasone,0.9265,Peginterferon Alfa-2a,0.9256
Gleevac,Imatinib Regimen,99,2,Glembatumumab,0.9086,Seviteronel,0.9027,Valspodar,0.9000,Imatinib,0.8954,Entospletinib,0.8907
HAI,Intrahepatic Infusion Procedure,99,2,Trastuzumab,0.9073,Peginterferon Alfa-2a,0.9007,Anti-HGF Monoclonal Antibody TAK-701,0.8981,Ifabotuzumab,0.8950,Pertuzumab,0.8946
HDAC inhibitor,Histone Deacetylase Inhibitor,1,2,Histone Deacetylase Inhibitor,0.9764,Vorinostat,0.9344,Topoisomerase-I Inhibitor,0.9330,Topoisomerase-II Inhibitor,0.9323,AKT Inhibitor,0.9319
HDR,High-Dose Rate Brachytherapy,1,2,High-Dose Rate Brachytherapy,0.9194,Daratumumab,0.9135,Dutasteride,0.9121,Pulsed-Dose Rate Brachytherapy,0.9088,Trastuzumab,0.9076
HGS-ETR1,Mapatumumab,99,2,Trastuzumab Emtansine,0.9121,Folate Receptor-Targeted Tubulysin Conjugate EC1456,0.9104,Gemtuzumab,0.9102,Trastuzumab,0.9085,DNA-PK/TOR Kinase Inhibitor CC-115,0.9037
HSPPC-96 vaccine,Vitespen,99,2,Heat-Treated Varicella-Zoster Virus Vaccine V212,0.9147,Pan-AKT Kinase Inhibitor GSK690693,0.9142,CENP-E Inhibitor GSK-923295A,0.9136,Polyamine Analogue PG11047,0.9112,Gamma-Secretase Inhibitor RO4929097,0.9073
HU,Hydroxyurea,1,2,Hydroxyurea,0.9214,Carboplatin,0.8865,Erlotinib Hydrochloride,0.8854,Anti-HGF Monoclonal Antibody TAK-701,0.8848,Anti-CD98 Monoclonal Antibody IGN523,0.8843
Haplo,Haploidentical Hematopoietic Cell Transplantation,1,2,Haploidentical Hematopoietic Cell Transplantation,0.9017,Sibling;Allogeneic Hematopoietic Stem Cell Transplantation,0.8868,Buparlisib,0.8840,Lymphadenectomy,0.8837,Tamoxifen,0.8820
Herceptin,Trastuzumab,1,2,Trastuzumab,0.9605,Lapatinib,0.9199,Trastuzumab Emtansine,0.9176,Ipilimumab,0.9156,HER2-targeting Agent,0.9118
Hydrea,Hydroxyurea,3,2,Vorinostat,0.9036,Proton Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9001,Hydroxyurea,0.8960,Pertuzumab,0.8944,Histone Deacetylase Inhibitor,0.8936
IDAC,Cytarabine,99,2,Idarubicin,0.9445,Idasanutlin,0.9378,Adalimumab,0.9132,Dabrafenib,0.9132,Iodine,0.9006
IDO1 inhibitor,IDO Inhibitor,1,2,IDO Inhibitor,0.9899,JAK1 Inhibitor,0.9332,MDM2 Inhibitor,0.9256,Aromatase Inhibitor,0.9241,HDM2 Inhibitor MK-8242,0.9228
IDO1 inhibitor (BMS986205),Linrodostat,99,2,IDO Inhibitor,0.9552,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9499,HDM2 Inhibitor MK-8242,0.9386,MDM2/MDMX Inhibitor ALRN-6924,0.9375,Anti-CD33 Monoclonal Antibody BI 836858,0.9372
IFR,Involved-Field Radiation Therapy,99,2,Ifosfamide,0.9505,Ifabotuzumab,0.9260,Fludarabine,0.9133,Fluorouracil,0.9129,Afatinib,0.9116
IGN523,Anti-CD98 Monoclonal Antibody IGN523,1,2,Anti-CD98 Monoclonal Antibody IGN523,0.9297,Indoximod,0.9054,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9038,mTOR Inhibitor;Immunotherapeutic Agent,0.8964,Dutasteride,0.8917
IL-2,Aldesleukin,99,2,Peginterferon Alfa-2a,0.9234,Interferon Alpha,0.9180,mTOR Inhibitor;Immunotherapeutic Agent,0.9173,Anti-LAG-3 Monoclonal Antibody,0.9157,Anti-TIM-3 Monoclonal Antibody,0.9156
IMATINIB,Imatinib,1,2,Imatinib,1.0000,Imatinib Regimen,0.9678,Dasatinib,0.9375,Sorafenib,0.9307,Tyrosine Kinase Inhibitor,0.9291
IMC-A12,Cixutumumab,99,2,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9228,Ifabotuzumab,0.8964,Cilengitide,0.8964,Denintuzumab Mafodotin,0.8957,Anti-CD33 Monoclonal Antibody BI 836858,0.8939
IMGN779 (Immunogen Trial),Anti-CD33 Antibody-drug Conjugate IMGN779,1,2,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9641,mTOR Inhibitor;Immunotherapeutic Agent,0.9171,Anti-CD98 Monoclonal Antibody IGN523,0.9168,Anti-CD33 Monoclonal Antibody BI 836858,0.9137,Immunotherapeutic Agent,0.9121
IMRT,Intensity-Modulated Radiation Therapy,1,2,Intensity-Modulated Radiation Therapy,0.9369,Radiation Therapy,0.9269,"Radiotherapy, Conformal",0.9259,Ipilimumab,0.9234,External Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9205
INK128-1110-028,Sapanisertib,99,2,AALL0232 ALL Study Identifier;Dexamethasone,0.9075,AALL0331 ALL Study Identifier,0.9047,AALL0232 ALL Study Identifier,0.9014,Iodine,0.8965,Anti-CD33 Monoclonal Antibody BI 836858,0.8963
INTERFERON_ALPHA,Interferon Alpha,1,2,Interferon Alpha,0.9887,Peginterferon Alfa-2a,0.9351,Adalimumab,0.9172,Gonadotropin-releasing Hormone Analog,0.9127,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9120
IODINE,Iodine,1,2,Iodine,1.0000,Epinephrine,0.9018,Peginterferon Alfa-2a,0.8981,Irinotecan,0.8979,Letrozole,0.8975
IPI,Ipilimumab,3,2,Pipobroman,0.9152,Plitidepsin,0.9125,Ipilimumab,0.9097,Pilaralisib,0.9091,Pidnarulex,0.9079
IT,Intrathecal Route of Administration,99,2,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9353,Retromammary space (body structure);Lymphadenectomy,0.9342,Other;Treatment Regimen,0.9330,Peginterferon Alfa-2a,0.9312,Other,0.9307
IT Methotrexate,Methotrexate,1,2,Methotrexate,0.9984,Mitomycin,0.9252,Mercaptopurine,0.9198,Mycophenolate Mofetil,0.9174,Mefloquine,0.9171
IT/IV Cytarabine,Cytarabine,1,2,Cytarabine,0.9568,Liposomal Cytarabine,0.9367,Ivosidenib,0.9352,Liposome-encapsulated Daunorubicin-Cytarabine,0.9194,Venetoclax,0.9121
Ida,Idarubicin,1,2,Idarubicin,0.9432,Idasanutlin,0.9355,Adalimumab,0.9172,Dabrafenib,0.9116,Iodine,0.9036
Ifosfamid,Ifosfamide,1,2,Ifosfamide,0.9949,Fludarabine,0.9242,Fluorouracil,0.9225,Afatinib,0.9196,Ifabotuzumab,0.9182
Il-2,Aldesleukin,99,2,Peginterferon Alfa-2a,0.9234,Interferon Alpha,0.9180,mTOR Inhibitor;Immunotherapeutic Agent,0.9173,Anti-LAG-3 Monoclonal Antibody,0.9157,Anti-TIM-3 Monoclonal Antibody,0.9156
Ileal conduit Creation,Urinary Diversion,99,2,Orthotopic;Neobladder,0.9029,Ureterectomy,0.9002,Robot-Assisted Surgery;Cystectomy,0.8997,Ureter;Biopsy,0.8983,Neobladder,0.8968
Implants-tandem,Tandem Brachytherapy,1,2,Tandem Brachytherapy,0.9423,Vagina;Implant,0.9226,Tissue Expander-Implant Breast Reconstruction;Bilateral,0.9197,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9033,Platinum Acetylacetonate-Titanium Dioxide Nanoparticles,0.8993
Imuran,Azathioprine Sodium,99,2,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9143,Vemurafenib,0.9090,Ivosidenib,0.9088,Indoximod,0.9071,Melphalan,0.9051
Interval Debulking,Interval Debulking Surgery,1,2,Interval Debulking Surgery,0.9814,Tumor Debulking,0.9283,Primary Debulking Surgery,0.9239,Secondary;Tumor Debulking,0.9040,Azacitidine Regimen,0.8915
Ipi,Ipilimumab,3,2,Pipobroman,0.9152,Plitidepsin,0.9125,Ipilimumab,0.9097,Pilaralisib,0.9091,Pidnarulex,0.9079
Ipilumumab,Ipilimumab,1,2,Ipilimumab,0.9347,Mapatumumab,0.9210,Anti-PLGF Monoclonal Antibody TB-403,0.9208,Glembatumumab,0.9206,Durvalumab,0.9193
JAK 1 inhibitor,JAK1 Inhibitor,1,2,JAK1 Inhibitor,0.9926,JAK2 Inhibitor AZD1480,0.9428,Tyrosine Kinase Inhibitor,0.9266,Cyclin-Dependent Kinase Inhibitor,0.9265,Mitogen-Activated Protein Kinase Kinase Inhibitor,0.9184
JNJ-40346527 (CSF1R inhibitor),Edicotinib,99,2,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9425,NAMPT Inhibitor STF-118804,0.9391,MDM2/MDMX Inhibitor ALRN-6924,0.9340,Gamma-Secretase Inhibitor RO4929097,0.9325,Topoisomerase I Inhibitor Genz-644282,0.9306
JNJ26481585,Quisinostat,99,2,Topoisomerase I Inhibitor Genz-644282,0.9092,NAMPT Inhibitor STF-118804,0.9045,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9002,AALL0232 ALL Study Identifier,0.8977,Purine Analogue NSC 750854,0.8976
JNJ26854165,Serdemetan,99,2,NAMPT Inhibitor STF-118804,0.9022,Topoisomerase I Inhibitor Genz-644282,0.9015,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9009,Gamma-Secretase Inhibitor RO4929097,0.8962,DNA-PK/TOR Kinase Inhibitor CC-115,0.8959
Jakafi,Ruxolitinib,99,2,JAK1 Inhibitor,0.9219,Afatinib,0.9157,Axitinib,0.9088,FLT3/CDK4/6 Inhibitor FLX925,0.9058,Ipilimumab,0.9036
KB004,Ifabotuzumab,99,2,FAK Inhibitor VS-4718,0.8957,Anti-PLGF Monoclonal Antibody TB-403,0.8882,Bevacizumab,0.8850,Dual IGF-1R/InsR Inhibitor BMS-754807,0.8849,Purine Analogue NSC 750854,0.8848
KPT-330,Selinexor,99,2,DNA-PK/TOR Kinase Inhibitor CC-115,0.9195,NAMPT Inhibitor STF-118804,0.9124,Paclitaxel,0.9080,Pan-AKT Kinase Inhibitor GSK690693,0.9073,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9035
L Radical Nephrectomy,Left;Radical Nephrectomy,1,2,Left;Radical Nephrectomy,0.9634,Nephrectomy,0.9458,Left;Radical;Nephroureterectomy,0.9394,Right;Partial Nephrectomy,0.9376,Right;Radical;Nephroureterectomy;Right;Nephroureterectomy,0.9354
L Total Mastectomy,Left;Total Mastectomy,2,2,Total Mastectomy,0.9755,Left;Total Mastectomy,0.9687,Right;Total Mastectomy,0.9632,Bilateral;Total Mastectomy,0.9562,Mastectomy,0.9432
L-Asparaginase,Asparaginase,1,2,Asparaginase,0.9729,l-Norepinephrine,0.9220,Leucovorin,0.9167,Peginterferon Alfa-2a,0.9159,Anthracycline Antineoplastic Antibiotic,0.9135
LAPATINIB,Lapatinib,1,2,Lapatinib,1.0000,Trastuzumab,0.9351,Letrozole,0.9336,Sorafenib,0.9284,Paclitaxel,0.9239
LAR,Low Anterior Resection,99,2,Leuprolide,0.9053,Leucovorin,0.9035,Retromammary space (body structure);Lymphadenectomy,0.9006,Axillary Lymph Node;Right,0.8998,Lapatinib,0.8995
LBH,Panobinostat,99,2,Lisavanbulin,0.9106,Laparoscopic Biopsy,0.9086,l-Norepinephrine,0.9061,Leuprolide,0.9030,Anti-PLGF Monoclonal Antibody TB-403,0.8996
LDR,Low-Dose Rate Brachytherapy,99,2,Plitidepsin,0.9097,Lapatinib,0.9057,Dexamethasone,0.9043,Lisavanbulin,0.9038,Decitabine,0.9037
LE,Local excision (procedure),2,2,Leuprolide,0.8950,Local excision (procedure),0.8923,Alpelisib,0.8847,Talimogene Laherparepvec,0.8804,l-Norepinephrine,0.8802
LENOLIDAMIDE,Lenalidomide,99,2,Lorazepam,0.9126,Lomustine,0.9088,Olaparib,0.9066,Thalidomide,0.9059,Talazoparib,0.9041
LHRH,Gonadotrophin Releasing Hormone,3,2,Leuprolide,0.9303,Gonadotropin-releasing Hormone Analog,0.9273,Gonadotrophin Releasing Hormone,0.9128,Fenretinide,0.9034,Cabiralizumab,0.9026
LHRH agonist,Gonadotropin-releasing Hormone Analog,1,2,Gonadotropin-releasing Hormone Analog,0.9429,Leuprolide,0.9253,Gonadotrophin Releasing Hormone,0.9141,Antiandrogen Therapy,0.9084,Anti-LAG-3 Monoclonal Antibody,0.9073
LN dissection,Lymphadenectomy,2,2,Axillary Lymph Node Dissection,0.9468,Lymphadenectomy,0.9394,Left;Axillary Lymph Node Dissection,0.9335,Bilateral Pelvic Lymph Node Dissection,0.9298,Endoscopic Submucosal Dissection,0.9163
LND,Lymphadenectomy,1,2,Lymphadenectomy,0.9171,Axillary Lymph Node Biopsy,0.9062,Sentinel Lymph Node Biopsy,0.9061,Axillary Lymph Node Level I;Axillary Lymph Node Level II;Lymphadenectomy,0.9053,Left;Axillary Lymph Node Dissection,0.9047
LUMPCTOMY,Lumpectomy,1,2,Lumpectomy,0.9544,Left;Lumpectomy,0.9414,Lumpectomy;Right Breast,0.9333,Laparoscopic Prostatectomy,0.9206,Venetoclax,0.9147
LUMPECTOMY,Lumpectomy,1,2,Lumpectomy,1.0000,Left;Lumpectomy,0.9748,Lumpectomy;Right Breast,0.9646,Re-Excision;Original;Lumpectomy;Surgical Site,0.9428,Sentinel Lymph Node;Lymphadenectomy;Right;Mammoplasty,0.9241
LV,Leucovorin,2,2,Valspodar,0.9063,Leucovorin,0.9019,Lisavanbulin,0.9012,Vadastuximab Talirine,0.8984,l-Norepinephrine,0.8978
LY 2606368,Prexasertib,99,2,mTOR Kinase Inhibitor AZD8055,0.9161,Gamma-Secretase Inhibitor RO4929097,0.9138,Purine Analogue NSC 750854,0.9065,Anti-CD33 Monoclonal Antibody BI 836858,0.9046,MDM2/MDMX Inhibitor ALRN-6924,0.9027
Left Rnu,Left;Radical;Nephroureterectomy,2,2,Left;Radical Nephrectomy,0.9381,Left;Radical;Nephroureterectomy,0.9305,Right Eye;Enucleation,0.9280,Right;Radical;Nephroureterectomy;Right;Nephroureterectomy,0.9218,Right;Partial Nephrectomy,0.9213
Left breast reexcision,Left Breast;Re-Excision,1,2,Left Breast;Re-Excision,0.9536,Right Breast;Re-Excision,0.9426,Left;Biopsy of Breast,0.9359,Lumpectomy;Right Breast,0.9346,Left;Total Mastectomy,0.9343
Left hemihepatectomy,Left Hemihepatectomy,1,2,Left Hemihepatectomy,1.0000,Right Hemihepatectomy,0.9885,Left;Total Mastectomy,0.9365,Lobectomy,0.9347,Lumpectomy;Right Breast,0.9298
Left segmental mastectomy,Segmental Mastectomy,3,2,Left;Segmental Mastectomy,0.9927,Right;Segmental Mastectomy,0.9842,Segmental Mastectomy,0.9810,Localized;Segmental Mastectomy,0.9773,Re-Excision;Segmental Mastectomy,0.9559
Leukine,Sargramostim,99,2,Aldesleukin,0.9195,Leucovorin,0.9137,Liposomal Cytarabine,0.9134,Lisavanbulin,0.9106,Leuprolide,0.9105
Liver Resection,Hepatectomy,2,2,Resection,0.9614,Hepatectomy,0.9555,Bile Duct;Resection,0.9530,Lung;Resection,0.9526,Partial Hepatectomy,0.9331
Lupron,Leuprolide,1,2,Leuprolide,0.9178,Lisavanbulin,0.9084,Peginterferon Alfa-2a,0.9022,Letrozole,0.9011,Lymphadenectomy,0.8970
MASTECTOMY,Mastectomy,1,2,Mastectomy,1.0000,Modified Radical Mastectomy,0.9572,Bilateral Mastectomy,0.9544,Total Mastectomy,0.9529,Left;Total Mastectomy,0.9499
MBG453 (TIM-3 inhibitor),Sabatolimab,99,2,Anti-TIM-3 Monoclonal Antibody,0.9457,NAMPT Inhibitor STF-118804,0.9381,mTOR Inhibitor;Immunotherapeutic Agent,0.9329,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9320,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9316
MEK,Mitogen-Activated Protein Kinase Kinase Inhibitor,1,2,Mitogen-Activated Protein Kinase Kinase Inhibitor,0.9228,Selumetinib,0.9140,Axitinib,0.9102,Ipilimumab,0.9102,Trametinib,0.9090
MEK162,Binimetinib,99,2,Mitogen-Activated Protein Kinase Kinase Inhibitor,0.9198,mTOR Kinase Inhibitor AZD8055,0.9155,Akt Inhibitor MK2206,0.9083,Axitinib,0.9073,Sunitinib Malate,0.9046
MET inhibitor,c-Met Inhibitor,1,2,c-Met Inhibitor,0.9626,mTOR Inhibitor,0.9273,Tyrosine Kinase Inhibitor,0.9223,Mitogen-Activated Protein Kinase Kinase Inhibitor,0.9179,mTOR Inhibitor;Immunotherapeutic Agent,0.9125
METASTASECTOMY,Metastasectomy,1,2,Metastasectomy,1.0000,Resection;Pulmonary;Metastasis,0.9474,Resection,0.9231,Lobectomy,0.9227,Appendectomy,0.9215
MGA271 anti B7H3 infusion,Enoblituzumab,99,2,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9385,Anti-CD33 Monoclonal Antibody BI 836858,0.9343,Anti-CD98 Monoclonal Antibody IGN523,0.9306,Anti-CD3 Monoclonal Antibody,0.9291,Anti-EGFR Monoclonal Antibody,0.9287
MGB453,Sabatolimab,99,2,Gemtuzumab Ozogamicin,0.9063,MDM2/MDMX Inhibitor ALRN-6924,0.9043,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9020,Gemtuzumab,0.9018,AALL0232 ALL Study Identifier;Dexamethasone,0.9015
MITOTANE,Mitotane,1,2,Mitotane,1.0000,Mitoxantrone,0.9338,Topotecan,0.9056,Coltuximab Ravtansine,0.9032,Memantine,0.9014
MK 3475,Pembrolizumab,99,2,Anti-HGF Monoclonal Antibody TAK-701,0.8973,HDM2 Inhibitor MK-8242,0.8949,Gemtuzumab,0.8906,mTOR Kinase Inhibitor AZD8055,0.8898,Anti-PLGF Monoclonal Antibody TB-403,0.8870
MK-2206,Akt Inhibitor MK2206,1,2,Akt Inhibitor MK2206,0.9393,HDM2 Inhibitor MK-8242,0.9298,mTOR Kinase Inhibitor AZD8055,0.9170,PIM Kinase Inhibitor SGI-1776,0.9062,Anti-HGF Monoclonal Antibody TAK-701,0.9002
MK-8242,HDM2 Inhibitor MK-8242,1,2,HDM2 Inhibitor MK-8242,0.9657,Akt Inhibitor MK2206,0.9357,mTOR Kinase Inhibitor AZD8055,0.9250,Topoisomerase I Inhibitor Genz-644282,0.9161,CENP-E Inhibitor GSK-923295A,0.9116
MK3475,Pembrolizumab,99,2,mTOR Kinase Inhibitor AZD8055,0.9247,HDM2 Inhibitor MK-8242,0.9241,Akt Inhibitor MK2206,0.9182,MDM2/MDMX Inhibitor ALRN-6924,0.9114,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9085
MLN0128 (mTORi),Sapanisertib,99,2,mTOR Inhibitor,0.9561,mTOR Inhibitor;Immunotherapeutic Agent,0.9465,mTOR Kinase Inhibitor AZD8055,0.9445,Everolimus,0.9285,NAMPT Inhibitor STF-118804,0.9270
MLN4924,Pevonedistat,99,2,MDM2/MDMX Inhibitor ALRN-6924,0.9136,Gamma-Secretase Inhibitor RO4929097,0.9110,mTOR Kinase Inhibitor AZD8055,0.9082,CENP-E Inhibitor GSK-923295A,0.9059,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9038
MLN8237,Alisertib,99,2,HDM2 Inhibitor MK-8242,0.9223,NAMPT Inhibitor STF-118804,0.9134,mTOR Kinase Inhibitor AZD8055,0.9123,MDM2/MDMX Inhibitor ALRN-6924,0.9120,Topoisomerase I Inhibitor Genz-644282,0.9118
MM-141,Istiratumab,99,2,Sunitinib Malate,0.9031,PIM Kinase Inhibitor SGI-1776,0.9002,HDM2 Inhibitor MK-8242,0.8998,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.8988,DNA-PK/TOR Kinase Inhibitor CC-115,0.8982
MMC,Mitomycin,1,2,Mitomycin,0.9406,Mastectomy,0.9099,Macitentan,0.9077,Tamoxifen,0.9070,Mycophenolate Mofetil,0.9041
MTOR inhibitor,mTOR Inhibitor,1,2,mTOR Inhibitor,1.0000,mTOR Inhibitor;Immunotherapeutic Agent,0.9548,mTOR Kinase Inhibitor AZD8055,0.9538,Akt Inhibitor MK2206,0.9338,MDM2 Inhibitor,0.9261
MTOR/VEGF inhibitor,mTOR Inhibitor;Immunotherapeutic Agent,2,2,mTOR Inhibitor,0.9686,mTOR Inhibitor;Immunotherapeutic Agent,0.9518,mTOR Kinase Inhibitor AZD8055,0.9356,Sirolimus,0.9232,Everolimus,0.9223
MTX,Methotrexate,1,2,Methotrexate,0.9535,Pemetrexed,0.9321,Mitoxantrone,0.9259,Ruxolitinib,0.9250,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9229
MUD,Matched Unrelated Donor;Allogeneic Hematopoietic Stem Cell Transplantation,99,2,Mercaptopurine,0.9017,Tremelimumab,0.8959,Momelotinib,0.8927,Mycophenolate Mofetil,0.8893,Lenalidomide,0.8885
Margin resection,Surgical Margin;Resection,1,2,Surgical Margin;Resection,0.9728,Resection,0.9527,Lung;Resection,0.9326,Vulva;Resection,0.9292,Re-Excision;Inferior;Margin,0.9287
Mastectomy NOS,Mastectomy,1,2,Mastectomy,0.9687,Total Mastectomy,0.9370,Modified Radical Mastectomy,0.9361,Bilateral Mastectomy,0.9344,Bilateral;Total Mastectomy,0.9341
Mito,Mitoxantrone,1,2,Mitoxantrone,0.9506,Mitotane,0.9432,Methotrexate,0.9048,Mefloquine,0.9004,Momelotinib,0.8995
Mk-3475,Pembrolizumab,99,2,HDM2 Inhibitor MK-8242,0.9143,Anti-HGF Monoclonal Antibody TAK-701,0.9093,mTOR Kinase Inhibitor AZD8055,0.9046,Gemtuzumab,0.9005,FAK Inhibitor VS-4718,0.8985
Modified Radical Masectomy,Modified Radical Hysterectomy,2,2,Modified Radical Mastectomy,0.9678,Modified Radical Hysterectomy,0.9510,Mastectomy,0.9263,Radical Cystectomy,0.9191,Radical Trachelectomy,0.9165
Modified radical mastectomy,Modified Radical Mastectomy,1,2,Modified Radical Mastectomy,1.0000,Modified Radical Hysterectomy,0.9716,Mastectomy,0.9572,Radical Hysterectomy,0.9345,Total Mastectomy,0.9333
Mto,Mitoxantrone,99,2,Mycophenolate Mofetil,0.9038,Methotrexate,0.9030,Motixafortide,0.9030,Momelotinib,0.9005,Memantine,0.8987
Mtx,Methotrexate,1,2,Methotrexate,0.9535,Pemetrexed,0.9321,Mitoxantrone,0.9259,Ruxolitinib,0.9250,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9229
Mylotarg,Gemtuzumab Ozogamicin,99,2,Melphalan,0.9143,Zoligratinib,0.9123,Dacomitinib,0.9100,Apalutamide,0.9074,Cilengitide,0.9072
NK cell infusion,NK Cell-enriched Donor Lymphocytes,1,2,NK Cell-enriched Donor Lymphocytes,0.9369,Donor Lymphocyte Infusion,0.9354,Hematopoietic Cell Transplantation,0.9302,Tumor Infiltrating Lymphocyte Therapy,0.9193,Autologous Hematopoietic Stem Cell Transplantation,0.9192
NOM,Have Not Had Cancer Surgery,99,2,Nirogacestat,0.8831,Robot-Assisted Surgery;Laparoscopy;Nephroureterectomy,0.8820,Urethrectomy,0.8809,Nab-paclitaxel,0.8794,Nintedanib,0.8791
NOREPINEPHRINE,l-Norepinephrine,1,2,l-Norepinephrine,0.9604,Epinephrine,0.9320,Nelarabine,0.9127,Dopamine,0.9032,Epirubicin,0.9020
NOVO-TTF,NovoTTF-100A Device,1,2,NovoTTF-100A Device,0.9317,Tamibarotene,0.9101,Docetaxel,0.8914,Paclitaxel,0.8913,Tretinoin,0.8910
NPT,Platinum Acetylacetonate-Titanium Dioxide Nanoparticles,99,2,Nab-paclitaxel,0.9192,Nitrogen Mustard Prodrug PR-104,0.9141,Panobinostat,0.9055,NAMPT Inhibitor STF-118804,0.9026,Paclitaxel,0.9017
NSC750854,Purine Analogue NSC 750854,1,2,Purine Analogue NSC 750854,0.9473,Pan-AKT Kinase Inhibitor GSK690693,0.9108,Gamma-Secretase Inhibitor RO4929097,0.9092,NAMPT Inhibitor STF-118804,0.9060,Cilengitide,0.9016
NY eso vaccine,NY-ESO-1 Peptide Vaccine,1,2,NY-ESO-1 Peptide Vaccine,0.9738,Vaccine,0.9121,Steroid Therapy,0.9049,Rovalpituzumab Tesirine,0.9007,Folate Receptor-Targeted Tubulysin Conjugate EC1456,0.9001
Nephro-ureterectomy,Nephroureterectomy,2,2,Ureterectomy,0.9786,Nephroureterectomy,0.9647,Right;Ureterectomy,0.9559,Nephrectomy,0.9530,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,0.9526
Nephroureterectomy with endoscopic bladder cuff resection,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,1,2,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,0.9940,Nephroureterectomy,0.9641,Transurethral Resection of Bladder Tumor,0.9523,Right;Nephroureterectomy,0.9466,Robot-Assisted Surgery;Laparoscopy;Nephroureterectomy,0.9457
Nipple Sparing Total Mastectomy,Subcutaneous Mastectomy,99,2,Bilateral;Skin-Sparing Mastectomy,0.9534,Total Mastectomy,0.9513,Left;Total Mastectomy,0.9495,Right;Total Mastectomy,0.9464,Skin-Sparing Mastectomy;Radical Mastectomy,0.9462
Nivo,Nivolumab,99,2,Seviteronel,0.8981,Vinorelbine,0.8956,Veliparib,0.8940,Denintuzumab Mafodotin,0.8925,Entospletinib,0.8896
Nivolumab (P1T986205),Nivolumab,1,2,Nivolumab,0.9602,mTOR Inhibitor;Immunotherapeutic Agent,0.9319,Anti-CD33 Monoclonal Antibody BI 836858,0.9311,Anti-HGF Monoclonal Antibody TAK-701,0.9246,Ipilimumab,0.9243
No (radiation),Radiation Therapy Not Received,1,2,Radiation Therapy Not Received,0.9374,Radiation Therapy,0.9251,Intensity-Modulated Radiation Therapy,0.9107,Radiation Therapy;Right Breast,0.9106,Radium Ra 223 Dichloride,0.9103
"ODSH (2 O, 3-O Desulfated Heparin)",Dociparstat sodium,99,2,Anti-HGF Monoclonal Antibody TAK-701,0.9196,Purine Analogue NSC 750854,0.9130,Buthionine Sulfoximine,0.9106,Peginterferon Alfa-2a,0.9102,Pylorus-sparing pancreaticoduodenectomy (procedure),0.9100
OSI-774,Erlotinib Hydrochloride,99,2,FAK Inhibitor VS-4718,0.8902,HDM2 Inhibitor MK-8242,0.8899,Purine Analogue NSC 750854,0.8889,Ifabotuzumab,0.8876,Anti-HGF Monoclonal Antibody TAK-701,0.8872
OX,Oxaliplatin,1,2,Oxaliplatin,0.9094,Buthionine Sulfoximine,0.8976,Olaparib,0.8896,Indoximod,0.8892,Mitoxantrone,0.8888
OX40 agonist MOXR0916,Vonlerolizumab,99,2,MDM2/MDMX Inhibitor ALRN-6924,0.9238,HDM2 Inhibitor MK-8242,0.9128,mTOR Inhibitor;Immunotherapeutic Agent,0.9096,Anti-ErbB3 Monoclonal Antibody REGN1400,0.9056,Anti-PLGF Monoclonal Antibody TB-403,0.9055
OXALIPLATIN,Oxaliplatin,1,2,Oxaliplatin,1.0000,Cisplatin,0.9214,Cetuximab,0.9204,Pertuzumab,0.9190,Olaparib,0.9176
OXi4503,Combretastatin A1 Diphosphate,99,2,Oxaliplatin,0.9136,Indoximod,0.9096,Gamma-Secretase Inhibitor RO4929097,0.9046,Capecitabine,0.9034,Olaparib,0.9001
Observation,Clinical Observation,1,2,Clinical Observation,0.9667,Unknown,0.8825,Estramustine,0.8801,Enucleation;Tail of the Pancreas,0.8756,Right Eye;Enucleation,0.8729
Optune device,NovoTTF-100A Device,2,2,mTOR Inhibitor;Immunotherapeutic Agent,0.8923,NovoTTF-100A Device,0.8879,Indoximod,0.8842,NAMPT Inhibitor STF-118804,0.8832,Right Eye;Enucleation,0.8826
Other regimens,Other;Treatment Regimen,1,2,Other;Treatment Regimen,0.9603,Imatinib Regimen,0.9308,Azacitidine Regimen,0.9216,Cinrebafusp Alfa,0.9108,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9093
Other surgery (specify),Other;Surgery,1,2,Other;Surgery,0.9849,Other;Treatment Regimen,0.9293,Surgical Procedure,0.9280,Other,0.9267,Robot-Assisted Surgery;Laparoscopy;Nephroureterectomy,0.9190
PACLITAXEL,Paclitaxel,1,2,Paclitaxel,1.0000,Nab-paclitaxel,0.9573,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9294,Docetaxel,0.9290,Topotecan,0.9285
PARTIAL_MASTECTOMY,Segmental Mastectomy,99,2,Left;Total Mastectomy,0.9508,Right;Total Mastectomy,0.9475,Bilateral;Total Mastectomy,0.9469,Mastectomy,0.9464,Partial Cystectomy,0.9452
PCI-32765,Ibrutinib,99,2,PIM Kinase Inhibitor SGI-1776,0.9204,Topoisomerase I Inhibitor Genz-644282,0.9201,Mapatumumab,0.9134,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9117,Irinotecan,0.9113
PE,Pelvic Exenteration,99,2,Pevonedistat,0.9395,Plitidepsin,0.9084,Pipobroman,0.9019,Pericardial Effusion,0.9007,Epinephrine,0.8982
PEITC,Phenethyl Isothiocyanate,1,2,Phenethyl Isothiocyanate,0.9228,Azacitidine,0.9053,Topotecan,0.9047,Cetuximab,0.9043,Pracinostat,0.9026
PEMBRO,Pembrolizumab,1,2,Pembrolizumab,0.9745,Pemetrexed,0.9473,Lorazepam,0.9006,Nivolumab,0.8994,Atezolizumab,0.8980
PEMBROLIZUMAB,Pembrolizumab,1,2,Pembrolizumab,1.0000,Pemetrexed,0.9542,Atezolizumab,0.9404,Monalizumab,0.9211,Mogamulizumab,0.9189
PF-03084014,Nirogacestat,99,2,Purine Analogue NSC 750854,0.9259,Polyamine Analogue PG11047,0.9224,Gamma-Secretase Inhibitor RO4929097,0.9221,FLT3/CDK4/6 Inhibitor FLX925,0.9198,FAK Inhibitor VS-4718,0.9186
PF-04449913 (Hedgehog Inhibitor),Glasdegib,99,2,FAK Inhibitor VS-4718,0.9367,Gamma-Secretase Inhibitor RO4929097,0.9285,CENP-E Inhibitor GSK-923295A,0.9279,Pan-AKT Kinase Inhibitor GSK690693,0.9269,FLT3/CDK4/6 Inhibitor FLX925,0.9212
PIM kinase inhibitor,Serine/Threonine Kinase Inhibitor,99,2,PIM Kinase Inhibitor SGI-1776,0.9538,Mitogen-Activated Protein Kinase Kinase Inhibitor,0.9473,Cyclin-Dependent Kinase Inhibitor,0.9396,JAK1 Inhibitor,0.9358,AKT Inhibitor,0.9313
PIXANTRONE,Pixantrone,1,2,Pixantrone,1.0000,Platinum,0.9042,Pexidartinib,0.9033,Galunisertib,0.9031,Pertuzumab,0.9026
PLAT CAR-T cell infusion,Chimeric Antigen Receptor T-Cell Therapy,1,2,Chimeric Antigen Receptor T-Cell Therapy,0.9378,Chimeric Antigen Receptor T-Cell Therapy;Therapeutic Apheresis,0.9290,Paclitaxel,0.9181,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9178,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9167
PLATINUM,Platinum,1,2,Platinum,1.0000,Cisplatin,0.9493,Platinum Acetylacetonate-Titanium Dioxide Nanoparticles,0.9287,Carboplatin,0.9244,Oxaliplatin,0.9138
PLX3397,Pexidartinib,99,2,FLT3/CDK4/6 Inhibitor FLX925,0.9259,Anti-PLGF Monoclonal Antibody TB-403,0.9256,Pan-AKT Kinase Inhibitor GSK690693,0.9153,FAK Inhibitor VS-4718,0.9141,Olaparib,0.9125
PR-104,Nitrogen Mustard Prodrug PR-104,1,2,Nitrogen Mustard Prodrug PR-104,0.9384,Anti-PLGF Monoclonal Antibody TB-403,0.9074,Polyamine Analogue PG11047,0.9032,Pravastatin,0.8942,Anti-ErbB3 Monoclonal Antibody REGN1400,0.8930
PROSTATECTOMY,Prostatectomy,1,2,Prostatectomy,1.0000,Radical Prostatectomy,0.9638,Laparoscopic Prostatectomy,0.9497,Laparoscopic Radical Prostatectomy with Robotics,0.9338,Hysterectomy,0.9322
PRS-343,Cinrebafusp Alfa,99,2,Nitrogen Mustard Prodrug PR-104,0.9143,Purine Analogue NSC 750854,0.9054,Pylorus-sparing pancreaticoduodenectomy (procedure),0.9053,Anti-PLGF Monoclonal Antibody TB-403,0.9016,Right;Partial Nephrectomy,0.9015
PSC,Valspodar,99,2,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9034,Prostatectomy,0.9029,Pravastatin,0.9019,Pylorus-sparing pancreaticoduodenectomy (procedure),0.9013,Phenethyl Isothiocyanate,0.8996
PSMA ADC,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,1,2,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9474,Adalimumab,0.9196,Ipilimumab,0.9158,Pracinostat,0.9116,Trastuzumab,0.9106
PSMA-ADC,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,1,2,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9524,Adalimumab,0.9198,Ipilimumab,0.9183,Pracinostat,0.9136,Anti-EGFR Monoclonal Antibody,0.9120
PUNCH,Punch Biopsy,1,2,Punch Biopsy,0.9653,Excisional Biopsy,0.8920,Skin Excision,0.8892,Excision,0.8882,Bortezomib,0.8867
Pancreaticoduodenectomy (Whipple Resection),Whipple Procedure,3,2,Pancreaticoduodenectomy,0.9696,Pylorus-sparing pancreaticoduodenectomy (procedure),0.9525,Whipple Procedure,0.9519,Distal Pancreatectomy,0.9429,Uncinate Process of Pancreas;Resection,0.9375
Partial Mastectomy,Segmental Mastectomy,99,2,Partial Cystectomy,0.9474,Mastectomy,0.9458,Partial Salpingectomy,0.9455,Left;Total Mastectomy,0.9449,Bilateral;Total Mastectomy,0.9424
Partial Vaginectomy,Partial;Vaginectomy,1,2,Partial;Vaginectomy,0.9943,Partial Cystectomy,0.9420,Partial Salpingectomy,0.9418,Left Hemihepatectomy,0.9277,Right Hemihepatectomy,0.9264
Partial hepatectomy,Partial Hepatectomy,1,2,Partial Hepatectomy,1.0000,Hepatectomy,0.9559,Total Hepatectomy,0.9479,Right;Partial Nephrectomy,0.9382,Partial Salpingectomy,0.9309
Partial mastectomy,Segmental Mastectomy,99,2,Partial Cystectomy,0.9474,Mastectomy,0.9458,Partial Salpingectomy,0.9455,Left;Total Mastectomy,0.9449,Bilateral;Total Mastectomy,0.9424
Patey's Surgery,Modified Radical Mastectomy,99,2,Abdominoperineal Resection,0.9014,Appendectomy,0.9007,Surgical Procedure,0.9006,Exploratory Surgery;Laparotomy,0.8919,Pancreaticoduodenectomy,0.8912
Pateys surgery,Modified Radical Mastectomy,99,2,Appendectomy,0.8973,Surgical Procedure,0.8957,Abdominoperineal Resection,0.8955,Anterior Pelvic Exenteration,0.8936,Radical;Anterior Pelvic Exenteration,0.8902
Peg interferon alfa-2a,Peginterferon Alfa-2a,1,2,Peginterferon Alfa-2a,0.9806,Interferon Alpha,0.9529,Gonadotropin-releasing Hormone Analog,0.9272,Adalimumab,0.9241,Cinrebafusp Alfa,0.9207
Pembro,Pembrolizumab,1,2,Pembrolizumab,0.9745,Pemetrexed,0.9473,Lorazepam,0.9006,Nivolumab,0.8994,Atezolizumab,0.8980
Pembrolizumab (Arizona),Pembrolizumab,1,2,Pembrolizumab,0.9695,Atezolizumab,0.9394,Pemetrexed,0.9373,Anti-EGFR Monoclonal Antibody,0.9229,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9213
Pentamadine,Pentamidine,1,2,Pentamidine,0.9416,Pexidartinib,0.9214,Pemetrexed,0.9119,Entospletinib,0.9055,Atezolizumab,0.9035
PiBr,Pipobroman,99,2,Bortezomib,0.9249,Ibrutinib,0.9248,Pravastatin,0.9245,Bevacizumab,0.9204,Buparlisib,0.9200
Plaque,Plaque Radiotherapy,1,2,Plaque Radiotherapy,0.9554,Pravastatin,0.9020,Uncinate Process of Pancreas;Resection,0.8946,Pertuzumab,0.8938,Peginterferon Alfa-2a,0.8899
Pred,Prednisone,99,2,Pravastatin,0.9112,Prexasertib,0.9102,Denintuzumab Mafodotin,0.9063,Durvalumab,0.8991,Decitabine,0.8953
Primary Debulking,Primary Debulking Surgery,1,2,Primary Debulking Surgery,0.9798,Secondary;Tumor Debulking,0.9485,Tumor Debulking,0.9325,Interval Debulking Surgery,0.9171,Durvalumab,0.8893
Proton 3d conformal,Proton Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,1,2,Proton Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9552,External Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9268,"Radiotherapy, Conformal",0.9197,Proton Beam Radiation Therapy,0.9115,Radical;Anterior Pelvic Exenteration,0.8820
Proton beam,Proton Beam Radiation Therapy,1,2,Proton Beam Radiation Therapy,0.9831,Proton Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9378,External Beam Radiation Therapy,0.9243,Radiation Therapy,0.9178,External Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9016
Provenge,Sipuleucel-T,99,2,Durvalumab,0.8853,Ponatinib,0.8845,Itacitinib,0.8804,Ipilimumab,0.8790,Crenolanib,0.8789
Pylorus preserving pancreatoduodenectomy,Pylorus-sparing pancreaticoduodenectomy (procedure),1,2,Pylorus-sparing pancreaticoduodenectomy (procedure),0.9819,Pancreaticoduodenectomy,0.9496,Distal Pancreatectomy,0.9307,Total Pancreatectomy,0.9272,Uncinate Process of Pancreas;Resection,0.9169
RAM,Ramucirumab,1,2,Ramucirumab,0.9381,Lenalidomide,0.9066,Rituximab,0.9063,Retromammary space (body structure);Lymphadenectomy,0.9000,Daratumumab,0.8922
RAPAMYCIN,Sirolimus,1,2,Sirolimus,0.9494,mTOR Inhibitor;Immunotherapeutic Agent,0.9324,mTOR Inhibitor,0.9295,Everolimus,0.9293,Rituximab,0.9266
REGN1400,Anti-ErbB3 Monoclonal Antibody REGN1400,1,2,Anti-ErbB3 Monoclonal Antibody REGN1400,0.9592,Regorafenib,0.9268,Regadenoson,0.9100,MDM2/MDMX Inhibitor ALRN-6924,0.8995,Ruxolitinib,0.8993
REN1400,Anti-ErbB3 Monoclonal Antibody REGN1400,1,2,Anti-ErbB3 Monoclonal Antibody REGN1400,0.8929,Radical;Anterior Pelvic Exenteration,0.8811,NY-ESO-1 Peptide Vaccine,0.8798,Phenethyl Isothiocyanate,0.8794,Anti-PLGF Monoclonal Antibody TB-403,0.8791
RG7112,MDM2 Inhibitor,99,2,Peginterferon Alfa-2a,0.9028,Gemtuzumab Ozogamicin,0.8960,Anti-ErbB3 Monoclonal Antibody REGN1400,0.8954,MDM2/MDMX Inhibitor ALRN-6924,0.8950,Gonadotropin-releasing Hormone Analog,0.8925
RO4929097,Gamma-Secretase Inhibitor RO4929097,1,2,Gamma-Secretase Inhibitor RO4929097,0.9615,Rovalpituzumab Tesirine,0.9173,FAK Inhibitor VS-4718,0.9080,Purine Analogue NSC 750854,0.9066,Anti-CD98 Monoclonal Antibody IGN523,0.9054
ROVA-T,Rovalpituzumab Tesirine,1,2,Rovalpituzumab Tesirine,0.9510,Gamma-Secretase Inhibitor RO4929097,0.9118,Vadastuximab Talirine,0.9065,Chimeric Antigen Receptor T-Cell Therapy,0.9042,Ifabotuzumab,0.9027
RUXOLITINB,Ruxolitinib,1,2,Ruxolitinib,0.9844,FLT3/CDK4/6 Inhibitor FLX925,0.9211,Pexidartinib,0.9205,Rivogenlecleucel,0.9129,Floxuridine,0.9128
Rabbit ATG,Lapine T-Lymphocyte Immune Globulin,99,2,Anti-EGFR Monoclonal Antibody,0.8932,Bortezomib,0.8905,mTOR Inhibitor;Immunotherapeutic Agent,0.8898,Rituximab,0.8883,Anti-PLGF Monoclonal Antibody TB-403,0.8879
Rad001,Everolimus,1,2,Everolimus,0.9112,Axitinib,0.9060,Purine Analogue NSC 750854,0.9025,MDM2/MDMX Inhibitor ALRN-6924,0.9009,Vadastuximab Talirine,0.9001
"Radiation Therapy, Unspecified",Radiation Therapy,1,2,Radiation Therapy,0.9329,Radiation Therapy Not Received,0.9309,Radiation Therapy;Right Breast,0.9250,Other;Treatment Regimen,0.9174,"Radiotherapy, Conformal",0.9171
Radiation to right breast,Radiation Therapy;Right Breast,1,2,Radiation Therapy;Right Breast,0.9869,Radiation Therapy,0.9397,Lumpectomy;Right Breast,0.9366,Right Breast;Re-Excision,0.9365,Total-Body Irradiation,0.9283
Radical anterior exenteration,Radical;Anterior Pelvic Exenteration,1,2,Radical;Anterior Pelvic Exenteration,0.9779,Anterior Pelvic Exenteration,0.9630,Pelvic Exenteration,0.9415,Radical Prostatectomy,0.9270,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9231
Radical cystectomy,Radical Cystectomy,1,2,Radical Cystectomy,1.0000,Cystectomy,0.9763,Radical Cystoprostatectomy,0.9690,Partial Cystectomy,0.9551,Radical Prostatectomy,0.9526
Radical cystoprostatectomy,Radical Cystoprostatectomy,1,2,Radical Cystoprostatectomy,1.0000,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9714,Radical Cystectomy,0.9690,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9690,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9614
Radical trachelectomy,Radical Trachelectomy,1,2,Radical Trachelectomy,1.0000,Radical Cystectomy,0.9405,Radical Hysterectomy,0.9405,Radical Cystoprostatectomy,0.9305,Radical Prostatectomy,0.9288
Radium-223 (Xofigo),Radium Ra 223 Dichloride,1,2,Radium Ra 223 Dichloride,0.9375,Radiation Therapy,0.9168,Letrozole,0.9136,Cixutumumab,0.9096,Peginterferon Alfa-2a,0.9095
Ram,Ramucirumab,1,2,Ramucirumab,0.9381,Lenalidomide,0.9066,Rituximab,0.9063,Retromammary space (body structure);Lymphadenectomy,0.9000,Daratumumab,0.8922
Re-Excision of Superior Margin,Re-Excision;Superior;Margin,1,2,Re-Excision;Superior;Margin,0.9868,Re-Excision;Inferior;Margin,0.9747,Inner;Upper;Surgical Margin;Re-Excision,0.9613,Re-Excision,0.9571,Left Breast;Re-Excision,0.9476
Re-excision of original lumpectomy site,Re-Excision;Original;Lumpectomy;Surgical Site,1,2,Re-Excision;Original;Lumpectomy;Surgical Site,0.9877,Left Breast;Re-Excision,0.9573,Re-Excision;Biopsy Site,0.9516,Right Breast;Re-Excision,0.9506,Lumpectomy,0.9489
Re-excision of the inferior margin,Re-Excision;Inferior;Margin,1,2,Re-Excision;Inferior;Margin,0.9875,Re-Excision;Superior;Margin,0.9724,Inner;Upper;Surgical Margin;Re-Excision,0.9568,Re-Excision,0.9508,Right Breast;Re-Excision,0.9454
Reexc of biopsy site,Re-Excision;Biopsy Site,1,2,Re-Excision;Biopsy Site,0.9390,Biopsy,0.9197,Wide;Re-Excision;Biopsy,0.9184,Skin Biopsy,0.9134,Ureter;Biopsy,0.9078
Reexcision,Re-Excision,5,2,Esophagectomy,0.9117,Wide;Re-Excision;Biopsy,0.9043,Re-Excision;Superior;Margin,0.9029,Re-Excision;Biopsy Site,0.9005,Re-Excision,0.8990
Reexcision of segmental mastectomy,Re-Excision;Segmental Mastectomy,1,2,Re-Excision;Segmental Mastectomy,0.9718,Segmental Mastectomy,0.9591,Right;Segmental Mastectomy,0.9543,Left;Segmental Mastectomy,0.9539,Localized;Segmental Mastectomy,0.9489
Regeneron,Cemiplimab,99,2,Sorafenib,0.9169,Rituximab,0.9114,Axitinib,0.9107,Re-Excision;Superior;Margin,0.9101,Imatinib,0.9094
Resection of Pelvic tumor,Resection;Pelvis;Tumor Mass,2,2,Tumor Resection;Pelvis,0.9849,Resection;Pelvis;Tumor Mass,0.9712,Pelvic Lymphadenectomy,0.9576,Transurethral Resection of Bladder Tumor,0.9410,Vulva;Resection,0.9371
Resection of pulmonary Mets,Resection;Pulmonary;Metastasis,1,2,Resection;Pulmonary;Metastasis,0.9524,Lung;Resection,0.9501,Resection,0.9407,Metastasectomy,0.9331,Resection;Pelvis;Tumor Mass,0.9282
Revlimid,Lenalidomide,99,2,Vorinostat,0.9050,Rovalpituzumab Tesirine,0.9035,Talimogene Laherparepvec,0.9032,Cladribine,0.9019,Adalimumab,0.9006
Revlmd,Lenalidomide,99,2,Rivogenlecleucel,0.9144,Volasertib,0.9104,Rovalpituzumab Tesirine,0.9098,Right Breast;Re-Excision,0.9097,Right;Radical;Nephroureterectomy;Right;Nephroureterectomy,0.9040
Right Breast Reexcision,Right Breast;Re-Excision,1,2,Right Breast;Re-Excision,0.9585,Radiation Therapy;Right Breast,0.9482,Left Breast;Re-Excision,0.9474,Right Hemihepatectomy,0.9414,Lumpectomy;Right Breast,0.9389
Right Breast reexcision,Right Breast;Re-Excision,1,2,Right Breast;Re-Excision,0.9585,Radiation Therapy;Right Breast,0.9482,Left Breast;Re-Excision,0.9474,Right Hemihepatectomy,0.9414,Lumpectomy;Right Breast,0.9389
Right Mediastinal Mass Excision,Right;Mediastinal Mass;Excision,1,2,Right;Mediastinal Mass;Excision,0.9846,Excision;Chest Wall Mass,0.9513,Right Breast;Re-Excision,0.9452,Left Breast;Re-Excision,0.9327,Right Hemihepatectomy,0.9287
Right Partial Nephrectomy,Right;Partial Nephrectomy,1,2,Right;Partial Nephrectomy,0.9909,Left;Radical Nephrectomy,0.9524,Right Hemihepatectomy,0.9429,Partial Hepatectomy,0.9428,Partial Cystectomy,0.9417
Right Rnu,Right;Radical;Nephroureterectomy;Right;Nephroureterectomy,1,2,Right;Radical;Nephroureterectomy;Right;Nephroureterectomy,0.9317,Right;Radical;Nephroureterectomy;Radical Cystectomy;Right;Nephroureterectomy;Radical Cystectomy,0.9295,Right;Nephroureterectomy,0.9281,Right;Partial Nephrectomy,0.9266,Right Eye;Enucleation,0.9251
Right Rnu / Rc,Right;Radical;Nephroureterectomy;Radical Cystectomy;Right;Nephroureterectomy;Radical Cystectomy,1,2,Right;Radical;Nephroureterectomy;Radical Cystectomy;Right;Nephroureterectomy;Radical Cystectomy,0.9339,Right;Radical;Nephroureterectomy;Right;Nephroureterectomy,0.9333,Right;Nephroureterectomy,0.9281,Right;Partial Nephrectomy,0.9259,Left;Radical;Nephroureterectomy,0.9253
Right Total Mastectomy,Right;Total Mastectomy,1,2,Right;Total Mastectomy,0.9884,Left;Total Mastectomy,0.9770,Total Mastectomy,0.9672,Bilateral;Total Mastectomy,0.9607,Right Hemihepatectomy,0.9482
Right eye enucleation,Right Eye;Enucleation,1,2,Right Eye;Enucleation,0.9912,Enucleation,0.9607,Right;Partial Nephrectomy,0.9364,Enucleation;Tail of the Pancreas,0.9357,Right Hemihepatectomy,0.9306
Right hemihepatectomy,Right Hemihepatectomy,1,2,Right Hemihepatectomy,1.0000,Left Hemihepatectomy,0.9885,Right;Partial Nephrectomy,0.9401,Right;Total Mastectomy,0.9376,Radiation Therapy;Right Breast,0.9355
Right mediastinal mass excision,Right;Mediastinal Mass;Excision,1,2,Right;Mediastinal Mass;Excision,0.9846,Excision;Chest Wall Mass,0.9513,Right Breast;Re-Excision,0.9452,Left Breast;Re-Excision,0.9327,Right Hemihepatectomy,0.9287
Right segmental mastectomy,Right;Segmental Mastectomy,1,2,Right;Segmental Mastectomy,0.9912,Left;Segmental Mastectomy,0.9819,Segmental Mastectomy,0.9750,Localized;Segmental Mastectomy,0.9686,Re-Excision;Segmental Mastectomy,0.9607
Right total mastectomy,Right;Total Mastectomy,1,2,Right;Total Mastectomy,0.9884,Left;Total Mastectomy,0.9770,Total Mastectomy,0.9672,Bilateral;Total Mastectomy,0.9607,Right Hemihepatectomy,0.9482
Right uterectomy,Right;Ureterectomy,1,2,Right;Ureterectomy,0.9518,Right Hemihepatectomy,0.9460,Radiation Therapy;Right Breast,0.9428,Right Breast;Re-Excision,0.9413,Right;Partial Nephrectomy,0.9398
Rituxan,Rituximab,1,2,Rituximab,0.9302,Radical;Anterior Pelvic Exenteration,0.9129,Mitoxantrone,0.9121,Plerixafor,0.9119,Splenectomy,0.9097
Robotic assisted laparoscopic nephroureterectomy,Robot-Assisted Surgery;Laparoscopy;Nephroureterectomy,1,2,Robot-Assisted Surgery;Laparoscopy;Nephroureterectomy,0.9789,Laparoscopic Radical Prostatectomy with Robotics,0.9605,Nephroureterectomy,0.9605,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9540,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9520
Robotic assisted laparoscopic radical cystoprostatectomy,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,3,2,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9856,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9836,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9812,Radical Cystoprostatectomy,0.9729,Laparoscopic Radical Prostatectomy with Robotics,0.9688
Robotic radical cystoprostatectomy,Robot-Assisted Surgery;Radical Cystoprostatectomy,2,2,Radical Cystoprostatectomy,0.9864,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9817,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9810,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9729,Laparoscopic Radical Prostatectomy with Robotics,0.9617
Robotic-Assisted Laparoscopic Radical Prostatectomy,Laparoscopic Radical Prostatectomy with Robotics,1,2,Laparoscopic Radical Prostatectomy with Robotics,0.9904,Laparoscopic Prostatectomy,0.9702,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9666,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9664,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9655
SAHA,Vorinostat,1,2,Vorinostat,0.9462,Histone Deacetylase Inhibitor,0.9246,Pracinostat,0.9190,Valproic Acid,0.9171,Azacitidine,0.9130
SAR3419,Coltuximab Ravtansine,99,2,MDM2/MDMX Inhibitor ALRN-6924,0.9039,Sargramostim,0.9039,Sirolimus,0.8947,Anti-CD33 Monoclonal Antibody BI 836858,0.8921,Veliparib,0.8916
SB-715992,Ispinesib,99,2,Purine Analogue NSC 750854,0.9222,NAMPT Inhibitor STF-118804,0.9138,Anti-CD33 Monoclonal Antibody BI 836858,0.9113,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9099,MDM2/MDMX Inhibitor ALRN-6924,0.9079
SCH 727965,Dinaciclib,99,2,Gamma-Secretase Inhibitor RO4929097,0.9146,Anti-HGF Monoclonal Antibody TAK-701,0.9128,Anti-CD33 Monoclonal Antibody BI 836858,0.9069,MDM2/MDMX Inhibitor ALRN-6924,0.9058,Purine Analogue NSC 750854,0.9055
SGI-1776,PIM Kinase Inhibitor SGI-1776,1,2,PIM Kinase Inhibitor SGI-1776,0.9479,Topoisomerase I Inhibitor Genz-644282,0.8952,NAMPT Inhibitor STF-118804,0.8908,Polyamine Analogue PG11047,0.8904,DNA-PK/TOR Kinase Inhibitor CC-115,0.8900
SGN-CD19A,Denintuzumab Mafodotin,99,2,PIM Kinase Inhibitor SGI-1776,0.9073,Dexamethasone,0.9023,Anti-CD33 Monoclonal Antibody BI 836858,0.8959,Anti-CD33 Antibody-drug Conjugate IMGN779,0.8946,Anti-CD3 Monoclonal Antibody,0.8924
SGN-CD33A,Vadastuximab Talirine,99,2,Anti-CD3 Monoclonal Antibody,0.9144,Anti-CD33 Monoclonal Antibody BI 836858,0.9114,PIM Kinase Inhibitor SGI-1776,0.9085,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9010,Dexamethasone,0.9005
SKIN LESION BIOPSY,Skin Biopsy,1,2,Skin Biopsy,0.9745,Biopsy,0.9420,Liver Biopsy,0.9394,Punch Biopsy,0.9330,Excisional Biopsy,0.9307
SKIN SPARING RADICAL MASTECTOMY,Skin-Sparing Mastectomy;Radical Mastectomy,1,2,Skin-Sparing Mastectomy;Radical Mastectomy,0.9850,Bilateral;Skin-Sparing Mastectomy,0.9772,Subcutaneous Mastectomy,0.9413,Mastectomy,0.9366,Re-Excision;Segmental Mastectomy,0.9267
SLND,Sentinel Lymph Node;Lymphadenectomy,2,2,Sentinel Lymph Node Biopsy,0.9436,Sentinel Lymph Node;Lymphadenectomy,0.9367,Left;Sentinel Lymph Node Biopsy,0.9341,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9331,Right;Sentinel Lymph Node Biopsy,0.9322
SMAC,Apoptotic Pathway-targeting Antineoplastic Agent,99,2,Macitentan,0.9034,Samalizumab,0.9019,Acalisib,0.8994,Mitotane,0.8940,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.8933
SORAFENIB,Sorafenib,1,2,Sorafenib,1.0000,Sunitinib,0.9370,Imatinib,0.9307,Sunitinib Malate,0.9302,Lapatinib,0.9284
STA9090 (GANETESPIB),Ganetespib,1,2,Ganetespib,0.9470,Sapacitabine,0.9199,Pan-AKT Kinase Inhibitor GSK690693,0.9081,Abiraterone,0.9067,Anti-HGF Monoclonal Antibody TAK-701,0.9024
STF-118804,NAMPT Inhibitor STF-118804,1,2,NAMPT Inhibitor STF-118804,0.9585,FAK Inhibitor VS-4718,0.9181,DNA-PK/TOR Kinase Inhibitor CC-115,0.9174,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9153,Purine Analogue NSC 750854,0.9149
SU11248,Sunitinib Malate,99,2,Gamma-Secretase Inhibitor RO4929097,0.9090,Anti-CD98 Monoclonal Antibody IGN523,0.9077,Polyamine Analogue PG11047,0.9045,Purine Analogue NSC 750854,0.8975,FAK Inhibitor VS-4718,0.8973
SVV-001,Seneca Valley Virus-001,1,2,Seneca Valley Virus-001,0.9220,Seviteronel,0.9122,FAK Inhibitor VS-4718,0.9001,Vadastuximab Talirine,0.8995,Valspodar,0.8930
SY-1425 (Tamibarotene),Tamibarotene,1,2,Tamibarotene,0.9560,PIM Kinase Inhibitor SGI-1776,0.9214,NAMPT Inhibitor STF-118804,0.9210,Folate Receptor-Targeted Tubulysin Conjugate EC1456,0.9198,Tamoxifen,0.9187
Sacrococcygeal Resection,Sacrococcygeal Teratoma;Resection,1,2,Sacrococcygeal Teratoma;Resection,0.9744,Resection,0.9337,Abdominoperineal Resection,0.9294,Vulva;Resection,0.9252,Surgical Margin;Resection,0.9206
Sapacitabine (CYC682-06),Sapacitabine,1,2,Sapacitabine,0.9768,Anti-CD33 Monoclonal Antibody BI 836858,0.9213,Itacitinib,0.9212,Cladribine,0.9177,PIM Kinase Inhibitor SGI-1776,0.9177
Secondary Debulking,Secondary;Tumor Debulking,1,2,Secondary;Tumor Debulking,0.9709,Primary Debulking Surgery,0.9592,Tumor Debulking,0.9285,Interval Debulking Surgery,0.9170,Sipuleucel-T,0.8910
Segmental mastectomy,Segmental Mastectomy,1,2,Segmental Mastectomy,1.0000,Localized;Segmental Mastectomy,0.9818,Left;Segmental Mastectomy,0.9789,Right;Segmental Mastectomy,0.9760,Re-Excision;Segmental Mastectomy,0.9672
Segmental ureterectomy,Ureterectomy,1,2,Ureterectomy,0.9656,Right;Ureterectomy,0.9449,Segmental Mastectomy,0.9432,Segmentectomy;Single,0.9375,Left;Segmental Mastectomy,0.9368
"Segmentectomy, Multiple",Segmentectomy;Multiple,1,2,Segmentectomy;Multiple,0.9980,Segmentectomy;Single,0.9680,Caudate Lobe;Segmentectomy,0.9274,Re-Excision;Segmental Mastectomy,0.9207,Re-Excision;Original;Lumpectomy;Surgical Site,0.9166
"Segmentectomy, Single",Segmentectomy;Single,1,2,Segmentectomy;Single,0.9965,Segmentectomy;Multiple,0.9659,Caudate Lobe;Segmentectomy,0.9440,Left;Segmental Mastectomy,0.9196,Ureterectomy,0.9182
Sentinel Node Biopsy,Sentinel Lymph Node Biopsy,1,2,Sentinel Lymph Node Biopsy,0.9952,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9772,Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Biopsy,0.9705,Left;Sentinel Lymph Node Biopsy,0.9694,Right;Sentinel Lymph Node Biopsy,0.9692
Simple Hysterectomy,Total Hysterectomy,2,2,Hysterectomy,0.9465,Total Hysterectomy,0.9281,Robotic Hysterectomy,0.9205,Modified Radical Hysterectomy,0.9196,Radical Hysterectomy,0.9166
Simple Mastectomy,Total Mastectomy,5,2,Mastectomy,0.9547,Bilateral;Skin-Sparing Mastectomy,0.9410,Modified Radical Mastectomy,0.9302,Bilateral Mastectomy,0.9288,Total Mastectomy,0.9285
Skin excision,Skin Excision,1,2,Skin Excision,1.0000,Excision,0.9746,Wide Skin Excision,0.9535,Excisional Biopsy,0.9473,Re-Excision,0.9428
Stereotactic,Stereotactic Radiosurgery,1,2,Stereotactic Radiosurgery,0.9639,Fractionated Stereotactic Radiation Therapy,0.9375,Seviteronel,0.9047,Wire-Guided Localization;Segmental Mastectomy,0.9021,Wire-Guided Localization;Right Breast;Biopsy;Wire-Guided Localization;Right Breast,0.8987
Steroids,Steroid Therapy,1,2,Steroid Therapy,0.9663,Prednisone,0.9398,Prednisolone,0.9383,Dexamethasone,0.9321,Sirolimus,0.9197
Surgical,Surgical Procedure,1,2,Surgical Procedure,0.9717,Other;Surgery,0.9398,Surgical Margin;Resection,0.9334,Sacrococcygeal Teratoma;Resection,0.9198,Craniotomy,0.9157
Surgical Resection,Resection,1,2,Resection,0.9826,Surgical Margin;Resection,0.9650,Lung;Resection,0.9567,Surgical Procedure,0.9465,Vulva;Resection,0.9460
Surgical resection,Resection,1,2,Resection,0.9826,Surgical Margin;Resection,0.9650,Lung;Resection,0.9567,Surgical Procedure,0.9465,Vulva;Resection,0.9460
Systemic,Systemic Therapy,1,2,Systemic Therapy,0.9740,Bilateral;Skin-Sparing Mastectomy,0.8976,Sunitinib Malate,0.8905,Intrathecal Route of Administration,0.8900,Sunitinib,0.8897
T cell apheresis,Chimeric Antigen Receptor T-Cell Therapy;Therapeutic Apheresis,1,2,Chimeric Antigen Receptor T-Cell Therapy;Therapeutic Apheresis,0.9429,Autologous Hematopoietic Stem Cell Transplantation,0.9198,Chimeric Antigen Receptor T-Cell Therapy,0.9188,Donor Lymphocyte Infusion,0.9136,Anti-CD3 Monoclonal Antibody,0.9109
TACE,Transarterial Chemoembolization,1,2,Transarterial Chemoembolization,0.9271,Erlotinib,0.9237,Trastuzumab,0.9224,Sorafenib,0.9202,Hepatectomy,0.9156
TACEb,Transarterial Chemoembolization,2,2,Trastuzumab,0.9204,Transarterial Chemoembolization,0.9181,Erlotinib,0.9173,Topotecan,0.9159,Bevacizumab,0.9156
TAE,Transanal Excision,99,2,Taselisib,0.9037,Topotecan,0.9036,Tamoxifen,0.9027,Trametinib,0.8957,Vadastuximab Talirine,0.8957
TAK-701,Anti-HGF Monoclonal Antibody TAK-701,1,2,Anti-HGF Monoclonal Antibody TAK-701,0.9574,NAMPT Inhibitor STF-118804,0.9109,Anti-CD33 Monoclonal Antibody BI 836858,0.9090,Ifabotuzumab,0.9080,Anti-CD98 Monoclonal Antibody IGN523,0.9072
TAMIS,Transanal Excision;Minimally Invasive Surgery,99,2,Tamibarotene,0.9446,Tamoxifen,0.9291,Mastectomy,0.9044,Tasadenoturev,0.9035,Letrozole,0.9007
TAMOXIFEN,Tamoxifen,1,2,Tamoxifen,1.0000,Trastuzumab,0.9327,Tamibarotene,0.9307,Letrozole,0.9288,Fulvestrant,0.9234
TB-403,Anti-PLGF Monoclonal Antibody TB-403,1,2,Anti-PLGF Monoclonal Antibody TB-403,0.9512,Tamibarotene,0.9054,Ifabotuzumab,0.8998,Anti-ErbB3 Monoclonal Antibody REGN1400,0.8997,Anti-CD33 Monoclonal Antibody BI 836858,0.8878
TBI,Total-Body Irradiation,1,2,Total-Body Irradiation,0.9181,Craniotomy,0.9079,Bleomycin,0.9071,Ifabotuzumab,0.9065,Bortezomib,0.9052
TDM-1,Trastuzumab Emtansine,99,2,DNA-PK/TOR Kinase Inhibitor CC-115,0.9078,Thalidomide,0.9009,NAMPT Inhibitor STF-118804,0.9008,Anti-HGF Monoclonal Antibody TAK-701,0.8990,Treosulfan,0.8983
TEMODAR,Temozolomide,99,2,Temsirolimus,0.9087,Topotecan,0.8890,Valspodar,0.8844,Doxorubicin,0.8826,Mitoxantrone,0.8809
TIL infusion,Tumor Infiltrating Lymphocyte Therapy,1,2,Tumor Infiltrating Lymphocyte Therapy,0.9263,Trastuzumab,0.9196,Donor Lymphocyte Infusion,0.9186,Intrahepatic Infusion Procedure,0.9080,Vadastuximab Talirine,0.9063
TKI,Tyrosine Kinase Inhibitor,3,2,Erlotinib,0.9497,Imatinib,0.9452,Tyrosine Kinase Inhibitor,0.9443,Sorafenib,0.9380,Gefitinib,0.9353
TL32711,Birinapant,99,2,AALL0232 ALL Study Identifier,0.9214,AALL0232 ALL Study Identifier;Dexamethasone,0.9166,AALL0331 ALL Study Identifier,0.9145,Anti-PLGF Monoclonal Antibody TB-403,0.9112,NAMPT Inhibitor STF-118804,0.9092
TLI,Total Lymphoid Irradiation,99,2,Dactolisib,0.9095,Anti-PLGF Monoclonal Antibody TB-403,0.9088,Thalidomide,0.9058,Venetoclax,0.9055,Topotecan,0.9054
TM,Trametinib,3,2,Tamoxifen,0.9092,Anti-TIM-3 Monoclonal Antibody,0.9052,Trametinib,0.9049,Trastuzumab Emtansine,0.9043,Macitentan,0.9037
TMZ,Temozolomide,1,2,Temozolomide,0.9536,Gemtuzumab,0.9251,Ipilimumab,0.9202,Carmustine,0.9201,Sorafenib,0.9197
TOPO_II_INH,Topoisomerase-II Inhibitor,1,2,Topoisomerase-II Inhibitor,0.9393,Topoisomerase-I Inhibitor,0.9317,Topotecan,0.9266,Topoisomerase I Inhibitor Genz-644282,0.9220,HDM2 Inhibitor MK-8242,0.9110
TOPO_I_INH,Topoisomerase-I Inhibitor,1,2,Topoisomerase-I Inhibitor,0.9348,Topotecan,0.9293,Topoisomerase-II Inhibitor,0.9283,Topoisomerase I Inhibitor Genz-644282,0.9232,CENP-E Inhibitor GSK-923295A,0.9111
TOPTECAN,Topotecan,1,2,Topotecan,0.9456,Thiotepa,0.9070,Tretinoin,0.9019,Docetaxel,0.9006,Temsirolimus,0.8994
TOTAL MASTECTOMY,Total Mastectomy,1,2,Total Mastectomy,1.0000,Left;Total Mastectomy,0.9709,Bilateral;Total Mastectomy,0.9700,Right;Total Mastectomy,0.9699,Total Hysterectomy,0.9589
TRAMP,TRAM Flap Procedure,2,2,Trametinib,0.9616,TRAM Flap Procedure,0.9485,Tamoxifen,0.9076,Ipilimumab,0.9044,Tamibarotene,0.9016
TRAS,Trastuzumab,2,2,Chimeric Antigen Receptor T-Cell Therapy,0.9060,Trastuzumab,0.9032,Chimeric Antigen Receptor T-Cell Therapy;Therapeutic Apheresis,0.9019,Tamibarotene,0.8995,Anti-TIM-3 Monoclonal Antibody,0.8983
TRASTUZUMAB,Trastuzumab,1,2,Trastuzumab,1.0000,Trastuzumab Emtansine,0.9543,Lapatinib,0.9351,Tamoxifen,0.9327,Daratumumab,0.9327
TRISENOX(ATO),Arsenic Trioxide,99,2,Tamoxifen,0.9135,Chimeric Antigen Receptor T-Cell Therapy;Therapeutic Apheresis,0.9105,Anti-CD33 Monoclonal Antibody BI 836858,0.9086,Topotecan,0.9081,Anti-TIM-3 Monoclonal Antibody,0.9048
TUR,Transurethral Resection,1,2,Transurethral Resection,0.9022,Transurethral Resection of Bladder Tumor,0.8997,Topotecan,0.8972,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,0.8878,Coltuximab Ravtansine,0.8868
TURBT,Transurethral Resection of Bladder Tumor,99,2,Ifabotuzumab,0.9003,Topotecan,0.9003,Tretinoin,0.8995,Docetaxel,0.8986,Tazemetostat,0.8964
TURBT (transurethral resection of bladder tumor),Transurethral Resection of Bladder Tumor,1,2,Transurethral Resection of Bladder Tumor,0.9619,Transurethral Resection,0.9480,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,0.9377,Resection;Pelvis;Tumor Mass,0.9312,Right;Radical;Nephroureterectomy;Radical Cystectomy;Right;Nephroureterectomy;Radical Cystectomy,0.9299
TVRC-biopsy,Biopsy,1,2,Biopsy,0.9248,Ureter;Biopsy,0.9176,Skin Biopsy,0.9114,Wide;Re-Excision;Biopsy,0.9106,Re-Excision;Biopsy Site,0.9094
Tasadeoturev,Tasadenoturev,1,2,Tasadenoturev,0.9666,Taselisib,0.9156,Vadastuximab Talirine,0.8983,Tisagenlecleucel,0.8931,Tamibarotene,0.8914
Taxol,Paclitaxel,1,2,Paclitaxel,0.9473,Docetaxel,0.9427,Nab-paclitaxel,0.9276,Topotecan,0.9255,Tamoxifen,0.9180
Taxotere,Docetaxel,1,2,Docetaxel,0.9348,Topotecan,0.9179,Paclitaxel,0.9134,Tamoxifen,0.9089,Nab-paclitaxel,0.9057
Temodar,Temozolomide,99,2,Temsirolimus,0.9087,Topotecan,0.8890,Valspodar,0.8844,Doxorubicin,0.8826,Mitoxantrone,0.8809
Temozolamide,Temozolomide,1,2,Temozolomide,0.9507,Dacarbazine,0.9123,Carmustine,0.9122,Celecoxib,0.9087,Procarbazine,0.9085
Thymoglobulin,Lapine T-Lymphocyte Immune Globulin,99,2,Anti-Thymocyte Globulin,0.9312,Gemtuzumab,0.9092,Trastuzumab,0.9079,Topotecan,0.9058,Immunoglobulin,0.9052
Thymoglobulin (Bu/Flu/ATG),Lapine T-Lymphocyte Immune Globulin,99,2,Ifabotuzumab,0.9271,Anti-Thymocyte Globulin,0.9268,Gemtuzumab,0.9221,mTOR Inhibitor;Immunotherapeutic Agent,0.9212,Anti-PLGF Monoclonal Antibody TB-403,0.9208
Thymoglobulin (Bu/Flu/Cy/ATG),Lapine T-Lymphocyte Immune Globulin,99,2,Anti-Thymocyte Globulin,0.9274,mTOR Inhibitor;Immunotherapeutic Agent,0.9242,Chimeric Antigen Receptor T-Cell Therapy;Therapeutic Apheresis,0.9238,Chimeric Antigen Receptor T-Cell Therapy,0.9228,Ifabotuzumab,0.9223
Total Abdominal,Total Abdominal Hysterectomy,1,2,Total Abdominal Hysterectomy,0.9658,Total Hepatectomy,0.9313,Total Hysterectomy,0.9263,Total-Body Irradiation,0.9227,Total Pancreatectomy,0.9215
Total Body Irradiation,Total-Body Irradiation,1,2,Total-Body Irradiation,0.9985,Total Lymphoid Irradiation,0.9622,Radiation Therapy,0.9312,Radiation Therapy;Right Breast,0.9260,Total Hepatectomy,0.9257
Total mastectomy,Total Mastectomy,1,2,Total Mastectomy,1.0000,Left;Total Mastectomy,0.9709,Bilateral;Total Mastectomy,0.9700,Right;Total Mastectomy,0.9699,Total Hysterectomy,0.9589
Total pancreatectomy,Total Pancreatectomy,1,2,Total Pancreatectomy,1.0000,Distal Pancreatectomy,0.9454,Total Hepatectomy,0.9451,Pancreaticoduodenectomy,0.9430,Total Abdominal Hysterectomy,0.9328
Transplant,Graft,5,2,Bone Marrow Transplantation,0.9354,Hematopoietic Cell Transplantation,0.9271,Autologous Hematopoietic Stem Cell Transplantation,0.9125,Sibling;Allogeneic Hematopoietic Stem Cell Transplantation,0.9091,Graft,0.9082
Transurethral resection,Transurethral Resection,1,2,Transurethral Resection,1.0000,Transurethral Resection of Bladder Tumor,0.9783,Resection,0.9427,Transanal Excision,0.9405,Transanal Excision;Minimally Invasive Surgery,0.9388
UNK,Unknown,1,2,Unknown,0.9083,Galunisertib,0.8978,Right Eye;Enucleation,0.8889,Enucleation,0.8887,Uncinate Process of Pancreas;Resection,0.8858
Uncinate process resection,Uncinate Process of Pancreas;Resection,1,2,Uncinate Process of Pancreas;Resection,0.9803,Resection,0.9242,Vulva;Resection,0.9186,Ureterectomy,0.9174,Resection;Pelvis;Tumor Mass,0.9166
Unilateral Salpingo- Oophorectomy,Unilateral Salpingo-oophorectomy,1,2,Unilateral Salpingo-oophorectomy,1.0000,Unilateral Oophorectomy,0.9876,Bilateral Salpingectomy with Oophorectomy,0.9733,Bilateral Salpingectomy,0.9649,Bilateral;Ovarian;Cystectomy,0.9473
Unilateral Salpingo-Oophorectomy,Unilateral Salpingo-oophorectomy,1,2,Unilateral Salpingo-oophorectomy,1.0000,Unilateral Oophorectomy,0.9876,Bilateral Salpingectomy with Oophorectomy,0.9733,Bilateral Salpingectomy,0.9649,Bilateral;Ovarian;Cystectomy,0.9473
Ureteral Biopsy,Ureter;Biopsy,1,2,Ureter;Biopsy,0.9773,Biopsy,0.9558,Ureterectomy,0.9378,Laparoscopic Biopsy,0.9346,Skin Biopsy,0.9333
V212,Heat-Treated Varicella-Zoster Virus Vaccine V212,1,2,Heat-Treated Varicella-Zoster Virus Vaccine V212,0.9308,HER2-targeting Agent,0.8904,Peginterferon Alfa-2a,0.8854,Akt Inhibitor MK2206,0.8854,AALL0232 ALL Study Identifier,0.8811
VB,Vinblastine,2,2,Bevacizumab,0.9213,Vinblastine,0.9178,Vinorelbine,0.9146,Valspodar,0.9122,Bortezomib,0.9121
VCR,Vincristine,3,2,Vorinostat,0.9159,Valspodar,0.9157,Vincristine,0.9150,Veliparib,0.9102,Vinblastine,0.9081
VINCRISTINE,Vincristine,1,2,Vincristine,1.0000,Vincristine Sulfate,0.9550,Vinorelbine,0.9401,Vinblastine,0.9390,Bortezomib,0.9195
VP-16,Etoposide,99,2,Valspodar,0.9149,Heat-Treated Varicella-Zoster Virus Vaccine V212,0.9107,Peginterferon Alfa-2a,0.9090,Veliparib,0.9086,Topoisomerase I Inhibitor Genz-644282,0.9013
VS-4718,FAK Inhibitor VS-4718,1,2,FAK Inhibitor VS-4718,0.9525,MDM2/MDMX Inhibitor ALRN-6924,0.9066,Gamma-Secretase Inhibitor RO4929097,0.9050,Rovalpituzumab Tesirine,0.9026,Topoisomerase I Inhibitor Genz-644282,0.9020
VT-464,Seviteronel,99,2,FAK Inhibitor VS-4718,0.9175,Vincristine,0.8936,Anti-HGF Monoclonal Antibody TAK-701,0.8921,Valspodar,0.8915,Fulvestrant,0.8914
Velcade,Bortezomib,4,2,Valspodar,0.9195,Vinblastine,0.9180,Veliparib,0.9164,Bortezomib,0.9137,Brentuximab Vedotin,0.9047
Vem,Vemurafenib,1,2,Vemurafenib,0.9539,Vorinostat,0.9296,Volasertib,0.9245,Ipilimumab,0.9214,Seviteronel,0.9144
Venetoclax (ABT-199),Venetoclax,1,2,Venetoclax,0.9752,Navitoclax,0.9305,Brentuximab Vedotin,0.9296,Bortezomib,0.9285,Navicixizumab,0.9267
Vidaza,Azacitidine Regimen,99,2,Vadastuximab Talirine,0.9112,Vincristine,0.9089,Ivosidenib,0.9083,Valspodar,0.9057,Vinorelbine,0.9029
Vinorelbrine,Vinorelbine,1,2,Vinorelbine,0.9789,Vinblastine,0.9567,Vincristine,0.9417,Bortezomib,0.9243,Vorinostat,0.9214
Vulvar resecetion,Vulva;Resection,1,2,Vulva;Resection,0.9305,Re-Excision;Superior;Margin,0.9176,Re-Excision,0.9162,Re-Excision;Original;Lumpectomy;Surgical Site,0.9134,Right Breast;Re-Excision,0.9099
Wertheim Meiggs,Wertheim operation (procedure),1,2,Wertheim operation (procedure),0.9361,Motixafortide,0.8993,Fotemustine,0.8920,Quizartinib,0.8900,Gemtuzumab,0.8895
Wide Excision,Wide Skin Excision,1,2,Wide Skin Excision,0.9912,Wide Local Excision,0.9853,Wide;Re-Excision;Biopsy,0.9515,Skin Excision,0.9301,Excision,0.9280
Wide local excision,Wide Local Excision,1,2,Wide Local Excision,1.0000,Wide Skin Excision,0.9816,Local excision (procedure),0.9496,Wide;Re-Excision;Biopsy,0.9451,Skin Excision,0.9299
Wide re-excisional biopsy,Wide;Re-Excision;Biopsy,1,2,Wide;Re-Excision;Biopsy,0.9786,Wide Skin Excision,0.9653,Re-Excision;Biopsy Site,0.9600,Wide Local Excision,0.9586,Re-Excision,0.9489
XL147,Pilaralisib,99,2,JAK2 Inhibitor AZD1480,0.9123,Anti-EGFR Monoclonal Antibody,0.9030,Anti-CD98 Monoclonal Antibody IGN523,0.9028,Folate Receptor-Targeted Tubulysin Conjugate EC1456,0.9028,Gamma-Secretase Inhibitor RO4929097,0.9023
Yes vaccine,Vaccine,1,2,Vaccine,0.9576,Dendritic Cell Vaccine,0.9140,NY-ESO-1 Peptide Vaccine,0.9117,Heat-Treated Varicella-Zoster Virus Vaccine V212,0.9101,Bacillus Calmette-Guerin Antigen,0.9067
abiraterone,Abiraterone,1,2,Abiraterone,1.0000,Abiraterone Acetate,0.9848,Sirolimus,0.9348,Dabrafenib,0.9330,Docetaxel,0.9315
abiraterone acetate,Abiraterone Acetate,1,2,Abiraterone Acetate,1.0000,Abiraterone,0.9848,Sirolimus,0.9295,Dabrafenib,0.9284,Bicalutamide,0.9268
abraxane,Nab-paclitaxel,99,2,Pexidartinib,0.9140,Crenolanib,0.9119,Lorazepam,0.9119,Afatinib,0.9075,Abiraterone,0.9068
added ipilimumab),Ipilimumab,1,2,Ipilimumab,0.9478,mTOR Inhibitor;Immunotherapeutic Agent,0.9077,Immunotherapeutic Agent,0.8965,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.8958,Anti-CD33 Antibody-drug Conjugate IMGN779,0.8941
adriamycin,Doxorubicin Hydrochloride,2,2,Doxorubicin,0.9634,Doxorubicin Hydrochloride,0.9431,Anthracycline Antineoplastic Antibiotic,0.9361,Daunorubicin,0.9317,Adalimumab,0.9202
amifostine,Amifostine,1,2,Amifostine,1.0000,Midostaurin,0.9219,Mitoxantrone,0.9216,Fludarabine,0.9150,Fluorouracil,0.9133
anterior exenteration,Anterior Pelvic Exenteration,1,2,Anterior Pelvic Exenteration,0.9762,Pelvic Exenteration,0.9513,Radical;Anterior Pelvic Exenteration,0.9493,Low Anterior Resection,0.9059,Exploratory Surgery;External,0.9044
anthracycline,Anthracycline Antineoplastic Antibiotic,1,2,Anthracycline Antineoplastic Antibiotic,0.9651,Doxorubicin,0.9547,Doxorubicin Hydrochloride,0.9335,Daunorubicin,0.9318,Imatinib,0.9280
anti-CD123,Immunotherapeutic Agent,99,2,Anti-CD3 Monoclonal Antibody,0.9496,Anti-CD33 Monoclonal Antibody BI 836858,0.9394,Anti-LAG-3 Monoclonal Antibody,0.9391,Anti-TIM-3 Monoclonal Antibody,0.9382,Anti-CD47 Monoclonal Antibody,0.9369
anti-CD33,Immunotherapeutic Agent,99,2,Anti-CD3 Monoclonal Antibody,0.9876,Anti-CD33 Monoclonal Antibody BI 836858,0.9685,Anti-TIM-3 Monoclonal Antibody,0.9441,Anti-LAG-3 Monoclonal Antibody,0.9432,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9420
anti-LAG3,Anti-LAG-3 Monoclonal Antibody,1,2,Anti-LAG-3 Monoclonal Antibody,0.9700,Anti-CD47 Monoclonal Antibody,0.9175,Anti-Thymocyte Globulin,0.9150,Anti-TIM-3 Monoclonal Antibody,0.9144,Anti-EGFR Monoclonal Antibody,0.9134
anti-TIM3,Anti-TIM-3 Monoclonal Antibody,1,2,Anti-TIM-3 Monoclonal Antibody,0.9738,Anti-Thymocyte Globulin,0.9287,Anti-LAG-3 Monoclonal Antibody,0.9281,Anti-CD3 Monoclonal Antibody,0.9270,Anti-CD33 Monoclonal Antibody BI 836858,0.9268
appendectomy,Appendectomy,1,2,Appendectomy,1.0000,Ureterectomy,0.9227,Metastasectomy,0.9215,Exploratory Surgery;Laparotomy,0.9187,Exploratory Surgery,0.9182
autologous stem cell transplant,Autologous Hematopoietic Stem Cell Transplantation,1,2,Autologous Hematopoietic Stem Cell Transplantation,0.9841,Hematopoietic Cell Transplantation,0.9359,Sibling;Allogeneic Hematopoietic Stem Cell Transplantation,0.9348,Bone Marrow Transplantation,0.9300,Matched Unrelated Donor;Allogeneic Hematopoietic Stem Cell Transplantation,0.9299
autologout SCT,Autologous Hematopoietic Stem Cell Transplantation,1,2,Autologous Hematopoietic Stem Cell Transplantation,0.9257,Matched Unrelated Donor;Allogeneic Hematopoietic Stem Cell Transplantation,0.9034,Chimeric Antigen Receptor T-Cell Therapy;Therapeutic Apheresis,0.9032,Sibling;Allogeneic Hematopoietic Stem Cell Transplantation,0.9020,Hematopoietic Cell Transplantation,0.9009
axillary dissection,Axillary Lymph Node Dissection,1,2,Axillary Lymph Node Dissection,0.9846,Left;Axillary Lymph Node Dissection,0.9643,Axillary Lymph Node Biopsy,0.9557,Axillary Lymph Node;Right,0.9363,Axillary Lymph Node Level I;Axillary Lymph Node Level II;Lymphadenectomy,0.9296
axillary lymph node biopsy,Axillary Lymph Node Biopsy,1,2,Axillary Lymph Node Biopsy,1.0000,Axillary Lymph Node Dissection,0.9729,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9690,Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Biopsy,0.9626,Left;Axillary Lymph Node Dissection,0.9607
axillary lymph node dissection,Axillary Lymph Node Dissection,1,2,Axillary Lymph Node Dissection,1.0000,Left;Axillary Lymph Node Dissection,0.9792,Axillary Lymph Node Biopsy,0.9729,Axillary Lymph Node;Right,0.9498,Axillary Lymph Node Level I;Axillary Lymph Node Level II;Lymphadenectomy,0.9470
axillary node dissection,Axillary Lymph Node Dissection,1,2,Axillary Lymph Node Dissection,0.9954,Left;Axillary Lymph Node Dissection,0.9715,Axillary Lymph Node Biopsy,0.9705,Axillary Lymph Node;Right,0.9461,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9421
axillary sentinel lymph node biopsy,Axillary Lymph Node;Sentinel Lymph Node Biopsy,1,2,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9926,Sentinel Lymph Node Biopsy,0.9868,Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Biopsy,0.9828,Axillary Lymph Node Biopsy,0.9779,Left;Sentinel Lymph Node Biopsy,0.9680
azacitidine,Azacitidine,1,2,Azacitidine,1.0000,Azacitidine Regimen,0.9771,Decitabine,0.9310,Azathioprine,0.9271,Pracinostat,0.9168
bevacizumab,Bevacizumab,1,2,Bevacizumab,1.0000,Bortezomib,0.9326,Sorafenib,0.9259,Rituximab,0.9245,Nab-paclitaxel,0.9214
bicalutamide,Bicalutamide,1,2,Bicalutamide,1.0000,Enzalutamide,0.9517,Abiraterone Acetate,0.9268,Abiraterone,0.9257,Antiandrogen Therapy,0.9230
bilateral pelvic lymph node dissection,Bilateral Pelvic Lymph Node Dissection,1,2,Bilateral Pelvic Lymph Node Dissection,1.0000,Bilateral;Pelvic Lymphadenectomy,0.9829,Pelvic Lymphadenectomy,0.9647,Bilateral Salpingectomy,0.9482,Extend;Pelvic Lymphadenectomy,0.9477
bilateral pelvic lymphadenectomy,Bilateral;Pelvic Lymphadenectomy,1,2,Bilateral;Pelvic Lymphadenectomy,0.9951,Bilateral Pelvic Lymph Node Dissection,0.9847,Pelvic Lymphadenectomy,0.9675,Bilateral Salpingectomy,0.9561,Extend;Pelvic Lymphadenectomy,0.9501
bilateral total mastectomies,Bilateral;Total Mastectomy,1,2,Bilateral;Total Mastectomy,0.9769,Total Mastectomy,0.9623,Left;Total Mastectomy,0.9609,Bilateral Mastectomy,0.9585,Right;Total Mastectomy,0.9580
biopsy,Biopsy,1,2,Biopsy,1.0000,Skin Biopsy,0.9629,Liver Biopsy,0.9552,Ureter;Biopsy,0.9523,Laparoscopic Biopsy,0.9452
bleomycin,Bleomycin,1,2,Bleomycin,1.0000,Vinblastine,0.9172,Bortezomib,0.9160,Bevacizumab,0.9121,Lapatinib,0.9120
breast conserving therapy,Breast Conservation Treatment,1,2,Breast Conservation Treatment,0.9747,Bilateral;Skin-Sparing Mastectomy,0.9241,Lumpectomy;Right Breast,0.9205,Radiation Therapy;Right Breast,0.9157,Skin-Sparing Mastectomy;Radical Mastectomy,0.9146
brentuximab vedotin,Brentuximab Vedotin,1,2,Brentuximab Vedotin,1.0000,Vinblastine,0.9226,Docetaxel,0.9226,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9206,Vadastuximab Talirine,0.9198
cape,Capecitabine,3,2,Cetuximab,0.9058,Cytarabine,0.9036,Capecitabine,0.9020,Celecoxib,0.9000,Entospletinib,0.8942
capecitabine,Capecitabine,1,2,Capecitabine,1.0000,Gemcitabine,0.9270,Temozolomide,0.9240,Docetaxel,0.9227,Letrozole,0.9211
carbo,Carboplatin,4,2,Celecoxib,0.8976,Cytosine,0.8972,Carboxyamidotriazole,0.8933,Carboplatin,0.8919,Cyclophosphamide,0.8899
carboplatin,Carboplatin,1,2,Carboplatin,1.0000,Cisplatin,0.9385,Cetuximab,0.9345,Cyclophosphamide,0.9253,Platinum,0.9244
carmustine,Carmustine,1,2,Carmustine,1.0000,Lomustine,0.9606,Fotemustine,0.9369,Gemtuzumab,0.9100,Temozolomide,0.9094
carvo,Carboplatin,99,2,Carmustine,0.9110,Vadastuximab Talirine,0.8971,Venetoclax,0.8911,Pevonedistat,0.8910,Valspodar,0.8894
cd47mAb,Anti-CD47 Monoclonal Antibody,1,2,Anti-CD47 Monoclonal Antibody,0.9628,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9218,Anti-CD98 Monoclonal Antibody IGN523,0.9065,Anti-CD3 Monoclonal Antibody,0.9033,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9032
cetuximab,Cetuximab,1,2,Cetuximab,1.0000,Carboplatin,0.9345,Anti-EGFR Monoclonal Antibody,0.9333,Pertuzumab,0.9320,Celecoxib,0.9257
cis,Cisplatin,1,2,Cisplatin,0.9037,Cixutumumab,0.9009,Carboplatin,0.8985,Azacitidine,0.8897,Cetuximab,0.8893
cisplatin,Cisplatin,1,2,Cisplatin,1.0000,Platinum,0.9493,Carboplatin,0.9385,Oxaliplatin,0.9214,Cetuximab,0.9208
clofarabine,Clofarabine,1,2,Clofarabine,1.0000,Fludarabine,0.9272,Fenretinide,0.9206,Cladribine,0.9175,Folic Acid,0.9167
cob,Cobimetinib,1,2,Cobimetinib,0.9441,Cetuximab,0.9149,Cytarabine,0.9097,Carboplatin,0.9043,Celecoxib,0.9032
cobimetinib,Cobimetinib,1,2,Cobimetinib,1.0000,Binimetinib,0.9585,Itacitinib,0.9241,Selumetinib,0.9240,Axitinib,0.9200
combo resection,Combination;Resection,2,2,Resection,0.9206,Combination;Resection,0.9136,Lung;Resection,0.9124,Sacrococcygeal Teratoma;Resection,0.9120,Vulva;Resection,0.9111
cos,Cisplatin,99,2,Oxaliplatin,0.8783,Etoposide,0.8768,Ifosfamide,0.8756,Liposome-encapsulated Daunorubicin-Cytarabine,0.8735,Treosulfan,0.8732
creation of ileal conduit,Urinary Diversion,99,2,Ureterectomy,0.9064,Orthotopic;Neobladder,0.9056,Ureter;Biopsy,0.9043,Robot-Assisted Surgery;Cystectomy,0.9030,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,0.8994
creation of neobladder,Neobladder,1,2,Neobladder,0.9669,Orthotopic;Neobladder,0.9414,Robot-Assisted Surgery;Laparoscopy;Nephroureterectomy,0.9144,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,0.9096,Nephroureterectomy,0.9091
creation of orthotopic neobladder,Orthotopic;Neobladder,1,2,Orthotopic;Neobladder,0.9648,Neobladder,0.9459,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,0.9154,Robot-Assisted Surgery;Cystectomy,0.9114,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9078
cvt,Regadenoson,99,2,Valspodar,0.9135,Cyclophosphamide,0.9117,Cixutumumab,0.9084,Cetuximab,0.9065,Cytarabine,0.9061
cyclophosphamide,Cyclophosphamide,1,2,Cyclophosphamide,1.0000,Carboplatin,0.9253,Azathioprine,0.9185,Temozolomide,0.9171,Cladribine,0.9170
cystoprostatectomy,Radical Cystoprostatectomy,1,2,Radical Cystoprostatectomy,0.9804,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9605,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9600,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9548,Partial Cystectomy,0.9444
cytarabine,Cytarabine,1,2,Cytarabine,1.0000,Liposomal Cytarabine,0.9671,Liposome-encapsulated Daunorubicin-Cytarabine,0.9303,Cytosine,0.9231,Cyclosporine,0.9182
dacarbazine,Dacarbazine,1,2,Dacarbazine,1.0000,Procarbazine,0.9504,Dactinomycin,0.9448,Decitabine,0.9320,Dactolisib,0.9291
dauna,Daunorubicin,1,2,Daunorubicin,0.9230,Dopamine,0.9028,Docetaxel,0.8881,Cediranib,0.8881,Liposome-encapsulated Daunorubicin-Cytarabine,0.8878
dauno,Daunorubicin,1,2,Daunorubicin,0.9487,Liposome-encapsulated Daunorubicin-Cytarabine,0.9021,Dinaciclib,0.8896,Cediranib,0.8892,Galunisertib,0.8884
dcVax,Dendritic Cell Vaccine,1,2,Dendritic Cell Vaccine,0.9349,Dactinomycin,0.9169,Decitabine,0.9154,Liposome-encapsulated Daunorubicin-Cytarabine,0.9147,Dexamethasone,0.9126
desatinib,Dasatinib,99,2,Cediranib,0.9077,Dutasteride,0.9057,Cladribine,0.9017,Entospletinib,0.9010,Devimistat,0.8970
dex,Dexamethasone,1,2,Dexamethasone,0.9567,Prednisolone,0.9296,Decitabine,0.9245,Prednisone,0.9227,Steroid Therapy,0.9222
dexamethasone,Dexamethasone,1,2,Dexamethasone,1.0000,Prednisolone,0.9406,Prednisone,0.9366,AALL0232 ALL Study Identifier;Dexamethasone,0.9338,Steroid Therapy,0.9332
docetaxel,Docetaxel,1,2,Docetaxel,1.0000,Abiraterone,0.9315,Paclitaxel,0.9290,Mitoxantrone,0.9280,Capecitabine,0.9227
doxorubicin,Doxorubicin,1,2,Doxorubicin,1.0000,Doxorubicin Hydrochloride,0.9710,Daunorubicin,0.9479,Anthracycline Antineoplastic Antibiotic,0.9451,Liposome-encapsulated Daunorubicin-Cytarabine,0.9348
doxorubicin hydrochloride,Doxorubicin Hydrochloride,1,2,Doxorubicin Hydrochloride,1.0000,Doxorubicin,0.9710,Irinotecan Hydrochloride,0.9502,Anthracycline Antineoplastic Antibiotic,0.9366,Erlotinib Hydrochloride,0.9327
enucleation,Enucleation,1,2,Enucleation,1.0000,Right Eye;Enucleation,0.9632,Enucleation;Tail of the Pancreas,0.9489,Enasidenib,0.9237,Enoblituzumab,0.9187
enucleation in the pancretic tail,Enucleation;Tail of the Pancreas,1,2,Enucleation;Tail of the Pancreas,0.9839,Enucleation,0.9497,Right Eye;Enucleation,0.9416,Pancreaticoduodenectomy,0.9347,Uncinate Process of Pancreas;Resection,0.9301
enzalutamide,Enzalutamide,1,2,Enzalutamide,1.0000,Bicalutamide,0.9517,Leuprolide,0.9170,Dutasteride,0.9170,Abiraterone,0.9163
epirubicin,Epirubicin,1,2,Epirubicin,1.0000,Idarubicin,0.9616,Abiraterone,0.9195,External Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9163,Liposome-encapsulated Daunorubicin-Cytarabine,0.9152
erlotinib,Erlotinib,1,2,Erlotinib,1.0000,Erlotinib Hydrochloride,0.9605,Gefitinib,0.9296,Everolimus,0.9275,Imatinib,0.9245
etoposide,Etoposide,1,2,Etoposide,1.0000,Etoposide Phosphate,0.9606,Topoisomerase-I Inhibitor,0.9240,Erlotinib,0.9222,Irinotecan,0.9201
etoposide phosphate,Etoposide Phosphate,1,2,Etoposide Phosphate,1.0000,Etoposide,0.9606,Topoisomerase-I Inhibitor,0.9174,Topoisomerase-II Inhibitor,0.9162,Prednisolone,0.9125
everolimus,Everolimus,1,2,Everolimus,1.0000,Axitinib,0.9394,Sirolimus,0.9393,mTOR Inhibitor;Immunotherapeutic Agent,0.9324,Ipilimumab,0.9276
excision of mass on chest wall,Excision;Chest Wall Mass,1,2,Excision;Chest Wall Mass,0.9913,Right;Mediastinal Mass;Excision,0.9592,Re-Excision;Original;Lumpectomy;Surgical Site,0.9393,Skin Excision,0.9384,Left Breast;Re-Excision,0.9372
excisional biopsy,Excisional Biopsy,1,2,Excisional Biopsy,1.0000,Excision,0.9607,Skin Excision,0.9473,Re-Excision;Biopsy Site,0.9366,Punch Biopsy,0.9339
extended pelvic lymph node dissection,Extend;Pelvic Lymphadenectomy,1,2,Extend;Pelvic Lymphadenectomy,0.9621,Bilateral Pelvic Lymph Node Dissection,0.9610,Pelvic Lymphadenectomy,0.9534,Bilateral;Pelvic Lymphadenectomy,0.9361,Axillary Lymph Node Dissection,0.9346
fluorouracil,Fluorouracil,1,2,Fluorouracil,1.0000,Fluoropyrimidine,0.9473,Fotemustine,0.9333,Floxuridine,0.9326,Fludarabine,0.9316
folinic acid,Leucovorin,99,2,Folic Acid,0.9374,Valproic Acid,0.9270,Fluorouracil,0.9112,Vinorelbine,0.9064,Fotemustine,0.9020
gem,Gemcitabine,3,2,Gemtuzumab,0.9676,Gemtuzumab Ozogamicin,0.9526,Gemcitabine,0.9300,Pemetrexed,0.9104,Gefitinib,0.9065
gemcitabine,Gemcitabine,1,2,Gemcitabine,1.0000,Gemtuzumab,0.9271,Capecitabine,0.9270,Gefitinib,0.9220,Gemtuzumab Ozogamicin,0.9185
gleevec,Imatinib Regimen,99,2,Glembatumumab,0.9093,Seviteronel,0.9053,Valspodar,0.9011,Imatinib,0.8943,Volasertib,0.8911
hydrea,Hydroxyurea,3,2,Vorinostat,0.9036,Proton Beam Radiation Therapy;3-Dimensional Conformal Radiation Therapy,0.9001,Hydroxyurea,0.8960,Pertuzumab,0.8944,Histone Deacetylase Inhibitor,0.8936
hysterectomy,Hysterectomy,1,2,Hysterectomy,1.0000,Robotic Hysterectomy,0.9583,Total Hysterectomy,0.9523,Radical Hysterectomy,0.9484,Modified Radical Hysterectomy,0.9385
ifosfamide,Ifosfamide,1,2,Ifosfamide,1.0000,Fludarabine,0.9235,Ifabotuzumab,0.9192,Afatinib,0.9151,Fluorouracil,0.9144
ileal conduit,Urinary Diversion,99,2,Orthotopic;Neobladder,0.9081,Neobladder,0.9029,J-Pouch Coloanal Anastomosis,0.9014,Ureter;Biopsy,0.8999,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,0.8991
ileal conduit urinary diversion,Urinary Diversion,1,2,Urinary Diversion,0.9664,Orthotopic;Neobladder,0.9208,Ureterectomy,0.9185,Neobladder,0.9180,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,0.9175
inner-upper margin re-excision,Inner;Upper;Surgical Margin;Re-Excision,1,2,Inner;Upper;Surgical Margin;Re-Excision,0.9817,Re-Excision;Superior;Margin,0.9605,Re-Excision;Inferior;Margin,0.9585,Re-Excision,0.9404,Left Breast;Re-Excision,0.9349
ipi,Ipilimumab,3,2,Pipobroman,0.9152,Plitidepsin,0.9125,Ipilimumab,0.9097,Pilaralisib,0.9091,Pidnarulex,0.9079
ipilimumab,Ipilimumab,1,2,Ipilimumab,1.0000,mTOR Inhibitor;Immunotherapeutic Agent,0.9360,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9281,Temozolomide,0.9278,Everolimus,0.9276
irinotecan,Irinotecan,1,2,Irinotecan,1.0000,Irinotecan Hydrochloride,0.9762,Sirolimus,0.9247,Paclitaxel,0.9245,Sorafenib,0.9225
isotretinoin,Isotretinoin,1,2,Isotretinoin,1.0000,Tretinoin,0.9356,Fenretinide,0.9242,Gonadotropin-releasing Hormone Analog,0.9135,Treosulfan,0.9131
left axillary lymph node dissection,Left;Axillary Lymph Node Dissection,1,2,Left;Axillary Lymph Node Dissection,0.9928,Axillary Lymph Node Dissection,0.9830,Axillary Lymph Node;Right,0.9602,Axillary Lymph Node Biopsy,0.9588,Bilateral Pelvic Lymph Node Dissection,0.9497
left breast biopsy,Left;Biopsy of Breast,1,2,Left;Biopsy of Breast,0.9819,Lumpectomy;Right Breast,0.9456,Left Breast;Re-Excision,0.9427,Wire-Guided Localization;Right Breast;Biopsy;Wire-Guided Localization;Right Breast,0.9417,Left;Axillary Lymph Node Dissection,0.9389
left segmental mastectomy,Left;Segmental Mastectomy,1,2,Left;Segmental Mastectomy,0.9927,Right;Segmental Mastectomy,0.9842,Segmental Mastectomy,0.9810,Localized;Segmental Mastectomy,0.9773,Re-Excision;Segmental Mastectomy,0.9559
left sentinel lymph node biospy,Left;Sentinel Lymph Node Biopsy,1,2,Left;Sentinel Lymph Node Biopsy,0.9749,Right;Sentinel Lymph Node Biopsy,0.9690,Sentinel Lymph Node Biopsy,0.9569,Sentinel Lymph Node;Lymphadenectomy;Right;Mammoplasty,0.9543,Sentinel Lymph Node;Lymphadenectomy,0.9541
lenalidomide,Lenalidomide,1,2,Lenalidomide,1.0000,Melphalan,0.9309,Thalidomide,0.9268,Rituximab,0.9248,Ramucirumab,0.9225
lenaloidomide,Lenalidomide,1,2,Lenalidomide,0.9435,Thalidomide,0.9133,Dexamethasone,0.9129,Ruxolitinib,0.9123,Temozolomide,0.9085
leucovorin,Leucovorin,1,2,Leucovorin,1.0000,Vincristine,0.9032,Liposomal Cytarabine,0.9025,Asparaginase,0.9021,FLT3/CDK4/6 Inhibitor FLX925,0.9017
level 1 and level 2 axillary dissection,Axillary Lymph Node Level I;Axillary Lymph Node Level II;Lymphadenectomy,1,2,Axillary Lymph Node Level I;Axillary Lymph Node Level II;Lymphadenectomy,0.9750,Axillary Lymph Node Dissection,0.9491,Left;Axillary Lymph Node Dissection,0.9447,Axillary Lymph Node Biopsy,0.9312,Axillary Lymph Node;Right,0.9295
limb infusion,Isolated Chemotherapeutic Limb Perfusion,1,2,Isolated Chemotherapeutic Limb Perfusion,0.9359,Intrahepatic Infusion Procedure,0.9313,Donor Lymphocyte Infusion,0.9151,Biochemotherapy,0.8975,Ureterectomy,0.8966
localized segmental mastectomy,Localized;Segmental Mastectomy,1,2,Localized;Segmental Mastectomy,0.9952,Segmental Mastectomy,0.9769,Left;Segmental Mastectomy,0.9678,Right;Segmental Mastectomy,0.9619,Wire-Guided Localization;Segmental Mastectomy,0.9584
lomustine,Lomustine,1,2,Lomustine,1.0000,Carmustine,0.9606,Fotemustine,0.9463,Melphalan,0.9269,Venetoclax,0.9132
lumpectomy right breast (breast cancer),Lumpectomy;Right Breast,1,2,Lumpectomy;Right Breast,0.9893,Left;Lumpectomy,0.9724,Lumpectomy,0.9649,Radiation Therapy;Right Breast,0.9500,Left;Biopsy of Breast,0.9483
lung resection,Lung;Resection,1,2,Lung;Resection,0.9891,Resection,0.9645,Resection;Pulmonary;Metastasis,0.9481,Lobectomy,0.9473,Surgical Margin;Resection,0.9364
lymph node dissection,Lymphadenectomy,3,2,Axillary Lymph Node Dissection,0.9720,Left;Axillary Lymph Node Dissection,0.9553,Lymphadenectomy,0.9549,Bilateral Pelvic Lymph Node Dissection,0.9534,Axillary Lymph Node Biopsy,0.9386
lymph node left axillary lymph node excision,Left;Axillary Lymph Node Dissection,1,2,Left;Axillary Lymph Node Dissection,0.9770,Axillary Lymph Node Dissection,0.9667,Axillary Lymph Node Biopsy,0.9587,Axillary Lymph Node;Right,0.9542,Left Breast;Re-Excision,0.9450
lymphadenectomy,Lymphadenectomy,1,2,Lymphadenectomy,1.0000,Pelvic Lymphadenectomy,0.9590,Sentinel Lymph Node;Lymphadenectomy,0.9542,Bilateral;Pelvic Lymphadenectomy,0.9473,Extend;Pelvic Lymphadenectomy,0.9412
mEK162,Binimetinib,99,2,Mitogen-Activated Protein Kinase Kinase Inhibitor,0.9198,mTOR Kinase Inhibitor AZD8055,0.9155,Akt Inhibitor MK2206,0.9083,Axitinib,0.9073,Sunitinib Malate,0.9046
mek162,Binimetinib,99,2,Mitogen-Activated Protein Kinase Kinase Inhibitor,0.9198,mTOR Kinase Inhibitor AZD8055,0.9155,Akt Inhibitor MK2206,0.9083,Axitinib,0.9073,Sunitinib Malate,0.9046
melphalan,Melphalan,1,2,Melphalan,1.0000,Lenalidomide,0.9309,Lomustine,0.9269,Liposomal Cytarabine,0.9209,Mycophenolate Mofetil,0.9170
methotrexate,Methotrexate,1,2,Methotrexate,1.0000,Mitomycin,0.9233,Mercaptopurine,0.9197,Mycophenolate Mofetil,0.9183,Mefloquine,0.9169
mitotane,Mitotane,1,2,Mitotane,1.0000,Mitoxantrone,0.9338,Topotecan,0.9056,Coltuximab Ravtansine,0.9032,Memantine,0.9014
mitoxantrone,Mitoxantrone,1,2,Mitoxantrone,1.0000,Mitotane,0.9338,Docetaxel,0.9280,Macitentan,0.9224,Amifostine,0.9216
needle directed right breast biopsy,Wire-Guided Localization;Right Breast;Biopsy;Wire-Guided Localization;Right Breast,1,2,Wire-Guided Localization;Right Breast;Biopsy;Wire-Guided Localization;Right Breast,0.9603,Left;Biopsy of Breast,0.9533,Radiation Therapy;Right Breast,0.9416,Lumpectomy;Right Breast,0.9348,Right Breast;Re-Excision,0.9339
needle localized segmental mastectomy,Wire-Guided Localization;Segmental Mastectomy,3,2,Localized;Segmental Mastectomy,0.9825,Segmental Mastectomy,0.9663,Wire-Guided Localization;Segmental Mastectomy,0.9636,Left;Segmental Mastectomy,0.9580,Right;Segmental Mastectomy,0.9538
nivo,Nivolumab,99,2,Seviteronel,0.8981,Vinorelbine,0.8956,Veliparib,0.8940,Denintuzumab Mafodotin,0.8925,Entospletinib,0.8896
nivolumab,Nivolumab,1,2,Nivolumab,1.0000,Sunitinib,0.9230,Ipilimumab,0.9196,Sorafenib,0.9193,Adalimumab,0.9157
novel agent,Pharmacologic Substance,99,2,mTOR Inhibitor;Immunotherapeutic Agent,0.9184,Apoptotic Pathway-targeting Antineoplastic Agent,0.9175,Immunotherapeutic Agent,0.9162,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9140,Nab-paclitaxel,0.9102
oncovex,Talimogene Laherparepvec,99,2,Oxaliplatin,0.9172,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9163,Capecitabine,0.9123,mTOR Inhibitor;Immunotherapeutic Agent,0.9075,Anthracycline Antineoplastic Antibiotic,0.9066
orthotopic neobladder,Orthotopic;Neobladder,1,2,Orthotopic;Neobladder,0.9830,Neobladder,0.9661,Nephroureterectomy with Cuff of Bladder;Endoscopic Resection,0.9198,Urethrectomy,0.9135,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9104
ovoids,Mini Ovoid Brachytherapy,1,2,Mini Ovoid Brachytherapy,0.9235,Vagina;Implant,0.9008,Vincristine,0.9008,Vinorelbine,0.9001,Vinblastine,0.8990
ox,Oxaliplatin,1,2,Oxaliplatin,0.9094,Buthionine Sulfoximine,0.8976,Olaparib,0.8896,Indoximod,0.8892,Mitoxantrone,0.8888
oxali,Oxaliplatin,1,2,Oxaliplatin,0.9411,Erlotinib,0.9038,Carboplatin,0.9037,Pertuzumab,0.9017,Cisplatin,0.8955
oxaliplatin,Oxaliplatin,1,2,Oxaliplatin,1.0000,Cisplatin,0.9214,Cetuximab,0.9204,Pertuzumab,0.9190,Olaparib,0.9176
paclitaxel,Paclitaxel,1,2,Paclitaxel,1.0000,Nab-paclitaxel,0.9573,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9294,Docetaxel,0.9290,Topotecan,0.9285
pancreatoduodenectomy,Pancreaticoduodenectomy,1,2,Pancreaticoduodenectomy,0.9714,Total Pancreatectomy,0.9556,Distal Pancreatectomy,0.9485,Pylorus-sparing pancreaticoduodenectomy (procedure),0.9419,Uncinate Process of Pancreas;Resection,0.9297
partial left mastectomy,Left;Lumpectomy,99,2,Left;Total Mastectomy,0.9620,Right;Total Mastectomy,0.9518,Right;Partial Nephrectomy,0.9506,Partial Salpingectomy,0.9460,Partial Cystectomy,0.9459
partial mastectomy,Segmental Mastectomy,99,2,Partial Cystectomy,0.9474,Mastectomy,0.9458,Partial Salpingectomy,0.9455,Left;Total Mastectomy,0.9449,Bilateral;Total Mastectomy,0.9424
pelvic lymphadenectomy,Pelvic Lymphadenectomy,1,2,Pelvic Lymphadenectomy,1.0000,Extend;Pelvic Lymphadenectomy,0.9689,Bilateral;Pelvic Lymphadenectomy,0.9667,Bilateral Pelvic Lymph Node Dissection,0.9647,Lymphadenectomy,0.9590
pembrolizumab,Pembrolizumab,1,2,Pembrolizumab,1.0000,Pemetrexed,0.9542,Atezolizumab,0.9404,Monalizumab,0.9211,Mogamulizumab,0.9189
pemetrexed treatment,Pemetrexed,1,2,Pemetrexed,0.9761,Pembrolizumab,0.9415,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9218,Pexidartinib,0.9212,Atezolizumab,0.9181
pertuzumab,Pertuzumab,1,2,Pertuzumab,1.0000,Cetuximab,0.9320,Lapatinib,0.9236,Paclitaxel,0.9217,Gemtuzumab,0.9204
plexifor,Plerixafor,2,2,Pipobroman,0.9079,Plerixafor,0.9064,Vemurafenib,0.9014,Interferon Alpha,0.8987,Seviteronel,0.8982
pouch res.,J-Pouch Coloanal Anastomosis,1,2,J-Pouch Coloanal Anastomosis,0.9007,Re-Excision,0.8956,Pilaralisib,0.8950,Resection,0.8942,Right Breast;Re-Excision,0.8935
pred,Prednisone,99,2,Pravastatin,0.9112,Prexasertib,0.9102,Denintuzumab Mafodotin,0.9063,Durvalumab,0.8991,Decitabine,0.8953
prednisone,Prednisone,1,2,Prednisone,1.0000,Prednisolone,0.9597,Dexamethasone,0.9366,Steroid Therapy,0.9359,Pexidartinib,0.9206
procarbazine,Procarbazine,1,2,Procarbazine,1.0000,Dacarbazine,0.9504,Temozolomide,0.9137,Apalutamide,0.9115,Plerixafor,0.9020
pulse dose rate,Pulsed-Dose Rate Brachytherapy,1,2,Pulsed-Dose Rate Brachytherapy,0.9457,High-Dose Rate Brachytherapy,0.9180,Low-Dose Rate Brachytherapy,0.9127,Prednisone,0.8956,Peginterferon Alfa-2a,0.8918
quizartinib,Quizartinib,1,2,Quizartinib,1.0000,Quizartinib Dihydrochloride,0.9505,Entospletinib,0.9152,Pexidartinib,0.8989,Galunisertib,0.8967
radical cystoprostatectomy,Radical Cystoprostatectomy,1,2,Radical Cystoprostatectomy,1.0000,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9714,Radical Cystectomy,0.9690,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9690,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9614
radical cystoprotatectomy,Radical Cystoprostatectomy,1,2,Radical Cystoprostatectomy,0.9814,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9594,Radical Cystectomy,0.9572,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9569,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9508
radical cytoprostatectomy,Radical Cystoprostatectomy,1,2,Radical Cystoprostatectomy,0.9508,Radical Cystectomy,0.9489,Radical Hysterectomy,0.9418,Radical Trachelectomy,0.9418,Radical Prostatectomy,0.9404
ram,Ramucirumab,1,2,Ramucirumab,0.9381,Lenalidomide,0.9066,Rituximab,0.9063,Retromammary space (body structure);Lymphadenectomy,0.9000,Daratumumab,0.8922
ramucirumab,Ramucirumab,1,2,Ramucirumab,1.0000,Daratumumab,0.9273,Lenalidomide,0.9225,Regorafenib,0.9211,Cobimetinib,0.9199
regorafenib,Regorafenib,1,2,Regorafenib,1.0000,Dabrafenib,0.9358,Regadenoson,0.9288,Vemurafenib,0.9227,Anti-ErbB3 Monoclonal Antibody REGN1400,0.9214
removal of pelvic,Tumor Resection;Pelvis,2,2,Pelvic Lymphadenectomy,0.9524,Tumor Resection;Pelvis,0.9470,Bilateral Pelvic Lymph Node Dissection,0.9410,Bilateral;Pelvic Lymphadenectomy,0.9402,Pelvic Exenteration,0.9380
resection,Resection,1,2,Resection,1.0000,Lung;Resection,0.9652,Surgical Margin;Resection,0.9567,Combination;Resection,0.9550,Bile Duct;Resection,0.9515
retromammary lymph node excision,Retromammary space (body structure);Lymphadenectomy,1,2,Retromammary space (body structure);Lymphadenectomy,0.9443,Re-Excision;Original;Lumpectomy;Surgical Site,0.9389,Axillary Lymph Node Dissection,0.9287,Axillary Lymph Node Biopsy,0.9284,Left Breast;Re-Excision,0.9270
right nephroureterectomy,Right;Nephroureterectomy,1,2,Right;Nephroureterectomy,0.9849,Left;Radical;Nephroureterectomy,0.9765,Right;Radical;Nephroureterectomy;Right;Nephroureterectomy,0.9757,Nephroureterectomy,0.9713,Right;Radical;Nephroureterectomy;Radical Cystectomy;Right;Nephroureterectomy;Radical Cystectomy,0.9707
right segmental mastectomy,Right;Segmental Mastectomy,1,2,Right;Segmental Mastectomy,0.9912,Left;Segmental Mastectomy,0.9819,Segmental Mastectomy,0.9750,Localized;Segmental Mastectomy,0.9686,Re-Excision;Segmental Mastectomy,0.9607
right sentinel lymph node biopsy,Right;Sentinel Lymph Node Biopsy,1,2,Right;Sentinel Lymph Node Biopsy,0.9859,Left;Sentinel Lymph Node Biopsy,0.9776,Sentinel Lymph Node Biopsy,0.9638,Sentinel Lymph Node;Lymphadenectomy;Right;Mammoplasty,0.9627,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9569
right sentinel node biopsy,Right;Sentinel Lymph Node Biopsy,1,2,Right;Sentinel Lymph Node Biopsy,0.9814,Left;Sentinel Lymph Node Biopsy,0.9715,Sentinel Lymph Node;Lymphadenectomy;Right;Mammoplasty,0.9573,Sentinel Lymph Node Biopsy,0.9553,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9481
right total mastectomy,Right;Total Mastectomy,1,2,Right;Total Mastectomy,0.9884,Left;Total Mastectomy,0.9770,Total Mastectomy,0.9672,Bilateral;Total Mastectomy,0.9607,Right Hemihepatectomy,0.9482
rigth axillary lymph node,Axillary Lymph Node;Right,1,2,Axillary Lymph Node;Right,0.9363,Axillary Lymph Node Biopsy,0.9265,Axillary Lymph Node Level I;Axillary Lymph Node Level II;Lymphadenectomy,0.9230,Axillary Lymph Node Dissection,0.9202,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9179
rituximab,Rituximab,1,2,Rituximab,1.0000,Ibrutinib,0.9315,Adalimumab,0.9265,Lenalidomide,0.9248,Bevacizumab,0.9245
robotic cystectomy,Robot-Assisted Surgery;Cystectomy,1,2,Robot-Assisted Surgery;Cystectomy,0.9794,Cystectomy,0.9706,Radical Cystectomy,0.9702,Robot-Assisted Surgery;Radical Cystoprostatectomy,0.9657,Radical Cystoprostatectomy;Robot-Assisted Surgery,0.9633
robotic_HYSTERECTOMY,Robotic Hysterectomy,1,2,Robotic Hysterectomy,0.9926,Hysterectomy,0.9618,Laparoscopic Radical Prostatectomy with Robotics,0.9551,Radical Hysterectomy,0.9477,Robot-Assisted Surgery;Laparoscopy;Radical Cystoprostatectomy,0.9434
segmental mastectomy,Segmental Mastectomy,1,2,Segmental Mastectomy,1.0000,Localized;Segmental Mastectomy,0.9818,Left;Segmental Mastectomy,0.9789,Right;Segmental Mastectomy,0.9760,Re-Excision;Segmental Mastectomy,0.9672
sentinel axillary lymph node biopsy,Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Biopsy,3,2,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9924,Sentinel Lymph Node Biopsy,0.9894,Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Biopsy,0.9830,Axillary Lymph Node Biopsy,0.9742,Left;Sentinel Lymph Node Biopsy,0.9691
sentinel lymoh node biopsy,Sentinel Lymph Node Biopsy,1,2,Sentinel Lymph Node Biopsy,0.9735,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9597,Sentinel Lymph Node;Lymphadenectomy,0.9585,Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Biopsy,0.9554,Left;Sentinel Lymph Node Biopsy,0.9548
sentinel lymph node,Sentinel Lymph Node Biopsy,1,2,Sentinel Lymph Node Biopsy,0.9815,Sentinel Lymph Node;Lymphadenectomy,0.9814,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9737,Left;Sentinel Lymph Node Biopsy,0.9645,Right;Sentinel Lymph Node Biopsy,0.9636
sentinel lymph node biopsy,Sentinel Lymph Node Biopsy,1,2,Sentinel Lymph Node Biopsy,1.0000,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9823,Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Biopsy,0.9764,Left;Sentinel Lymph Node Biopsy,0.9750,Right;Sentinel Lymph Node Biopsy,0.9737
sentinel lymph node dissection,Sentinel Lymph Node;Lymphadenectomy,2,2,Sentinel Lymph Node Biopsy,0.9754,Sentinel Lymph Node;Lymphadenectomy,0.9749,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9641,Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Biopsy,0.9613,Left;Sentinel Lymph Node Biopsy,0.9594
sentinel lymph node dissection right reconstruction,Sentinel Lymph Node;Lymphadenectomy;Right;Mammoplasty,1,2,Sentinel Lymph Node;Lymphadenectomy;Right;Mammoplasty,0.9641,Right;Sentinel Lymph Node Biopsy,0.9614,Left;Sentinel Lymph Node Biopsy,0.9524,Sentinel Lymph Node;Lymphadenectomy,0.9479,Left;Axillary Lymph Node Dissection,0.9427
sentinel lymph node excision,Sentinel Lymph Node;Lymphadenectomy,2,2,Sentinel Lymph Node Biopsy,0.9745,Sentinel Lymph Node;Lymphadenectomy,0.9676,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9622,Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Biopsy,0.9572,Left;Sentinel Lymph Node Biopsy,0.9557
sentinel node biopsy,Sentinel Lymph Node Biopsy,1,2,Sentinel Lymph Node Biopsy,0.9952,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9772,Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Biopsy,0.9705,Left;Sentinel Lymph Node Biopsy,0.9694,Right;Sentinel Lymph Node Biopsy,0.9692
sentinel node dissection,Sentinel Lymph Node;Lymphadenectomy,2,2,Sentinel Lymph Node Biopsy,0.9703,Sentinel Lymph Node;Lymphadenectomy,0.9698,Axillary Lymph Node;Sentinel Lymph Node Biopsy,0.9580,Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Biopsy,0.9547,Left;Sentinel Lymph Node Biopsy,0.9527
sib Allo,Sibling;Allogeneic Hematopoietic Stem Cell Transplantation,1,2,Sibling;Allogeneic Hematopoietic Stem Cell Transplantation,0.9222,Matched Unrelated Donor;Allogeneic Hematopoietic Stem Cell Transplantation,0.9099,Anti-HGF Monoclonal Antibody TAK-701,0.9017,Autologous Hematopoietic Stem Cell Transplantation,0.9002,Sabatolimab,0.8997
simple mastectomy,Total Mastectomy,5,2,Mastectomy,0.9547,Bilateral;Skin-Sparing Mastectomy,0.9410,Modified Radical Mastectomy,0.9302,Bilateral Mastectomy,0.9288,Total Mastectomy,0.9285
sorafenib,Sorafenib,1,2,Sorafenib,1.0000,Sunitinib,0.9370,Imatinib,0.9307,Sunitinib Malate,0.9302,Lapatinib,0.9284
splenectomy,Splenectomy,1,2,Splenectomy,1.0000,Nephrectomy,0.9288,Hepatectomy,0.9275,Pylorus-sparing pancreaticoduodenectomy (procedure),0.9251,Lymphadenectomy,0.9220
stem cell transplant,Hematopoietic Cell Transplantation,2,2,Autologous Hematopoietic Stem Cell Transplantation,0.9507,Hematopoietic Cell Transplantation,0.9497,Bone Marrow Transplantation,0.9407,Sibling;Allogeneic Hematopoietic Stem Cell Transplantation,0.9399,Matched Unrelated Donor;Allogeneic Hematopoietic Stem Cell Transplantation,0.9281
steroids,Steroid Therapy,1,2,Steroid Therapy,0.9663,Prednisone,0.9398,Prednisolone,0.9383,Dexamethasone,0.9321,Sirolimus,0.9197
study drug,Pharmacologic Substance,99,2,Dual IGF-1R/InsR Inhibitor BMS-754807,0.9213,AALL0232 ALL Study Identifier;Dexamethasone,0.9179,PSMA-targeting Agent;Antineoplastic Antibody-Drug Conjugate,0.9146,Anti-CD33 Antibody-drug Conjugate IMGN779,0.9124,Anti-CD33 Monoclonal Antibody BI 836858,0.9116
surgical resection,Resection,1,2,Resection,0.9826,Surgical Margin;Resection,0.9650,Lung;Resection,0.9567,Surgical Procedure,0.9465,Vulva;Resection,0.9460
tamoxifen,Tamoxifen,1,2,Tamoxifen,1.0000,Trastuzumab,0.9327,Tamibarotene,0.9307,Letrozole,0.9288,Fulvestrant,0.9234
taxol,Paclitaxel,1,2,Paclitaxel,0.9473,Docetaxel,0.9427,Nab-paclitaxel,0.9276,Topotecan,0.9255,Tamoxifen,0.9180
tem,Temozolomide,99,2,Temsirolimus,0.9302,Topotecan,0.8986,Gemtuzumab,0.8960,Tamoxifen,0.8915,Tasadenoturev,0.8898
temodar,Temozolomide,99,2,Temsirolimus,0.9087,Topotecan,0.8890,Valspodar,0.8844,Doxorubicin,0.8826,Mitoxantrone,0.8809
temozolomide,Temozolomide,1,2,Temozolomide,1.0000,Ipilimumab,0.9278,Capecitabine,0.9240,Sorafenib,0.9235,Azathioprine,0.9216
tissue reconstruction,Tissue Flap Breast Reconstruction,1,2,Tissue Flap Breast Reconstruction,0.9612,Tissue Expander-Implant Breast Reconstruction;Bilateral,0.9224,Anastomosis,0.9097,Resection,0.9060,Transurethral Resection,0.9055
topotecan,Topotecan,1,2,Topotecan,1.0000,Temsirolimus,0.9347,Paclitaxel,0.9285,Topoisomerase-I Inhibitor,0.9245,Tamoxifen,0.9223
total hip arthroplasty,Total;Hip Replacement;Total,1,2,Total;Hip Replacement;Total,0.9742,Total Hysterectomy,0.9421,Total Abdominal Hysterectomy,0.9358,Total Hepatectomy,0.9336,Total Mastectomy,0.9254
total mastectomy,Total Mastectomy,1,2,Total Mastectomy,1.0000,Left;Total Mastectomy,0.9709,Bilateral;Total Mastectomy,0.9700,Right;Total Mastectomy,0.9699,Total Hysterectomy,0.9589
transplant,Graft,5,2,Bone Marrow Transplantation,0.9354,Hematopoietic Cell Transplantation,0.9271,Autologous Hematopoietic Stem Cell Transplantation,0.9125,Sibling;Allogeneic Hematopoietic Stem Cell Transplantation,0.9091,Graft,0.9082
tras,Trastuzumab,2,2,Chimeric Antigen Receptor T-Cell Therapy,0.9060,Trastuzumab,0.9032,Chimeric Antigen Receptor T-Cell Therapy;Therapeutic Apheresis,0.9019,Tamibarotene,0.8995,Anti-TIM-3 Monoclonal Antibody,0.8983
trastuzumab,Trastuzumab,1,2,Trastuzumab,1.0000,Trastuzumab Emtansine,0.9543,Lapatinib,0.9351,Tamoxifen,0.9327,Daratumumab,0.9327
vaccine,Vaccine,1,2,Vaccine,1.0000,Dendritic Cell Vaccine,0.9337,Heat-Treated Varicella-Zoster Virus Vaccine V212,0.9217,Bacillus Calmette-Guerin Antigen,0.9162,Immunotherapeutic Agent,0.9141
vaginal implant,Vagina;Implant,1,2,Vagina;Implant,0.9761,Aromatase Inhibitor,0.9166,Mini Ovoid Brachytherapy,0.9101,Tissue Expander-Implant Breast Reconstruction;Bilateral,0.9093,Fulvestrant,0.9067
vem,Vemurafenib,1,2,Vemurafenib,0.9539,Vorinostat,0.9296,Volasertib,0.9245,Ipilimumab,0.9214,Seviteronel,0.9144
vemurafenib,Vemurafenib,1,2,Vemurafenib,1.0000,Dabrafenib,0.9393,Ipilimumab,0.9231,Regorafenib,0.9227,Vorinostat,0.9218
vinblastine,Vinblastine,1,2,Vinblastine,1.0000,Vinorelbine,0.9590,Vincristine,0.9390,Bortezomib,0.9247,Brentuximab Vedotin,0.9226
vincrisinte,Vincristine,1,2,Vincristine,0.9310,Vincristine Sulfate,0.9207,Vinblastine,0.9123,Vinorelbine,0.9120,Vorinostat,0.9120
vincristine,Vincristine,1,2,Vincristine,1.0000,Vincristine Sulfate,0.9550,Vinorelbine,0.9401,Vinblastine,0.9390,Bortezomib,0.9195
vincristine sulfate,Vincristine Sulfate,1,2,Vincristine Sulfate,1.0000,Vincristine,0.9550,Vinorelbine,0.9231,Vinblastine,0.9186,Valspodar,0.9185
wide local excision,Wide Local Excision,1,2,Wide Local Excision,1.0000,Wide Skin Excision,0.9816,Local excision (procedure),0.9496,Wide;Re-Excision;Biopsy,0.9451,Skin Excision,0.9299
wire localization,Wire-Guided Localization,1,2,Wire-Guided Localization,0.9811,Wire-Guided Localization;Right Breast;Biopsy;Wire-Guided Localization;Right Breast,0.9531,Excision;Wire-Guided Localization,0.9521,Wire-Guided Localization;Segmental Mastectomy,0.9439,Localized;Segmental Mastectomy,0.8816
xeloda,Capecitabine,99,2,Selinexor,0.9151,Pexidartinib,0.9012,Atezolizumab,0.8989,Cixutumumab,0.8973,Ruxolitinib,0.8954
